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Exercise induced muscle damage (EIMD) is a consequence of lengthening muscle 
actions, with the amount of strain placed on the muscle a key determinant of the 
magnitude of damage experienced. When exposed to lengthening muscle actions, 
skeletal muscle rapidly adapts so that when the same exercise is repeated, these 
markers of EIMD are attenuated, with this adaptation termed the repeated bout effect 
(RBE). Changes in muscle lengthening and increases in tendon compliance between 
exercise sessions have been hypothesised to be a mechanism underpinning the RBE, 
but this currently remains unclear. Moreover, muscle and tendon behaviour between 
two bouts of muscle damaging exercise has yet to be investigated in a female 
population. Therefore, the aim of this was to use US to further understand the 
properties and behaviour of the patella tendon (PT) and vastus lateralis (VL) in males 
and females and how these properties contribute to the EIMD response to ECC 
exercise and the magnitude of the repeated bout effect.  In chapter 3, measures of PT 
cross sectional area (CSA) using ultrasonography were validated against magnetic 
resonance imaging. Additionally, the test-retest reliability of these measures were 
tested between two independent US operators. Measures of PT CSA were found to be 
valid and reliable and could be used interchangeably. Moreover, inter- and intra rater 
reliability was deemed excellent. In chapter 4, procedures for using ultrasonography 
to assess VL and PT behaviour at rest and during maximal exercise was shown to have 
excellent test-retest reliability, which did not differ between males and females. 
Finally, in chapter 5, it was found that VL muscle fascicle lengthening was 
approximately 7.6% lower following a repeated bout of lengthening exercise, and this 
was coupled with an attenuated EIMD response following the second bout.  
Additionally, this response did not differ between males, females using an oral 
contraceptive pill and eumenorrheic females. This work extends the understanding of 
muscle and tendon behaviour during repeated bouts of damaging lengthening 
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Exercise induced muscle damage (EIMD) of varying magnitudes will be experienced 
by most people at some point in their life, and likely on several occasions. EIMD is 
generally a consequence of movements the individual is unaccustomed to (Clarkson 
and Hubal, 2002) and produces a number of symptoms, most commonly, feelings of 
muscle soreness, although this does not always reflect the amount of damage that has 
occurred due to a lack of correlation between muscle soreness and other markers of 
EIMD (Nosaka et al., 2002). The types of movements most likely to induce EIMD 
involve muscle actions that require a large eccentric (ECC) component, which occur 
when the momentary force produced by the muscle is itself less than the force being 
applied to the muscle, which results in the forced lengthening of the muscle-tendon 
unit (MTU) (Lindstedt et al., 2002). In comparison to other types of contractions, ECC 
contractions consistently result in the most severe symptoms of EIMD (Hody et al., 
2019, Newham et al., 1986). These symptoms can be quantified and measured to give 
an indication of the extent of EIMD experienced. These measures are known as 
markers of EIMD, the most invasive of which requires direct sampling of muscle 
tissue using biopsy techniques. Indirect measurements of EIMD are more commonly 
employed, such as the measurement of the impairment of muscle function, muscle 
soreness, swelling, and the leakage of intramuscular proteins into the blood (Warren 
et al., 1999), though this is not an exhaustive list. Several factors might dictate the 
severity of the EIMD experienced by a person. As highlighted earlier, contraction type 
is one factor but other determinants of EIMD magnitude include the speed and force 
of the contraction, the volume of exercise performed and which limb is exercised 
(Hyldahl et al., 2017, Chen et al., 2019).  
3 
 
An additional determinant of EIMD is the length of which muscle contracts 
eccentrically, where exercise at longer muscle lengths typically results in higher levels 
of damage than exercise at shorter muscle lengths (Nosaka et al., 2005a). Eccentric 
exercise at longer muscle lengths expose the muscle fibres to a high level of strain, 
which can result in EIMD (Lieber and Friden, 1993, Hoffman et al., 2014). Levels of 
strain can be measured in human skeletal muscle by using real-time 2D B-mode 
ultrasonography (US) to track the length of muscle fascicles at rest and during 
movement (Fukunaga et al., 1997, Guilhem et al., 2011, Reeves and Narici, 2003). 
Indeed, using this technique, the amount that a muscle fascicle lengthens during ECC 
exercise has been shown to correlate with markers of EIMD in the plantar flexors 
(Guilhem et al., 2016) and knee extensors (Hicks et al., 2017). However, the muscle 
fascicle is part of the MTU and therefore the role of the tendon must be considered 
when assessing muscle behaviour. The behaviour of both the tendon and the muscle 
fascicle can be measured independently during contractions (Fukunaga et al., 1997, 
Reeves and Narici, 2003) and research has shown that the behaviour of the tendon can 
indeed mediate the behaviour of the muscle fascicle, as more compliant tendons have 
led to reduced muscle fascicle lengthening in the plantar flexors (Guilhem et al., 2016) 
and knee extensors (Hicks et al., 2013). The increased use of US is uncovering more 
evidence to suggest that MTU behaviour is intrinsically linked to the magnitude of 
EIMD following ECC exercise. As with any measurement tool, the reliability and 
validity of US is dependent on a number of factors, notably, scanning technique, user 
experience and the standardisation of the scanning protocol (Van Hooren et al., 2020, 
McAuliffe et al., 2017). Therefore, when assessing MTU behaviour using US, the 
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accuracy of the measurement tool must be established, particularly when repeated 
measures are used.   
A remarkable feature of skeletal muscle is its ability to regenerate and adapt to muscle 
damaging exercise, so much so that when the same exercise is repeated in the days 
and weeks after the first exercise, muscles generally do not succumb to the same 
magnitude of damage. This adaptation is known as the repeated bout effect (RBE) 
(Nosaka and Clarkson, 1995) and is a key theme in this thesis. Several theories have 
attempted to explain this adaptation that occurs between two bouts of damaging 
exercise, including neuromuscular adaptations, a modified inflammatory response, 
extracellular matrix (ECM) remodelling and changes in the behaviour of the MTU 
(McHugh et al., 1999a, McHugh, 2003, Hyldahl et al., 2017). Changes in MTU 
behaviour between bouts of ECC exercise have been evidenced in recent years. 
Specifically, (Lau et al., 2015) found that there was a decrease in the amount of 
displacement of the muscle-tendon junction (MTJ) during the second bout of ECC 
exercise in the elbow flexors. Additionally, Penailillo et al. (2015) found that muscle 
fascicle lengthening was reduced in the vastus lateralis during a repeat bout of ECC 
cycling exercise. Both Lau et al. (2015) and Penailillo et al. (2015) reported a reduction 
in some, but not all,  EIMD markers after the second bout of exercise and indicated 
that a change in tendon compliance might be the mechanistic driver behind the change 
in MTU behaviour, though neither study measured this. As mentioned earlier, MTU 
behaviour, particularly muscle fascicle lengthening, can influence the amount of 
EIMD suffered after a bout of ECC exercise (Hicks et al., 2017, Guilhem et al., 2016). 
Therefore, it would seem that if muscle fascicle lengthening is reduced upon exposure 
to a repeated bout of exercise, and a lower magnitude of EIMD is reported, the 
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behaviour of the MTU might mediate the RBE, though no study has measured both 
muscle and tendon behaviour independently over the two bouts of exercise. 
Finally, there is evidence to suggest that variation in the magnitude of EIMD 
experienced differs between males and females (Wolf et al., 2012, Minahan et al., 
2015, Joyce et al., 2014). A proposed explanation for this is the membrane stabilising 
effect that oestrogen might have (Tiidus, 2005, Kendall and Eston, 2002), as evidenced 
by lower levels of intramuscular proteins circulating in the blood in females, compared 
to males (Joyce et al., 2014, Enns and Tiidus, 2010). Another reported difference 
between males and females is the greater tendon compliance found in females 
(Onambele et al., 2007, Hansen and Kjaer, 2014) which can result in lower muscle 
fascicle lengthening over the same range of motion during ECC exercise (Hicks et al., 
2013). This greater tendon compliance is thought to be due to the direct action of 
oestrogen on the tendon (Hansen and Kjaer, 2016), although oestrogen fluctuations 
across the menstrual cycle do not alter tendon compliance in the short term (Burgess 
et al., 2010). The use of oral contraceptive pill (OCP) supresses oestrogen 
concentrations throughout the menstrual cycle (van Heusden and Fauser, 2002, Elliott-
Sale et al., 2013) leading to OCP using females reporting low oestrogen levels in 
comparison to eumenorrheic females (Bryant et al., 2008). Moreover, as oestrogen can 
directly act on tendinous tissues and might increase compliance (Hansen and Kjaer, 
2016), the suppression of oestrogen in OCP using females might affect this action of 
oestrogen on tendons. However, there is mixed evidence for (Bryant et al., 2008) and 
against (Hansen et al., 2013, Burgess et al., 2009) differences in tendon properties 
between OCP using and eumenorrheic females. Nevertheless, given the relationship 
between MTU behaviour, EIMD and the RBE, there is precedent to further explore 
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the role that sex and OCP use might have in this area. Therefore, the aim of this thesis 
is to use US to determine if adaptations in the behaviour and properties of the vastus 
lateralis MTU influences the degree of EIMD and the protective effect conferred by 
a repeated bout of ECC exercise, and whether this differs between males, OCP using 
females, and eumenorrheic females.
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The objective of this literature review is to highlight the pertinent research that has led 
to the aims of each individual experimental chapter in this thesis, and the wider thesis 
as whole. The review begins with an overview of skeletal muscle structure and 
function, followed by a description of EIMD and regeneration, including how EIMD 
is measured and the potential determinants. The review then progresses to discuss the 
RBE and the mechanisms underpinning the phenomenon. The review finishes by 
summarising the evidence from studies that explore a potential sex difference in the 
EIMD and RBE response, with a focus on the role of reproductive hormones on 
skeletal muscle and tendon function. The collated evidence aims to provide a rationale 
for exploring the responses of the muscle tendon unit to repeat bouts of maximal 
eccentric exercise in males and females.  
2-2 SKELETAL MUSCLE 
Skeletal muscle is a highly organised structure of proteins accounting for 
approximately 40-45% of body mass (Snow, 2003), responsible for the production of 
joint movement and force exertion. Figure 2-1 illustrates the structure of the whole 
muscle to the myofibril, as currently accepted. 
2-2.1 Skeletal Muscle Structure 
A skeletal muscle consists of hundreds of muscle fibres arranged into bundles called 
fascicles (Jones et al., 2004). Each muscle fibre is surrounded by a selectively 
permeable membrane named the sarcolemma, which consists of a soluble layer of lipid 
molecules, predominantly phospholipids, with membrane proteins embedded within it 
(Widmaier et al., 2004). The sarcolemma encapsulates the water-based internal 
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environment of the muscle fibre termed the sarcoplasm, which hosts ions, enzymes, 
















Figure 2-1 Structure and organisation of skeletal muscle (Tortora, 2017). 
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Each muscle fibre is made up of thousands of myofibrils, 1-2 µm diameter structures, 
which contain the contractile proteins that are responsible for force production 
(Woledge et al., 1985). Surrounding each myofibril is the internal system known as 
the sarcoplasmic reticulum (SR) which contains a highly concentrated store of CA2+, 
contained in lateral sacs (McComas, 1996). The main function of the SR is to control 
the movement of CA2+ across the sarcolemma, to allow muscle contraction and 
relaxation to occur. 
Myofibrils consist of hundreds of repeating units called sarcomeres, which contain the 
contractile proteins actin and myosin (Huxley, 1957), collectively constituting 
approximately 80% of skeletal muscle mass (Jones et al., 2004). The arrangement of 
these filaments is pictorially represented in Figure 2-1. Actin and myosin interact to 
produce the sliding of the filaments, with the actin bound proteins, tropomyosin and 
troponin, providing a controlling function (Woledge et al., 1985). The individual actin 
filaments are fixed in place to the Z-line by α-actinin, positioning them at the end of 
each sarcomere. The thick filaments, mainly consisting of myosin, are located in the 
middle of the sarcomere and joined to adjacent thick filaments by transverse 
connective tissue at the M-line. At the Z-line, thick filaments are attached via an elastic 
link provided by the spring like, giant structural protein, titin.  
Figure 2-1 displays that titin connects to both the M-line and the Z-line, however only 
the I-band region of titin is functionally extensible via two, structurally distinct 
segments (Horowits and Podolsky, 1987). The first is the immunoglobulin (Ig)-like 
regions, arranged in tandem and located at the proximal and distal regions of the I-
band. The second is the PEVK region, consisting of the four amino acids proline (P), 
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glutamate (E), valine (V) and lysine (K) (Labeit and Kolmerer, 1995). When exposed 
to stretch, the Ig-like segments lengthen first, followed by the PEVK regions, with the 
latter becoming the primary force-producing element (Trombitas et al., 1998). A 
second, large structural protein named nebulin contributes to the structural integrity to 
the sarcomere by strengthening the actin filaments (Jones et al., 2004).  
A series of other cytoskeleton proteins including α-actinin, vinculin, talin, β1 integrins 
and desmin (Patel and Lieber, 1997), form what is termed the costamere, which align 
circumferentially with the Z-disks in striated muscle, coupling the sarcolemma to the 
force generating sarcomeres (Ervasti, 2003). In addition to contributing to the 
structural integrity of the myofiber, costameres might function to laterally transmit 
force to adjacent muscle fibres, maintaining consistent sarcomere lengths between 
contracting and relaxing muscle cells (Street, 1983, Danowski et al., 1992, Craig and 
Pardo, 1983). Finally, in addition to the contributing to costamere formation, desmin 
is a major component of intermediate filaments that act as a mechanical stabiliser of 
the myofiber (Lazarides, 1980), which acts to limit extreme sarcomere lengths (Wang 
and Ramirez-Mitchell, 1983). For optimal muscle function to occur, the integrity of 
these structural proteins must be intact. Therefore, the loss or damage of one or more 
of these proteins can lead to impaired muscle performance, such that is seen as a result 
of EIMD. 
2-3 SKELETAL MUSCLE FUNCTION 
2-3.1 Sliding filament theory 
The theory that the thick and thin, myosin and actin filaments in skeletal muscle ‘slide’ 
over each other to produce force was developed in the early 1950’s and termed the 
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‘sliding filament theory’ (Huxley, 1957). This was evidenced using light (Huxley and 
Hanson, 1954, Huxley and Niedergerke, 1954) and electron (Page and Huxley 1963) 
microscopy that showed that the length of the individual filaments did not change, 
despite the shortening of the muscle fibre. It is widely accepted that the sliding 
movement of the filaments is produced via the formation of cross-bridges between the 
actin filament and the myosin head (Woledge et al., 1985). Although cross-bridge 
kinetics are beyond the scope of this thesis, in brief, actin, myosin and adenosine 
triphosphate (ATP) interact to produce cross-bridge movement and subsequent force 
production, with the requirement of ATP hydrolysis to detach the cross-bridge and 
repeat the cyclical process (Huxley and Simmons, 1971, Huxley, 1957). One 
observation of the cross-bridge theory is that the ATP cost for lengthening (eccentric) 
muscle actions is lower than that for constant-length (isometric) and shortening 
(concentric) muscle actions (Abbott et al., 1952), which will be discussed further in 
section 2-3.3. 
Cross-bridges occur via a sequence of events termed excitation-contraction (E-C) 
coupling, which is initiated via a signal form the central nervous system that stimulates 
the muscle. This sequence of events involves (1) the initiation and propagation of an 
action potential along the sarcolemma, (2) The spread of the potential along the 
transverse-tubule system, (3) dihydropyridine receptors (DHPR)-mediated detection 
of changes in membrane potential, (4) interaction of DHPR with ryanodine receptors 
in the SR, (5) release of  Ca2+ from the SR and transient increase of Ca2+ in the 
sarcoplasm, (6) Ca2+ interacts with troponin-tropomyosin complex, removing the 
inhibitory effect of troponin I and tropomyosin, allowing the actin-myosin interaction 
to occur and the thin filaments to slide over the thick ones, thus producing tension, 
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followed by (7) the reuptake of Ca2+ from sarcoplasm, mainly by the reuptake by the 
SR through the SR Ca2+ adenosine triphosphatase, leading to the removal of tension 
and allowing for subsequent muscle relaxation (Sandow, 1965, Fill and Copello, 2002, 
Calderon et al., 2014). In healthy, undamaged muscle, this process will repeat until 
there is no longer a requirement for contraction. However, damage to one  or more 
elements of the muscle contraction process could impair the ability of the muscle to 
contract and produce force. It is therefore important to understand the effect that 
damaging exercise can have on the muscle contraction process and this is discussed in 
section 2.4. 
2-3.2 Length-tension relationship 
The force produced by muscle fibres is widely accepted to be proportionate to the 
length of the sarcomere and the degree of actin and myosin overlap (Gordon et al., 
1966). This is known as the length-tension (LT) relationship and is demonstrated in 
Figure 2-2. However, it must be noted that the model by Gordon et al., (1966) is based 
on isolated muscle and in vivo, the skeletal muscle length-tension relationship 
typically operates in a narrower range, and can be affected by changes in passive 
tension throughout the contraction (Hoffman et al., 2014). This will be discussed in 














Figure 2-2 Gordon’s length-tension relationship (Gordon et al., 1966). 
 
In Figure 2-2 at point C, the maximum amount of tension is produced due to maximum 
myosin-actin filament overlap, with tension plateauing between points B and C, due 
to no cross-bridge sites being added. At point D (short sarcomere lengths) the thick 
filaments collide with the Z-disks and tension decreases rapidly. At this point, Gordon 
et al., (1966) stated that tension is also reduced at short sarcomere lengths due to the 
thin filaments interfering with one another. At lengths beyond point B (lengthening 
actions), there is a linear reduction in tension. On this descending limb o f the LT 
relationship, the sliding filament theory cannot explain the amount of tension produced 
at long sarcomere lengths. If the only factor determining the LT relationship was the 
number of cross-bridges formed, the LT curve would be U-shaped, with tension equal 
to cross-bridge formation either side of the plateau (points B to C). Herzog (2014) 
proposed that the passive force produced by titin during sarcomere lengthening can 
account for the slower decline in tension on the LT curve.   
In the original LT relationship study, Gordon et al. (1966) was unable to achieve a 
steady force state at maximum tension at a given sarcomere length, known as the 
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“creep” phase of contraction. The authors therefore used force extrapolation before 
reaching maximum tension to avoid the creep phase and provided the LT relationship 
described in Figure 2-2, with several other studies showing a similar response using 
this method (Granzier and Pollack, 1990, Edman and Reggiani, 1987, Bagni et al., 
1988). These studies, in addition to using extrapolated forces, allowed sarcomeres to 
shorten freely. Several other studies that measured maximal forces whilst clamping a 
portion of the sarcomeres produced contrasting results, which can be seen in Figure 2-
3 (Terkeurs et al., 1978, Martyn and Gordon, 1988, Fabiato and Fabiato, 1978, Endo, 







Figure 2-3 Length tension relationship without (b) and with (a) sarcomere length clamping. 
Adapted from Pollack (1983). 
These studies found that there was little force variation between maximum thick/thin 
filament overlap and 50% overlap, and forces of ~20% at sarcomere lengths of 3.8 µm 
- 4.0 µm, where no force should be produced according to the LT relationship reported 





clamping, can been attributed to sarcomere length non-uniformity which develops 
when fibres lengthen after they have been allowed to shorten first (Rassier, 2017). This 
theory is supported by evidence showing that proximal sarcomeres in the fibre shorten 
during contractions at long muscle lengths, whilst more central sarcomeres lengthen 
(Edman and Reggiani, 1987, Edman and Reggiani, 1984). The forces produced by the 
fibre will be closer to isometric strength of the shorter and stronger sarcomeres, rather 
than the longer sarcomeres, due to the elongating side of the force-velocity curve being 
steeper than the shortening side (Morgan et al., 1982, Morgan et al., 1991). This could 
mean that the lengthened (weaker) sarcomeres could be vulnerable to “popping” on 
the descending limb of the LT curve, as suggested by Morgan (1990), however there 
is evidence to suggest that sarcomeres are stable at different lengths of the LT 
descending limb. Specifically, following the active stretching of single myofibrils onto 
the descending limb of the LT curve, Rassier et al. (2003) reported that the anticipated 
over-stretching of the actin-myosin overlap did not occur, and that sarcomeres were 
stable at all recorded lengths of the LT curve. Given the mixture of evidence of 
sarcomere stability at different lengths, a comprehensive and satisfactory explanation 
for the observation of increased force on the descending limb of the LT relationship is 
still needed. 
Several other factors can affect the LT relationship. For example, lower muscle 
activation produces maximal force generation at longer muscle lengths (Stephenson 
and Wendt, 1984, Rack and Westbury, 1969, Close, 1972, Balnave and Allen, 1996), 
attributed to a length dependence of calcium sensitivity (Stephenson and Wendt, 1984, 
Rassier et al., 1999). The LT relationship has also been shown to be related to changes 
in myofilament lattice spacing (Fuchs and Smith, 2001, MacIntosh, 2017, Rassier et 
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al., 1999, Williams et al., 2013, Yang et al., 1998), thick and thin filament regulation 
(de Tombe et al., 2010), and the effect of Ca2+ sensitive sarcomeric regulatory proteins 
at the actin-myosin binding site (de Tombe et al., 2010). The LT relationship is an 
extremely important concept to understand in the context of this thesis, as it is part of 
the underlying theory of EIMD. The relevance of the LT relationship to ECC muscle 
action will be discussed in section 2-3.4. 
2-3.3 The in vivo application of the popping sarcomere theory 
The evidence pertaining to the popping sarcomere theory presented in the previous 
section is largely based on single muscle fibre studies in situ or in vitro, and therefore 
cannot be directly extrapolated to in vivo applications. For example, Hoffman et al. 
(2014) found that during backwards downhill walking, gastrocnemius fascicles 
predominantly contracted to the ascending and plateau regions of the LT curve, despite 
losses in iMVC torque following exercise. Previous literature has suggested that the 
role of the tendon in vivo might be responsible for this altered fascicle behaviour 
(Butterfield and Herzog, 2005, Austin et al., 2010), something that single fibre in situ 
and in vitro studies does not account for. This lack of tendon interaction during in vitro 
and in situ studies can result in fascicle lengthening of up to 125% (Lieber & Friden, 
1993) versus in vivo studies, where fascicle lengthening of ~18% in the gastrocnemius 
(Hoffman et al., 2014) and 58% and 40% in the VL for males and females, respectively 
(Hicks et al., 2013), can occur. The popping sarcomere theory remains an important 
and plausible explanation for the early stages of EIMD, however, there is a lack of in 
vivo evidence to support this and therefore the extrapolation of findings from in vitro 
and in situ research should be made with caution. 
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2-3.4 Skeletal muscle actions 
The action of skeletal muscle provides the force required to initiate the movement of 
joints, however not all muscle actions are mechanistically equal. In comparison to 
concentric (CON) or isometric (ISO), ECC muscle actions produce specific 
adaptations that might be explained by the unique features of the ECC action 
(Duchateau and Baudry, 2014, Guilhem et al., 2010). In comparison to CON 
contractions, ECC muscle actions require less motor unit activation and consume less 
oxygen and use less energy at a given force (Abbott et al., 1952), whilst producing 
greater forces for a given angular velocity (Hortobágyi and Katch, 1990). Although 
not fully understood, it is generally well accepted that there are considerably different 
neural strategies for controlling ECC muscle actions, when compared to CON and ISO 
contractions (Duchateau and Baudry, 2014). These differences are evidenced at the 
cortical level, as well as the contracting muscle, with research suggesting that, when 
compared to CON and ISO actions, reduced central activation is present during ECC 
muscle actions, which has implications for fine motor control during eccentric actions 
(Hoppeler and Herzog, 2014). Further unique characteristics of ECC muscle actions 
include a greater cortical excitability but a lower motor unit discharge rate, and a 
greater voluntary deficit compared to CON contractions when assessed using the 
twitch interpolation technique, such that untrained individuals are usually unable to 
fully activate their muscles during maximal eccentric muscle actions (Hoppeler and 
Herzog, 2014). Collectively, the unique qualities of ECC muscle actions that lead to 
increase force production are not well understood, but there are several theories that 
might provide an explanation.  
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The original cross-bridge theory (Huxley, 1957) cannot explain the increased force 
production encountered during ECC muscle actions for several reasons. It is assumed 
that each cross-bridge has the same force-potential and that they are aligned uniformly 
along the myosin filament (Huxley, 1957). The point at which the thick/thin filament 
overlap is equal on the ascending and descending side of the length-tension 
relationship should, according to the cross-bridge theory, produce equal force, 
however this is not the case. Additionally, the cross-bridge theory suggests that the 
hydrolysis of 1 ATP molecule is required for the detachment of the myosin head to 
the actin binding site for CON and ISO contractions (Huxley, 1957). Huxley (1957) 
realised that this energy cost did not fit with ECC muscle actions and suggested that 
multiple cross-bridge sites per ATP molecule might be possible. Other explanations 
for the low energy cost of ECC muscle actions include that energy is dissipated rather 
than produced (Ryschon et al., 1997) and actin and myosin bonds ‘breaking’ 
mechanically rather than requiring ATP hydrolysis (Huxley 1957, Ryschon et al., 
1997), with the latter potentially contributing to the increased amount of EIMD 
experienced following ECC muscle actions. Although there is no one theory that can 
explain the low energy cost of ECC contractions, it is clear that they are unique in 
nature. It has been suggested that structural components within skeletal muscle might 
have an effect on the low energy cost of ECC contractions (Herzog, 2014). This 
interplay between muscle structure and action will be discussed in the next section.  
2-3.5 Kinetics of active muscle lengthening 
An actively lengthened muscle fibre can produce an increased amount of force at a 
given length in comparison to an isometric control, a discovery made by Edman et al., 
(1982) and termed residual force enhancement (RFE), which was later supported by 
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Herzog et al. (2006). Not only did the actively stretched fibre produce more force, it 
was done with a lower amount of ATPase activity in compared to a non-stretched 
fibre, indicating that fibres become more efficient after stretch (Joumaa and Herzog, 
2013), which makes the mechanism behind RFE an excellent fit to explain the unique 
contractile behaviour of ECC muscle actions. Herzog and Leonard (2002) tested this 
hypothesis on the cat soleus muscle and concluded that when actively stretched, 
passive structural elements engaged, producing increased passive force which 
persisted for minutes following activation, but the force enhancement disappeared 
quickly if the muscle was returned to starting length. The engagement of the structural 
protein titin was demonstrated to be responsible for this passive force enhancement. 
This was confirmed when single myofibrils showed the increase in passive force after 
active lengthening but did not show this increase when titin was removed in the 
sarcomeres of the myofibril (Leonard et al., 2010). 
The engagement of titin during muscle action has been proposed to occur in two ways: 
(1) titin binds with calcium upon activation, increasing its inherent stiffness in the 
PEVK (Labeit et al., 2003) and Ig regions (DuVall et al., 2013), and (2) titin can bind 
proximally to actin, thus shortening the active length of its spring (Herzog, 2018), as 
demonstrated in Figure 2-4. Ca2+ binding to titin only accounts for 10-20% of the 
increased force observed during and after ECC muscle action (Leonard and Herzog, 
2010). Using fluorescently labelled titin antibodies, it was observed that in passive 
stretching, both the proximal and distal segments of titin elongated. However, in active 
stretching (presence of Ca2+) there was reduced lengthening of titin in the proximal 
region, whereas the distal region continued to lengthen, with the authors interpreting 
that the proximal region of titin bound with actin, therefore reducing lengthening 
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capacity and increasing stiffness and subsequent force production (DuVall et al., 
2017). Although still in its infancy, this theory of the adaptability of titin could explain 
the higher force producing and more energy efficient attributes of ECC muscle actions 







Figure 2-4 The mechanics of titin in passive (A) and active (B, C) sarcomeres. (A) passive 
stretching elongates the entire I-band region of titin. (B) the presence of calcium in active 
lengthening increases titin’s stiffness. (C) Titin binds to actin upon activation and stretching, 
reducing the free spring length (Herzog, 2018). 
2-4 EXERCISE INDUCED MUSCLE DAMAGE  
Following strenuous exercise, it is common for humans to experience  a range of 
symptoms that include a loss of muscle function, soreness, swelling, a decreased range 
of motion and leakage of muscle proteins into the blood occurring both immediately 
and for up to ~14 days after exercise (Clarkson et al., 1992, Proske and Allen, 2005). 
This collection of symptoms is commonly termed exercise-induced muscle damage. 
Eccentric muscle actions produce significantly higher levels of EIMD in comparison 
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to CON and ISO muscle contractions (Penailillo et al., 2013, Willoughby and Taylor, 
2004), which is thought to  be due to the unique contractile mechanisms of ECC 
muscle actions, as discussed in the previous section, leading to greater amounts of total 
force (or torque), particularly at long muscle lengths (Guilhem et al., 2016, Lieber and 
Friden, 1993, Nosaka et al., 2005a, Penailillo et al., 2013, Penailillo et al., 2015). 
Although other mechanistic properties of ECC muscle actions are thought to be 
involved in the increased levels of EIMD, the greater levels of force during active 
muscle lengthening in comparison to ISO or CON muscle actions, are the primary 
focus of this review.  
Typically, EIMD is characterised by a multitude of symptoms that are present both 
immediately after exercise and can last up to 14 days, depending on the individual’s 
susceptibility to the damaging stimulus (Douglas et al., 2017). Consequences of EIMD 
include a reduction in functional capacity, increased muscle soreness (Proske and 
Morgan, 2001), disturbed sense of force production and limb position (Paschalis et al., 
2010) and reductions in exercise capacity (Marcora and Staiano, 2010). Exercise 
induced muscle damage can be identified via observations of direct adjustments in the 
muscle apparatus, such as sarcomere disruption and EC coupling failure, or via 
indirect adjustments, such as loss of muscle function, soreness, and the presence of 
intramuscular proteins in the blood (Hyldahl and Hubal, 2014, Clarkson and Hubal, 
2002). Armstrong (1990, 1991) proposed that the pathologies associated with EIMD 
occur as part of a four-stage process (1) initial stage, (2) loss of Ca2+ homeostasis / 
autogenic phase, (3) phagocytic phase and (4) regenerative stage. For the purposes of 
this thesis, the four stages promoted by Armstrong (1990) will be combined to describe 
primary and secondary muscle damage. 
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2-4.1 Primary muscle damage 
2-4.1.1 The popping sarcomere theory 
Eccentric muscle actions, as aforementioned, require different neural strategies to 
control muscle force in comparison to CON and ISO actions (Duchateau and Baudry, 
2014). In addition to this, ECC muscle actions have a lower motor unit recruitment for 
a given force in comparison to CON and ISO contractions (McHugh et al., 2000) 
meaning that a smaller number of fibres experience greater mechanical stress (Enoka, 
1996). It is generally well accepted that the initial stage of muscle damage is 
orchestrated by asymmetrical lengthening of sarcomeres, leading to high levels of 
mechanical stress, mechanical overload and subsequent damage. This theory, known 
as the ‘popping sarcomere theory’ (Morgan, 1990) suggests that the weakest 
sarcomeres in the fibre absorb most of the length change over the range of motion, 
beyond the point of myofilament overlap, resulting in a ‘popping’ of the sarcomere 
and an increase in tension on the passive structures.  Upon relaxation, some weakened 
sarcomeres fail to re-interdigitate and become disrupted (Talbot and Morgan, 1996). 
These weaker and disrupted sarcomeres might lead to the shearing of myofibrils, 
leading to a loss of calcium homeostasis and subsequent EIMD, due to the deformation 
of membranes and t-tubules. The contribution of a loss of calcium ion homeostasis to 
EIMD will be discussed further in the next section. Morgan (1990) suggested that as 
a result of fibres failing to re-interdigitate, repeated active lengthening would place 
extra tension on neighbouring sarcomeres, resulting in “tearing” of those sarcomeres. 
This could inevitably result in the amount of fibre disruption increasing as muscle 
actions are repeated (Proske and Allen, 2005). The popping sarcomere theory is 
supported by evidence suggesting that the length of the muscle during ECC muscle 
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action (Talbot and Morgan, 1998, Patel et al., 2004, Lieber and Friden, 1993) and 
number of contractions (Hyldahl and Hubal, 2014), are key factors in determining the 
extent of EIMD following ECC exercise. However, as discussed earlier in section 2-
3.3, the in vivo evidence supporting the popping sarcomere theory is weak and 
therefore its application should be used cautiously. 
2-4.1.2 Failure of the excitation-contraction coupling process 
An alternative theory proposed by Warren et al. (2002) suggests that a failure of the 
E-C coupling process is the primary event initiating EIMD. This theory was originally 
constructed by Warren et al. (1993b) after investigating the use of caffeine to stimulate 
Ca2+ release from mouse muscle fibres. It was found that by triggering the release of 
Ca2+ from the SR, the decrement of force loss following twenty ECC contractions was 
negated (Warren et al., 1993b). Corona et al. (2010) further explored E-C coupling 
failure and EIMD by examining the muscle damage response to fifty ECC contractions 
in mice. Following exercise there was a reduction of tetanic isometric force 
immediately post exercise, day one and day three vs baseline (70.7 ± 1.6, 77.4 ± 3.1 
and 89.2 ± 3.9 vs 111.9 ± 2.5 N·mm-1·kg-1 (P < 0.05), respectively). Corona et al. 
(2010) then compared caffeine contracture and peak tetanic force deficits following 
the ECC exercise and estimated that ~49%, 58% and 45% of the force deficits 
observed at immediately post exercise, day one and day three, respectively, was 
attributable to E-C coupling failure. Moreover, it was then concluded that the E-C 
coupling failure was associated with the reduction of junctophilins 1 (~50% reduction) 
and 2 (35% reduction), which are the primary proteins involved in T-tubule and SR 
membrane apposition (Komazaki et al., 2002, Ito et al., 2001, Takeshima et al., 2000). 
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Although Corona et al. (2010) stated that the role of other triadic proteins require 
further investigation, their evidence suggests that junctophilin damage might account 
for, in part, the early force deficit due to E-C coupling failure.  
The failure of E-C coupling can also be evidenced by the measurement of Low-
frequency fatigue (LFF), which is characterised by reductions in forces at low (10-20 
Hz) compared to higher (50-100 Hz) electromyostimulation frequencies (Jones, 1996, 
Clarkson and Hubal, 2002). It has been suggested that these force losses at low 
stimulation intensities can be attributed to reduced Ca2+ release form the SR, indicating 
E-C coupling impairment (Dundon et al., 2008). Although, Jones (1996) suggested 
that in addition to reductions in Ca2+ release, structural damage to the myofibril might 
contribute to LFF, based on observations of the force-frequency relationship being 
length dependent. Jones (1996) stated that if the popping sarcomere theory was correct 
and the central sarcomeres in the fibre “popped” while the total fibre length remained 
the same (Morgan, 1990), the force-frequency curve following damaging exercise 
would shift to the right, as it would if the muscle was placed in a shorter position. This 
was indeed evidenced by Child et al. (1998), who observed a shift to the right in the 
L-T relationship, with the greatest loss in force evident when tested at the shortest 
muscle length. Nevertheless, the actual contribution of Ca2+ release or myofibril 
structural damage to LFF remains unclear but it remains evident that LFF is due, in 
part, to a deficit in E-C coupling (Muanjai et al., 2020). The theory of E-C coupling 
failure as a mechanism of primary muscle damage, proposed by Warren (1993) has 
been challenged by Proske and Allen (2005), stating that E-C coupling failure was a 
consequence of sarcomere damage, not an initiating event. Although there are 
contrasting arguments to explain the initial events of EIMD, it is generally accepted 
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that ECC muscle action disrupts both the contractile and non-contractile elements and 
the E-C coupling process, suggesting that both mechanisms are likely to contribute to 
the manifestation of EIMD (Hyldahl and Hubal, 2014). Ingalis et al. (1998) stated that 
over the first three days following damaging exercise, 57-75% can be ascribed to the 
impairment of the E-C coupling process, with the remainder attributed to contractile 
apparatus damage in the first one to two days, followed by decreased contractile 
protein content in the days following. Whilst the exact proportion that E-C coupling 
failure plays in the loss of strength following damaging exercise is debatable, it is clear 
that strength loss following ECC exercise is derived from a complex interplay between 
various mechanisms that require further clarification, particularly in human studies.  
2-4.1.3 Metabolic Damage 
Another theory to explain the initial cause of EIMD is the metabolic stress experienced 
during exercise (Tee et al., 2007). Exercise that has involved low levels of ECC muscle 
action but high levels of metabolic stress, such as repeated sprint cycling (Rankin et 
al., 2018),  has reportedly increased markers of EIMD (discussed in detail in section 
2-5), such as increased serum creatine kinase (CK and a reduction in force production, 
although the change in these markers are modest (Saunders et al., 2004, Rankin et al., 
2018) and the mechanism of this result is not well understood. Within the model of 
metabolic stress and EIMD by Tee et al. (2007), there are theories pertaining to EIMD: 
insufficient mitochondrial respiration, the production of reactive oxygen and nitrogen 
species (RONS) and high intramuscular temperatures. These theories are however, 
beyond the scope of this thesis and the interested reader is referred to Tee et al. (2007).  
27 
 
2-4.2 Secondary Muscle damage 
The initial events of EIMD trigger several events that lead to a more severe, secondary 
damage to the muscle. These are categorised into three main processes, (1) The 
disturbance of Ca2+ homeostasis, (2) The inflammatory response to EIMD, and (3) 
Oxidative stress. 
2-4.2.1 – Disturbance of calcium homeostasis 
Following the primary events of EIMD there is uncontrolled movement of Ca2+ into 
the cytoplasm that might cause further damage (Ebbeling and Clarkson, 1989, 
Armstrong, 1984), which is a potential consequence of membrane disruption (Lieber 
and Friden, 2002) or the opening of stretch activated channels (Overgaard et al., 2002). 
This movement results in abnormally high levels of intracellular Ca2+ which can result 
in the degradation of structural proteins, following the activation of Ca2+ dependant 
proteolytic and phospholipase A2 pathways (Gissel and Clausen, 2001, Gissel, 2005). 
Specifically, these proteases, named calpains, are suggested to contribute to EIMD, as 
they are responsible for cleaving the proteins in charge of myofibril integrity (desmin 
and alpha-actinin) (Zhang et al., 2008), with these structural proteins being further 
degraded by other proteolytic pathways such as the ubiquitin -proteasome system 
(Raastad et al., 2010). In addition, increased entry of Ca2+ into the cell might also occur 
as a result of the degradation of membrane components, resulting from the activation 
of calpains (Raastad et al., 2010).  
In a normal intracellular environment, mitochondria help maintain Ca2+ homeostasis 
by excess uptake (Ebbeling and Clarkson, 1989, Gissel, 2005). However, Ca2+ 
overload following EIMD can alter mitochondrial respiration (Rattray et al., 2013) and 
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lead to the permeabilisation of the inner mitochondrial membrane followed by the 
opening of the mitochondrial permeability transition pore (Gissel, 2005). This in turn, 
can cause a large influx of intracellular Ca2+ from the mitochondria, and a further 
increase in calpain proteolytic activity, resulting in mitochondrial dysfunction, 
apoptosis and necrosis (Gissel, 2005). Further consequences of increased intracellular 
Ca2+ include uncontrolled muscle contraction, which might contribute to the increases 
in passive forces observed following EIMD (Proske and Morgan, 2001, Proske and 
Allen, 2005, Allen, 2001). Furthermore, increased calpain activity can promote the 
activation of neutrophils and macrophages, eventually leading to  the production of 
RONS (Powers and Jackson, 2008). The process of secondary muscle damage is 
thought to be predominantly instigated by the aforementioned inflammatory response 
and will be discussed below. 
2-4.2.2 – Inflammatory Response 
The inflammatory response to EIMD is a dynamic, co-ordinated process that is 
necessary to produce adaptive remodelling of muscle tissue and an eventual return to 
homeostasis (Chazaud, 2016). This process is primarily co-ordinated by intracellular 
signalling molecules labelled cytokines (Cannon and St Pierre, 1998). Cytokines 
regulate the inflammatory process, which begins with the accumulation of leukocytes 
(neutrophils, macrophages and t-lymphocytes) in the damaged muscle tissue, 
evidenced by histological observations following muscle damaging exercise in 
humans (Paulsen et al., 2012). Neutrophils are the first leukocyte group to infiltrate 
the damaged tissue, evidenced by elevated circulating neutrophils between 2-12 hours 
following EIMD (Suzuki, 2018, Pizza et al., 1995, Kawanishi et al., 2016). It is 
29 
 
thought that the initial function of neutrophils is a phagocytic action (Chazaud, 2016, 
Butterfield and Herzog, 2006), achieved by the deployment of proteolytic and 
cytotoxic molecules that phagocytose necrotic myofibers and cellular debris (Pizza et 
al., 2005). Neutrophils also secrete a number of pro-inflammatory cytokines, which 
attract an increased number of neutrophils to the damaged tissue via a positive 
feedback loop that magnifies the inflammatory response (Butterfield and Herzog, 
2006). This intensified local immune response can aggravate existing damage and has 
implicated neutrophils in the secondary damage process (Nguyen and Tidball, 2003), 
which has been evidenced by further loss of muscle function in subsequent days 
following EIMD (Toumi and Best, 2003, Howatson and van Someren, 2008), although 
this is not always the case (Warren et al., 2017).  
The second group of leukocytes that play a role in the inflammatory response to EIMD 
are macrophages, which like neutrophils, produce cytotoxic molecules that contribute 
to the degradation of necrotic tissue (Nguyen and Tidball, 2003). However, unlike 
neutrophils, macrophages produce several growth factors that support tissue 
remodelling (Tidball, 2005). In addition, macrophages also have three distinct 
populations (ED1+, ED2+ and ED3+), that are activated sequentially, suggesting 
multiple different functions (Smith et al., 2008, Butterfield and Herzog, 2006). ED1+ 
macrophages appear within damaged muscle fibre within 24 hours of EIMD and have 
phagocytic functions, promoting the removal of damaged tissue (Butterfield and 
Herzog, 2006), and pro-inflammatory functions, via the attraction of additional 
neutrophils, further exacerbating the inflammatory response (Kharraz et al., 2013). 
ED2+ and ED3+ macrophage groups are not thought to be involved in the phagocytic 
stage of the immune response (Smith et al., 2008), but instead might promote tissue 
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regeneration through the promotion of growth factors such as insulin-like growth 
factor, transforming growth factor beta, and fibroblast growth factor, all of which are 
necessary for tissue regeneration and growth (Urso, 2013, Smith et al., 2008). It is 
clear from the available evidence that there is a targeted immune response from 
predominantly neutrophils and macrophages, however the distinct role of each 
leukocyte is unclear and it is likely that the four stage model proposed by Armstrong 
(1990) overlaps at several stages.  
2-4.2.3 – Oxidative Stress 
Intense exercise can produce excess RONS that can shift the metabolic environment 
out of homeostasis into a state of oxidative stress (Nikolaidis et al., 2008, Kohen and 
Nyska, 2002), which can lead to molecular damage and a reduction in redox signalling 
(Sies, 2017). Specifically, intense ECC based muscle damaging protocols have been 
shown to produce a higher amount of RONS than CON or ISO contractions, with 
levels peaking between 24-96 hours (Nikolaidis et al., 2008), most likely due to the 
increased inflammatory response associated with ECC induced EIMD (Nikolaidis et 
al., 2012, Nikolaidis et al., 2008). There is evidence to suggest that this increased 
production of RONS, resulting from ECC muscle actions, might contribute to 
secondary muscle damage, leading to a further increase in muscle soreness (Zerba et 
al., 1990) and an impairment of muscle function (McArdle et al., 1999), albeit this 
evidence is based on animal studies. Nevertheless, it is possible that if RONS remain 
within specific parameters following exercise, an endogenous antioxidant response 
can maintain homeostasis without performance being affected (Mello et al., 2017), 
however this protective mechanism is insufficient if RONS levels are too great and tip 
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the balance into an oxidative state, subsequently compromising exercise performance 
(Powers and Jackson, 2008). Therefore, effective endogenous antioxidant compounds, 
such as nutritional and pharmacological interventions (Howatson and van Someren, 
2008, Owens et al., 2018) might play a role in mediating the potential for RONS to 
elicit secondary muscle damage.  
2-4.3 Regenerative phase 
Skeletal muscle has an excellent regenerative capacity that is evident on a daily basis 
and in response to exercise induced damage (Doyonnas et al., 2004). The process of 
muscle regeneration is a highly co-ordinated process that is dependent on the balance 
between pro-inflammatory and anti-inflammatory factors, that ultimately mediate 
repair (Prisk and Huard, 2003, Mourkioti and Rosenthal, 2005).  
Following EIMD, the repair process is initiated by the subsequent inflammatory 
response that was discussed in section 2-4.2. Following the co-ordinated inflammatory 
response, after the initial stage of injury and the removal of cellular debris, certain 
cytosolic structures and disrupted myofilaments, macrophages also activate 
mononuclear myogenic cells, commonly known as satellite cells, in preparation for 
tissue regeneration (Lescaudron et al., 1999). When not exposed to a stressed 
condition, satellite cells remain quiescent, but once activated, proliferate, and 
differentiate to contribute to the repair of damaged fibres, as well as forming new 
myofibers (Hirata et al., 2003). This process of satellite cell fusion is possible through 
the creation of intracellular junctions, which contribute to the intracellular 
cytoskeleton, through the action of such molecules as M-cadherin and M-Calpain 
(Karalaki et al., 2009). M-cadherin, a calcium dependent intracellular adhesion 
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molecule, is expressed in skeletal muscle cells and myoblasts in response to injury  and 
plays an important role in the fusion of myoblasts into myotubes (Kaufmann et al., 
1999). M-calpain is a nonlysosomal cysteine protease which is more abundant during 
myoblast fusion (Dedieu et al., 2002) and produces the modification of cytoskeleton 
and membrane organisation during myoblast fusion (Dourdin et al., 1999). Once the 
muscle fibres are repaired, the satellite cell pool is restored and remains quiescent until 
required, giving the muscle the ability to repeatedly and completely regenerate 
(Karalaki et al., 2009). However, myogenic satellite cells are only one part of the 
muscle tissue regeneration process. 
The extracellular matrix was originally thought to act as a scaffold for the arrangement 
of cells between tissues, playing only a passive role in muscle regeneration (Karalaki 
et al., 2009). However, elements that form part of the ECM, such as proteoglycans and 
collagen, might play a key energetic role in muscle development (Midwood et al., 
2004, Osses and Brandan, 2002), although the role of these ECM components in 
muscle regeneration are not fully understood. What has been observed is that satellite 
cells are surrounded by ECM components, with evidence of the regeneration of these 
ECM molecules during migration, fusion and maturation of the myotubes, suggesting 
a relationship between the satellite cells and ECM components (Lewis et al., 2000, 
Carmeli et al., 2004, Guérin and Holland, 1995). Additionally, upon degradation, the 
ECM releases a number of growth factors such as decorin, that can upregulate the 
muscle tissue regeneration process (Hirata et al., 2003, Koutsilieris et al., 1997). 
Finally, the key component of the ECM, collagen, is synthesised as type III collagen 
following the initial stages of EIMD, with the synthesis of type I collagen increasing 
after approximately one week (Lehto et al., 1985). This collagen remodelling might 
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play a key role in the adaptive process of the muscle in response to EIMD by increasing 
the structural integrity of the muscle and more efficiently transmitting lateral force 
(Grounds et al., 2005), subsequently protecting the muscle from repeated bouts of 
similar exercise (Takagi et al., 2016), which is discussed in detail in section 2-7.2.3.  
The regeneration process of muscle tissue and the contribution of the ECM to this 
process is not fully understood. However, it is clear that there are both individual and 
integrated roles of each component, north of which might mediate the extent of the 
regeneration and adaption process.  
2-5 MARKERS OF EXERCISE INDUCED MUSCLE DAMAGE 
The effects of EIMD are predominantly reported at the sub-cellular level, however 
quantifying the magnitude of this effect is often done via both direct and indirect 
measures (Warren et al., 1999). Direct measures require collection of muscle tissue in 
the area(s) of interest, whereas indirect measures are less invasive (with the exception 
of blood sampling) and typically encompass the collection of data pertaining to 
changes in muscle function, muscle soreness, limb girth, or intramuscular proteins, 
inflammatory, or oxidative stress markers in the circulation. Direct measures of EIMD 
can be expensive and difficult to measure, therefore, indirect measures of EIMD are 
used by many researchers. The subsequent sections will discuss each type of 
measurement method and how they have been commonly used to quantify the 
magnitude of EIMD experienced following damaging exercise. 
2-5.1 Direct markers of exercise induced muscle damage 
The use of muscle biopsies has commonly been used to measure damage to the 
structural components of the muscle. Typically, muscle samples of 10-50 g are used 
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for ultrastructural and histochemical analysis (Friden et al., 1983), with evidence 
suggesting that histochemical abnormalities are present 12 hours post-exercise, with 
peak muscle damage occurring at 48 hours (Yasuda et al., 1997). The use of muscle 
biopsies has been used to determine structural damage to both the sarcomere and the 
E-C coupling apparatus, which will be discussed further below.  
Disruption to the sarcomere has been described as a loss of myofibrillar integrity, 
specifically, Z-disk damage and A-band disorganisation (Friden and Lieber, 1998). 
Damage to the Z-disk has been evidenced in the elbow flexors following ECC 
exercise, with the non-exercised arm displaying significantly fewer disrupted or 
destroyed Z-disks (Lauritzen et al., 2009). Hansen et al. (2009b) produced similar 
findings following 100 maximal ECC actions of the knee extensors. The authors 
reported a significant increase in disrupted Z-lines at 5 and 24 h post-exercise, with a 
significant number of destroyed Z-lines at 24 h post-exercise. Friden et al. (1983) also 
suggested that maximal Z-line disruption was largest immediately post-exercise, with 
every third fibre disrupted, compared to 144 h post-exercise, with every tenth fibre 
disrupted. The initial damage to the Z-disk might involve Z-line streaming (Friden and 
Lieber, 1998) with the progression of the Z-band extending into the A-band, most 
likely due to a loss of Z-disk material, such as desmin and titin (Friden & Lieber, 1996, 
Friden, Sjostrom & Ekblom, 1983), with both structural proteins contributing to the 
force producing capacity of the muscle. Desmin loss following ECC exercise has been 
shown to occur within 5-15 minutes (Friden and Lieber, 1996) and at 1-3 days post 
exercise (Friden and Lieber, 1998), with titin shown to be significantly reduced at 24 
h, following ECC exercise (Trappe et al., 2002). The loss of these structural proteins 
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could explain the loss of force producing capacity, commonly observed following 
ECC exercise (see section 2-5.2.1). 
In addition to the ultrastructural damage to the sarcomere, muscle biopsy techniques 
can detect structural changes to the elements involved in the E-C process, namely, 
changes in t-tubule (Takekura et al., 2001, Yeung et al., 2002), and sarcoplasmic 
reticulum structure (Friden and Lieber, 1996), in the 2-3 days post ECC exercise, 
contributing to the disruption of the post-exercise disturbance in E-C coupling 
highlighted in section 2-4.2.1.  
Although considered a gold standard for measuring markers of EIMD (Warren et al., 
1999), biopsies also have limitations. For example, the procedure is uncomfortable for 
the participant, requires specialised storage and analysis of tissues and can exacerbate 
muscle damage through the sampling technique (Warren et al., 1999). Moreover, there 
are inherent issues with using such a small sample to measure damage for a whole 
muscle (Clarkson and Hubal, 2002). These limitations have resulted in researchers 
more commonly using indirect measures to quantify EIMD. 
2-5.2 Indirect markers of Exercise Induced Muscle Damage  
2-5.2.1 Loss of muscle function 
A decline in the maximal amount of force a muscle can produce is one of the most 
commonly used indirect measures of EIMD and as of 1999, muscle force was reported 
in 50% of muscle damage studies reviewed by Warren et al. (1999). This is frequently 
in the form of a maximal voluntary contraction (MVC) which can either be isometric, 
concentric or eccentric. In a recovery context, this is an applicable method of assessing 
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EIMD, as athletes often implement strategies to resume maximal performance as quick 
as possible. Maximal isometric voluntary contractions (iMVC) are used routinely in 
muscle damage research as they are relatively easy to implement and have been shown 
to be a valid and reliable marker of EIMD (Warren et al., 1999, Damas et al., 2016). 
In addition, iMVCs have been shown to decrease immediately and in the days 
following EIMD in a range of muscle groups (Warren et al., 1999, Proske and Morgan, 
2001, Chen et al., 2019). Reductions in force of 10-70% are commonly reported in the 
literature (Paulsen et al., 2010, Brown et al., 1997) with a return to baseline often not 
being achieved after seven days (Paulsen et al., 2012, Lavender and Nosaka, 2008, 
Goodall et al., 2017, Foure et al., 2019). The large range of force loss reported between 
studies can be partially explained by the responses varying between muscle groups  
examined. For example, the upper limb muscles produce greater losses in strength 
following ECC exercise than the lower limb muscles (Chen et al., 2019). Additionally, 
the loss in strength following damaging exercise is affected by both the nature of the 
damaging stimulus (Sayers et al., 2003). For example, high-force, high volume ECC 
muscle actions of isolated muscle groups produce the greatest and most lengthy 
reductions in iMVC compared to exercise involving a high metabolic demand such as 
marathon running (Paulsen et al., 2012). However, variations do exist within (Nosaka 
and Clarkson, 1996) and between studies (Vincent and Vincent, 1997, Clarkson and 
Hubal, 2002), although these variations are more attributable to the response to the 
muscle damaging stimulus (Baumert et al., 2016), not due to the variability of iMVC 
as a measure, which has been shown to be reliable (Warren et al., 1999).  
The explanation for loss of force following ECC exercise has been attributable to 
several theories, including, but not limited to, peripheral and central mechanisms. 
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Central mechanisms that cause a reduction in force producing capacity can occur from 
a reduction in neural drive to the muscle from the brain, including a reduction in motor 
neuron firing rate (Sayers et al., 2003, Hubal et al., 2007). Recently, SOURON (2018) 
reported a significant reduction in voluntary activation (VA) and iMVC in the knee 
extensors, measured via the interpolated twitch technique, immediately following a 
bout of ECC exercise. However, VA had returned to pre-exercise levels by 1 h post-
exercise, indicating that central fatigue is present in the time immediately following 
exercise. Souron et al. (2018) also reported iMVC still being significantly reduced at 
96 h post-exercise, despite VA being at pre-exercise levels, with the authors claiming 
that peripheral, not central mechanism are responsible for the loss in force 1 h + after 
ECC exercise. Conversely, Goodall et al. (2017), reported that VA relative to pre-
exercise levels did not recover until 48 h post-ECC exercise and iMVC force loss 
persisted after seven days post-exercise, indicating that central mechanisms played a 
part in force decrement until at least 24 h after exercise. The study by Souron et al. 
(2018) examined the quadriceps whilst Goodall et al. (2017) examined the biceps, 
which is the notable difference between the studies. It is possible that the higher 
susceptibility of the upper limbs to EIMD than the lower limbs (Chen et al., 2019) is 
the reason for the difference in VA recovery between the studies. Nevertheless, the 
iMVC force loss in the studies by Souron et al. (2018) and Goodall et al. (2017) 
persisted past the point of VA recovery, suggesting that peripheral damage is 
responsible for prolonged force decrements following ECC exercise. 
Peripheral mechanisms, which have previously discussed in this chapter, include 
structural damage to the contractile elements of the muscle, or a disruption of the E-C 
coupling process, which Warren et al. (1999) suggested could be responsible for an 
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immediate loss of muscle force following damaging exercise, due to a reduced amount 
of CA2+ released per action potential (Balnave and Allen, 1996, Warren et al., 1993b). 
However, these findings were from mouse muscle fibres, which were not replicable in 
amphibian muscle (Morgan et al., 1996). In human studies, peripheral mechanisms of 
force loss can be measured indirectly by the use of the potentiated twitch technique, 
whereby an electrical impulse is delivered to the muscle or nerve, following a maximal 
contraction, with the forces subsequently recorded (Oskouei et al., 2003). This method 
of measuring the function of the contractile elements of the muscle has been shown to 
be reliable in the biceps (Todd et al., 2004) and quadriceps (Morton et al., 2005). Using 
this technique, Goodall et al. (2017) found that potentiated twitch was reduced at seven 
days post-ECC exercise, despite VA recovering by 48 h, giving further indication that 
peripheral and not central mechanisms are responsible for the prolonged force loss 
after a damaging stimulus. The evidence presented suggests that there is a mixture of 
central and peripheral mechanisms responsible for the force loss suffered after ECC 
exercise, with the central element unlikely to contribute past 48 h post-exercise. 
However, the exact contributions of the two mechanisms remain unclear and warrant 
further investigation. 
2-5.2.2 Intramuscular proteins: Creatine kinase 
Circulating concentrations of specific intramuscular proteins, such as CK, myoglobin, 
lactate dehydrogenase and troponin, are commonly measured as an indirect marker of 
EIMD (Clarkson and Hubal, 2002, Brancaccio et al., 2010). The measure of CK is the 
most common in EIMD literature (Baird et al., 2012) and is the only intramuscular 
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protein measured in this thesis, therefore, the other markers mentioned will not be 
discussed; for an overview the reader is directed to Warren et al. (1999). 
Creatine kinase is a dimeric protein responsible for catalysing the reversible exchange 
of phosphocreatine and adenosine diphosphate (Brancaccio et al., 2010). There are at 
least five isoforms of CK, three of which are located in the cytoplasm; (1) CK-BB, 
found in the brain, (2) CK-MB, found in cardiac muscle and (3) CK-MM, which is 
specific to the muscle (Dawson and Fine, 1967, Baird et al., 2012). For the remainder 
of this thesis, CK will refer to the muscle specific isoform.  
Creatine kinase is present in a number of domains of the myofiber where ATP 
consumption is high, and specifically is bound to the M-line structure of the sarcomere 
(Hornemann et al., 2003), meaning that exercise that damages the muscle fibre 
structure at the sarcolemma and Z-disk level produces a decrease in membrane 
permeability and an increase in total serum CK (Noakes, 1987, Epstein, 1995). 
Circulating levels of CK in healthy individuals are generally <175 IU·L-1. The degree 
to which serum levels of CK are raised after exercise is determined by several factors. 
For example, the highest immediate post-exercise CK levels are produced by long 
duration exercise with repetitive impact forces, such as marathon running (Nuviala et 
al., 1992) or triathlon events (Denvir et al., 1999). However, the absolute levels of CK 
following this type of exercise are relatively low (100-1000 IU·L-1) and peak at ~24 
hours post exercise (Sorichter et al., 2001, Malm et al., 2004). High-intensity exercise 
with a large ECC component produces the largest and most prolonged rise in serum 
CK levels (Baird et al., 2012), especially isolated muscle groups of the upper body 
(Hyldahl et al., 2011), producing serum CK levels of 4000-6000 IU·L-1 at 96 hours 
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post-exercise (Hirose et al., 2004). With such a large detectable response, it is 
unsurprising that CK is a commonly used indirect marker of EIMD. It should be noted 
however, that even in participant groups with closely matched characteristics, CK is 
subject to high inter-subject variability (Paulsen et al., 2012). Additionally, increases 
in serum CK do not always correlate with other markers of EIMD (Warren et al., 1999, 
Damas et al., 2016), such as Z-line disruption (Stupka et al., 2000) and loss of muscle 
function (Fridén and Lieber, 2001). Although a commonly utilised and useful measure, 
the limitations of CK measurement following EIMD must be considered and not used 
to quantify the magnitude of EIMD. Ideally, CK measures should be used in 
conjunction with other direct or indirect markers, to further understand the magnitude 
of the EIMD. 
2-5.2.3 Muscle soreness 
Exercise that involves unaccustomed movements with a large ECC component 
typically produce muscle soreness (Asmussen, 1956), which is typically measured as 
a marker of EIMD (Warren et al., 1999). The time-course of muscle soreness varies 
between individuals; however, soreness typically appears between 12 -24 h post 
exercise, peaks between 24-72 h and is alleviated after seven days but can last longer 
(Newham, 1988, Graven-Nielsen and Arendt-Nielsen, 2003, Armstrong, 1984). Due 
to the non-immediate manifestation of the sensation, the term delayed onset of muscle 
soreness (DOMS) is used.  
The mechanism responsible for the appearance of DOMS remains unclear, however 
several theories attempt to explain this. One theory is that the build of lactic acid after 
the cessation of exercise causes an excess of metabolic ‘waste product’, leading to a 
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noxious stimulus and the sensation of pain (MacIntyre et al., 1995, Gulick et al., 1996, 
Armstrong, 1984). However, the lactic acid theory has been strongly discredited, due 
to CON exercise producing high levels of lactic acid with no accompanying DOMS 
and ECC exercise producing high levels of DOMS with little/no change in lactic acid 
(Schwane et al., 1983). Other mechanisms proposed to be the cause of DOMS, albeit 
derived from animal studies, include an increase in resting muscle electromyography 
(EMG) activity (De Vries, 1966), damage to the connective tissue (Lieber and Friden, 
1988), or the involvement of neurotrophic factors, such as the post-exercise activation 
of the B2 bradykinin receptor-nerve growth factor and cyclooxygenase-2 pathways 
(Murase et al., 2013).  
The measurement of DOMS is often conducted via the use of a visual analogue scale 
(VAS) (MacIntyre et al., 1995), which requires participants to rate their perception of 
soreness on a fixed scale, typically, 0 mm (no pain at all) to 100 mm (unbearable pain) 
(Chen et al., 2016). These perceived ratings of soreness can be performed passively 
(seated or supine), actively (during contraction) or during the application of a set 
pressure (Lau et al., 2015). A common criticism of the VAS technique is that 
participants might be prone to biasing their score, based on previous measurements, 
particularly if measurements are taken on consecutive days (MacIntyre et al., 1995). 
Additionally, it is important to note that the time course and intensity of DOMS does 
not always correlate with other direct or indirect markers of EIMD, such as muscle 
function (Nosaka et al., 2002) and serum CK levels (Hyldahl and Hubal, 2014). 
Nevertheless, measuring DOMS is a useful practice, due to the influence of perceived 
soreness on subsequent athletic performance (Fletcher et al., 2016), however this 
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should not be a stand-alone measure and should be used in conjunction with other 
markers of EIMD (Paulsen et al., 2012). 
There is a multitude of ways to measure the EIMD response to exercise, all of which 
have applications and limitations. Basing the EIMD response on one particular 
measure would not be appropriate, given the lack of correlation between various 
markers of EIMD and the variation between studies (Warren et al., 1999). Therefore, 
it is advisable that a battery of tests are performed within EIMD research so that more 
valid conclusions can be drawn from the data and comparisons between the literature 
can be performed. 
2-6 DETERMINANTS OF EXERCISE INDUCED MUSCLE 
DAMAGE 
As previously mentioned, variations in the response to a damaging bout of ECC 
exercise exist within (Nosaka and Clarkson, 1996) and between studies (Vincent et 
al., 2010, Clarkson et al., 2005), that are not attributable to methodological 
inconsistencies. Furthermore, participants have previously been categorised into high 
and low responders to the same bout of exercise, after measuring force loss (Hubal et 
al., 2007) and the CK response (Isaacs et al., 2019, Brancaccio et al., 2007). 
Nevertheless, there is strong evidence to suggest that differences in the damage 
inducing stimulus can produce varying responses in markers of EIMD. The following 
section will discuss these determinants.  
2-6.1.1 High fascicle strain 
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The ‘popping sarcomere’ theory, where muscle fibres are stretched under forceful 
actions on the descending limb of the LT curve (Morgan, 1990), might be an 
explanation as to why EIMD occurs following ECC exercise. This theory is supported 
by the notion that excessive fascicle strain, defined as the amount of lengthening 
beyond the optimal fascicle length for maximal isometric force production (Lieber and 
Friden, 1993), is a determinant of EIMD. For example, Lieber and Friden (1993) 
reported that isolated rabbit tibialis anterior muscle fibres subjected to 25% strain 
produced significantly lower levels of tetanic force post exercise, compared to fibres 
at 12.5% strain. Data from Talbot and Morgan (1998) supported the conclusions from 
Lieber and Friden (1993), finding that a greater amplitude of strain resulted in a greater 
fall in post-contraction active tension in isolated toad fibres. Contrary to these 
findings, Warren et al., (1993a) concluded that during five ECC contractions at 110, 
120 and 130% of muscle length at peak isometric tetanic tension, the theory that initial 
length of the muscle fibre elicited a greater loss in sarcolemma integrity, as well as 
increased markers of EIMD (CK), was not supported.. One explanation for the 
difference in findings could be that Warren et al., (1993a) only used five eccentric 
contractions to elicit EIMD, in comparison to 900 in the study by Lieber and Friden 
(1993). In addition, both Lieber and Friden (1993) and Talbot and Morgan (1998) 
measured the optimal length to maximise force production, allowing a quantification 
of the amount of strain applied to the fibre. Warren et al., (1993a) did not measure this, 
therefore it is difficult to ascertain the proportion of muscle lengthening that is on the 
descending limb of the LT curve, a key factor in the popping sarcomere theory 
(Morgan, 1990) The studies by Lieber and Friden (1993), Talbot and Morgan (1998) 
and Warren et al., (1993a) used in vitro experimental conditions on rabbit, toad and 
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rat muscle fibres, respectively, to draw their conclusions, which makes it difficult to 
extrapolate to a human muscle in vivo. 
Translating fascicle strain and EIMD data from in vitro and animal studies is not 
straight-forward due to key methodological differences. Studies using these methods 
typically only use a small number of fibres which are stretched beyond their normal 
physiological range and under a non-voluntary, electro-induced stretch (Butterfield, 
2010, Brooks et al., 1995), something that is not reflective of muscle and tendon unit 
behaviour in vivo. 
For studies using in vivo voluntary activation of muscles, the elastic behaviour of the 
MTU creates a more complicated EIMD process which cannot be explained by data 
from single fibre studies (Butterfield, 2010). In vivo studies that have measured 
fascicle behaviour during ECC exercise and the magnitude of EIMD have produced 
varying results. For example, following 300 maximal ECC contractions of the plantar 
flexors, Guilhem et al. (2016) found a significant correlation (r = ‒0.47, P <0.05) 
between maximal fascicle lengthening (0.55 ± 0.16 cm) and the decrease in force loss 
(~15%) at 48 h post-exercise. In a study investigating the amount of fascicle 
lengthening and EIMD in the VL following 72 maximal ECC contractions, Hicks et 
al. (2017) reported a significant correlation between the relative change in VL fascicle 
length (59.4 ±12.0%) and the relative change in CK (883 ± 667%) from pre to peak 
levels. However, the authors found no significant correlations between the magnitude 
of iMVC torque loss and the amount of fascicle lengthening at any time-point, albeit 
a significant reduction in iMVC force was reported between pre-damage (264 ± 35 
N∙m) and 48 h post-exercise (221.0 ± 48.4 N∙m, P = 0.004) (Hicks et al., 2017). 
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Conversely, Penailillo et al. (2015), reported that fascicles in the VL lengthened by 
8.0 cm on average during sub-maximal, ECC cycling exercise, resulting in no loss of 
iMVC torque at 48 h post-exercise. Interestingly, Hoffman et al. (2014) found that one 
hour of backward downhill walking induced a ~23% loss in iMVC. However, this loss 
in force could not be explained by the amount of fascicle lengthening of the medial 
gastrocnemius as there was only a relatively small stretch amplitude (~18% of optimal 
fascicle length), occurring predominantly on the ascending limb and plateau regions 
of the LT curve.  
The inconsistencies in the relationship between fascicle lengthening and markers of 
EIMD make drawing firm conclusions challenging, however, the differences in study 
design might explain the discrepancies. For example, in the two studies involving the 
ankle joint, Guilhem et al. (2016) reported a fascicle lengthening of 1.36 × fascicle 
slack length [the muscle length beyond which the muscle begins to develop passive 
elastic force (Guilhem et al., (2016)] during maximal ECC exercise, whereas Hoffman 
et al. (2014) reported fascicle lengthening of 1.18 optimal length during the downhill 
backward walking protocol. This additional stretch could account for the lack of iMVC 
force reduction seen by Hoffman et al. (2014). It must be noted however, that both 
studies normalised fascicle lengths differently, therefore direct comparisons of fascicle 
lengthening can be problematic, especially as particularly short fascicle slack lengths 
occur in some participants (Guilhem et al., 2016). Despite the greater amount of 
relative fascicle lengthening in the study by Hicks et al. (2017) in comparison to 
Guilhem et al. (2016) (79% vs 51%, respectively), Hicks did not report a significant 
correlation between fascicle lengthening and iMVC force loss, whereas Guilhem et al. 
(2016) did. Most likely, the end range of motion of 90° knee angle in the study by 
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Hicks et al. (2017) was well within the normal physiological range of the knee joint. 
Guilhem et al. (2016) employed a range of motion that was closer to the end 
physiological range of the ankle joint, although the differences in the range of motion 
used by the two studies might have been mitigated by differences in the lengthening 
of the patella and Achilles tendons. Nevertheless, previous research typically shows 
that ECC exercise at long muscle lengths induces a greater EIMD response (Nosaka 
and Sakamoto, 2001, Child et al., 1998). However, this is not always the case as 
Penailillo et al. (2015) performed exercise at a knee angle cycling from 20° to 120° 
knee angle, 30° more than the range of motion employed by Hicks et al. (2017). 
Although no correlations between fascicle lengthening and post-exercise iMVC force 
loss was reported in either study, Hicks et al. (2017) still reported a significant loss in 
iMVC force from baseline, post ECC whereas Penailillo et al. (2015), reported no such 
loss in force. The most likely explanation is that the submaximal nature of the ECC 
cycling protocol in the study by Penailillo et al. (2015), resulted in lower resistance of 
fascicles to active stretch, due to lower muscle activity levels, resulting in high fascicle 
lengthening in lieu of a force impairment post-exercise. 
The varying response to fascicle lengthening and markers of EIMD, specifically the 
loss of iMVC force, seem to be determined by a number of factors including, the joint 
studied (knee vs ankle), the proximity to end physiological range (i.e. maximal fascicle 
lengthening) and the intensity of the exercise protocol (maximal vs submaximal), 





2-6.1.2 High torque 
Eccentric muscle actions can lead to EIMD, especially if an unaccustomed movement 
is performed (Proske and Morgan, 2001). What is less clear is how differing intensities 
of ECC muscle action produce differing magnitudes of EIMD. Nosaka and Newton 
(2002) was the first to investigate in vivo the effect of maximal and submaximal ECC 
on markers of EIMD in the elbow flexors. Participants performed three sets of 10 
repetitions at either maximal effort or at 50% of iMVC. It was reported that at 1-day 
post-exercise, iMVC force recovery was significantly higher in the 50% group (80.8 
± 5.3%) vs the maximal group (54.1 ± 9.7%). This significant difference in iMVC 
recovery was still present at day five post-exercise, with the 50% group recovering to 
a greater extent than the maximal group (92.7 ± 5.5% vs 68.7 ± 6.3%, respectively). 
Paschalis et al. (2005) adopted a similar approach to test the effect of high (maximal) 
and low (50% of maximum) ECC contractions on EIMD in the knee extensors. 
Participants performed 12 sets of 10 maximal ECC actions in one bout, followed by 
continuous ECC exercise at 50% of maximum ECC torque on the contralateral leg two 
weeks later. The sub-maximal exercise protocol was continued until the total work 
was approximately equal to the maximal session. Paschalis et al. (2005) reported that 
the muscle damage response, measured by iMVC, between the maximal and sub-
maximal exercises was different at each time-point post-exercise. However, the only 
significant reduction of force producing capacity was recorded at 24 hours post-
exercise in the maximal intensity group. It must be noted that the muscle following 
the continuous ECC bout might have suffered less damage due to the contralateral 
RBE (Howatson and van Someren, 2007) (see section 2-7), therefore the results of this 
study should be interpreted with some caution. Barroso et al. (2011) investigated the 
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effect of intensity on markers of EIMD by asking three groups of participants to 
perform one of the following protocols on the elbow flexors: 1) 5 sets of 6 ECC actions 
at 70% 1 repetition max (1RM), 2) 10 sets of 6 ECC actions at 70% 1RM, 3) 5 sets of 
6 ECC actions at 110% of 1RM. It was reported that force producing capacity had 
returned to pre-exercise levels after 48 h for all groups but only the group exercising 
at 110% 1RM showed significantly higher DOMS and lower range of motion at 48 
hours post exercise, in comparison to baseline. In contrast, Peake et al. (2006) reported 
that submaximal ECC exercise (10 sets of 60 ECC actions at 10% peak iMVC) 
resulted in a significantly lower loss of force at 24, 48, 72 and 96 hours, compared to 
maximal ECC exercise with a lower volume (10 sets of three maximal ECC actions). 
Additionally, isometric strength in the submaximal group had returned to pre-exercise 
levels by 48 hours, whereas strength in the maximal ECC group had still not returned 
to pre-exercise levels by 96 hours, indicating a prolonged effect of higher ECC torque 
and lower volume on loss of muscle function. 
Evidence from previous studies fails to give a conclusive answer as to whether higher 
levels of ECC torque produce greater magnitudes of EIMD. Paschalis et al. (2005) 
argued that the reduced difference between high and low intensity exercise and 
markers of EIMD, in comparison to Nosaka and Newton (2002) could be due to 
participants in the latter study not performing similar amounts of total work. However, 
Gauche et al. (2009) had participants perform work matched bouts of high (80% max 
ECC torque) or low (40% max ECC torque) and found no differences in markers of 
EIMD between groups. Another argument against total work being the main driver of 
increased markers of EIMD is that Barroso et al. (2011) found no difference between 
high or low intensity groups, despite the high intensity group performing more total 
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work. In addition, participants in the low intensity group in the study by Peake et al. 
(2006) performed 6791 ± 187 J vs 1288 ± 36 J in the high intensity group. Despite the 
higher amount of total work done in the low intensity group, the force loss was 
significantly lower than the high intensity group at all time points. However, Peake et 
al. (2006) implemented a submaximal intensity of 10% peak iMVC, creating a 
difference between groups of 90% intensity, whereas other studies have used 
differences in  intensities of 40% (Gauche et al., 2009, Barroso et al., 2011) and 50% 
(Paschalis et al., 2005, Nosaka and Newton, 2002), indicating that a greater difference 
in intensity, irrespective of total work done, produces greater differences in the 
magnitude of EIMD recorded. Whilst no studies have reported that lower ECC torques 
produced greater magnitudes of EIMD than high ECC torque, further study is required 
to identify the specific effect of ECC torque on EIMD markers. 
2-6.2 Tendon as a Determinant of exercise induced muscle damage 
2-6.2.1 – Tendon properties and measurement technique 
The structure of the human tendon is dominated by collagen molecules that are 
organized in a strict hierarchical manner, that results in the formation of collagen 
fibrils, which group together to form tendon fascicle bundles, separated by an 
endotenon (Kastelic et al., 1978). Numerous fascicle bundles then group together to 
form the tendon unit, which is surrounded by the epitenon (Figure 2-5) (Wang, 2006). 
Collagen molecules are approximately 1.5 nm in diameter and 300 nm in length and 
are organised into a precise pattern, stabilised by covalent intramolecular cross-links 
that bind the collagen molecules together (Kadler et al., 1996, Bailey, 2001). Type I 
collagen is the predominant collagen protein in tendon structure (Riley, 2005), 
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accounting for 60% of tendon dry mass and 95% of total collagen (Riley et al., 1994, 
Evans and Barbenel, 1975).  Type III and Type V collagens make up the remaining 
5% of tendon collagen, with type III collagen predominantly found in the epitenon and 
endotenon (Duance et al., 1977). Tendon collagen is configured in a unique pattern 
that appears wavy under light microscope (Figure 2-6a), appearing as a “crimp 
pattern” (Whittaker and Canham, 1991, Stouffer et al., 1985), which is lost upon 
stretching of the tendon (Figure 2-6b) but returns if <4% stretch of the tendon is 
performed (Rigby et al., 1959). This recovery of the crimped region of the tendon 
might be due to the elastic f ibres (Butler et al., 1978) which are made up of 
microfibrillar proteins, and elastin, with the latter making up ~2% of the tendon dry 
weight (Jozsa et al., 1989).  Stretches of beyond 4% can result in microscopic tearing 
of the tendon, whereas stretch beyond 8-10% can lead to macroscopic failure (Butler 
et al., 1978), however there is reason to believe that these percentages might be 
underestimated, due to in vitro evidence suggesting that 14% stretch can be applied to  
avian wing tendons (Devkota and Weinhold, 2003) and human patella tendons, 
without rupture (Johnson et al., 1994). However, much lower strain percentages of 
between 5-6% have been reported in the human patella tendon in vivo, with this low 
strain unlikely to be at a point where the tendon is approaching failure during 
measurement  (Hansen et al., 2006, Carroll et al., 2008). The amount of stretch applied 
to the tendon determines stiffness, with tendon stiffness being the property associated 
with the ability for the tendon to transmit force effectively (Onambele et al., 2007). 
Tendon stiffness is calculated by the amount of force applied to the tendon divided by 
the change in tendon length from starting length, however, these stiffness measures do 
not account for the anatomical properties of the tendon such as cross-sectional area 
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(CSA). To account for this, Young’s Modulus (YM) can be calculated by multiplying 
the tendon stiffness value by the ratio of tendon length to tendon CSA (Maganaris and 









Figure 2-5 Tendon structure. Modified from Silver et al. (2003). 
Modern methods of measuring in vivo mechanical properties of tendon are 
predominantly performed using B-mode ultrasound, during graded isometric 
contractions (Fukashiro et al., 1995). When essential precautions are taken, 
ultrasound-based measures of tendon properties are reliable and able to detect changes 
in the mechanical properties of tendons (Hansen et al., 2006, Schulze et al., 2012). 
Despite this, studies with similar methodologies can produce varying differences in 
material properties of tendon, for example a 30% variation in patella tendon properties 
(Couppe et al., 2009, Seynnes et al., 2015), highlighting the importance of consistency 
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between trials. Several factors could influence the reliability of ultrasound -based 
tendon measurements such as 1) Tracking, where the ultrasound probe is misaligned 
longitudinally, producing an overestimation of tendon elongation (Magnusson et al., 
2001), 2) Scanning, or more specifically, incomplete scanning; for example, if tibial 
movement is not accounted for in the measurement of patella tendon elongation, strain 
can be underestimated by 38-45%, meaning that both the proximal and distal end of 
the patella tendon needs to be measured (Onambele et al., 2007, Hansen et al., 2006), 
3) Tracking technique, which mainly includes slight movements of the US transducer 
during contraction, which can influence the grey-scale pattern of the images produced, 
subsequently influencing data analysis (Seynnes et al., 2015) and 4) Estimation of 
tendon force, specifically due to estimations of patella tendon moment arm (PTMA) 
which can see variations of 40-50% between different methods (Tsaopoulos et al., 
2006) which could lead to errors of up to 67% in calculated tendon force (Seynnes et 
al., 2015). As previously mentioned, the use of ultrasound to measure tendon 
properties is reliable (Stenroth et al., 2019, Gellhorn and Carlson, 2013), however 
there must be a high level of precaution taken to ensure consistent technique, as well 
as an understanding that results might not be transferable to other studies due to 
methodological differences (Seynnes et al., 2015). Nevertheless, the use of ultrasound 
as an imaging technique has allowed research into the interaction of the muscle and 
tendon during contraction and specifically, how this might affect the magnitude of 















Figure 2-6 Strained (A) and unstrained (B) Achilles tendon, using bright fields of view stained 
with hematoxylin and eosin. Adapted from Whittaker and Canham, (1991). 
2-7.2.2 The role of the tendon in force transmission and dissipation 
Research has suggested that the elastic properties of the tendon serve as a means of 
conserving energy during locomotion (Roberts, 2002, Cavagna, 1977) and increasing 
the power output of a muscle when required (Bobbert et al., 1986, Alexander, 2002). 
For humans, the differing roles that a tendon might play in specific situations will 
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require differences in stiffness, depending on the action (e.g. running vs maximal 
strength exercises). These differences in tendon stiffness are evident across various 
muscles in the body (Ker et al., 1988) and is highly dependent on muscle and tendon 
architecture (Roberts, 2002). For example, muscles that are involved with running and 
walking (i.e. the Soleus and Gastrocnemius) tend to have short f ibres with high 
pennation angles and a long tendon (i.e. the Achilles tendon). During this kind of 
action, muscle fascicles produce less work by remaining quasi-isometrically 
contracted (or shortening) despite total MTU lengthening (Fukunaga et al., 2002), 
indicating that the tendon acts to optimise the efficiency of the muscle. For example, 
Reeves and Narici (2003) reported that muscle fascicles in the tibialis anterior 
contracted quasi-isometrically during ECC contractions in an isokinetic dynamometer, 
independently of angular velocity. The authors attributed this behaviour to the 
elongation of the tendon, outlining the implications in energy saving, releasing stored 
energy during tendon recoil following ground contact. Additionally, Spanjaard et al. 
(2007) found that during stair descent, most of the muscle fascicle lengthening 
occurred in the late phase of the step, when little MTU changes occurred. Once again, 
indicating that there is a significant influence of the tendon in energy absorption 
(Roberts and Konow, 2013). 
Although it is evident that the tendon acts to increase the metabolic efficiency of the 
muscle, it is important to note that this behaviour can vary across movement types and 
intensities. For example, Kouno et al. (2019) found that in both the plantar flexors and 
the knee extensors, the behaviour observed in the tendon was different between 
ramped contractions and ballistic exercise. Specifically, Kouno et al. (2019) reported 
that hysteresis was lower and tendon elongation was higher in ramped vs ballistic 
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exercise. This therefore has implications for the extrapolation of tendon behaviour 
from ramped contractions to ballistic movements, creating the need to revalidate 
tendon properties during other types of movement (Kouno et al., 2019). Moreover, the 
behaviour of the MTU can be altered despite the same exercise being performed, 
which was recently demonstrated by Hollville et al. (2019). The authors investigated 
the differences in MTU behaviour of the gastrocnemius medialis (GM) and VL during 
double-leg and single-leg landing from two differing heights using US. It was found 
that for both the GM and VL, single-leg landings induced a greater amount of tendon 
stretch than double-leg landings, protecting fascicles from high ECC stress. 
Interestingly, the effect of drop height (25 cm, 50 cm and 75 cm) produced no 
difference in GM fascicle lengthening amplitude, whereas VL fascicles increased their 
contribution to total MTU lengthening as drop height increased. This indicates that the 
longer, more compliant Achilles tendon (AT) protected the GM fascicles from 
increased lengthening, despite the increased height, whereas the patella tendon did not 
protect VL fascicles in the same manner. These findings by Hollville et al. (2019) 
indicated the need to understand how exercise intensity can alter MTU behaviour 
differently across different muscle groups. Something that must be taken into 
consideration when interpreting results from studies with different exercise modalities. 
In addition to the tendon acting as an energy efficiency vehicle, research has suggested 
that the tendon acts as a mechanical buffer during ECC exercise in the lower leg, 
providing a protective mechanism against markers of EIMD (Roberts and Azizi, 2010, 
Roberts and Konow, 2013). During backwards downhill walking, Hoffman et al. 
(2014), found that ~91% of MTU lengthening was attributed to stretch in the AT, 
which agrees with findings in similar studies in animals (Azizi and Roberts, 2010). 
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Hoffman et al. (2014) suggested that this high degree of AT contribution to total MTU 
lengthening might reduce the amount of EIMD experienced, however, markers of 
EIMD over two h post-exercise were not measured; therefore, the longer-term 
implications of this study require investigation. More recently, this mechanical 
buffering behaviour of the AT was suggested to reduce the magnitude of EIMD 
experienced during 30 maximal ECC actions on an isokinetic dynamometer (Guilhem 
et al., 2016). Most notably, the authors reported a significant correlation (r = 0.68, P 
< 0.05), between negative muscle fascicle work [i.e. fascicle braking work; (Azizi & 
Roberts 2014)] beyond slack length and the amount of iMVC force decrement at 48 
hours post exercise. Additionally, the authors stated that AT compliance reduced the 
amount of strain on the fascicle, attenuating the amount of EIMD experienced 
(Guilhem et al., 2016). This relationship between tendon behaviour and the reduction 
in magnitude of EIMD experienced was also demonstrated in the upper leg by both 
McHugh et al. (1999b) and Marginson et al. (2005), who both attributed lower 
magnitudes of EIMD in groups with more compliant MTU’s in the hamstrings and 
quadriceps, respectively. This pattern was repeated in the elbow flexors in a study by 
Chen et al. (2014), when the authors reported a lower magnitude of EIMD experienced 
by pre-adolescent males, in comparison to adolescent and adult males, following 30 
maximal ECC actions on an isokinetic dynamometer. Chen et al. (2014) suggested that 
higher muscle mass and greater mechanical strain in the adolescent and adult groups 
vs the pre-adolescent group was unlikely to explain the difference in markers of 
EIMD. However, the authors suggested that, in line with Marginson et al. (2005), the 
lower magnitude of EIMD experienced by the pre-adolescent group was due to 
differences in the MTU. Although differences in EIMD magnitude between groups 
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might be explained by MTU behaviour, it must be noted that McHugh et al. (1999b), 
Marginson et al. (2005) and Chen et al. (2014) did not directly measure tendon 
stiffness and conclusions drawn from these studies must therefore be interpreted with 
some caution. 
As previously mentioned, there is evidence to suggest that MTU behaviour can affect 
markers of EIMD following damaging exercise, albeit f rom indirect interpretations 
(McHugh et al., 1999b, Marginson et al., 2005, Chen et al., 2014). Recent research by 
Hicks et al. (2013) has investigated this relationship directly. During 12 maximal ECC 
actions of the knee extensors, Hicks et al. (2013) reported that increased muscle 
fascicle lengthening in the VL during maximal ECC exercise was significantly 
correlated with higher patella tendon stiffness (r= 0.476,  P = 0.023) and YM (r = 0.470, 
P = 0.049). Although Hicks et al. (2013) did not measure markers of EIMD, the same 
authors identified a significant correlation between VL fascicle lengthening and the 
subsequent CK response (Hicks et al., 2017), following 6 sets of 12 maximal ECC 
actions of the knee extensors. Although the authors in this study found no relationship 
between MTU properties and a loss in muscle function, there was a correlation trend 
between estimated patella tendon lengthening during ECC exercise and peak CK 
response (r = -0.41, P = 0.06).  This trend between increased patella tendon 
lengthening and reduced markers of EIMD, taken together with a greater CK response 
with increased VL fascicle lengthening provides some evidence that the tendon can 
mediate the muscle damage response following maximal ECC exercise of the knee 
extensors, albeit limited to CK response. 
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From the evidence provided, there is a clear indication that differences in MTU 
behaviour that are directly measured within groups (Hicks et al., 2017, Guilhem et al., 
2016) or indirectly assumed between groups (McHugh et al., 1999b, Marginson et al., 
2005, Chen et al., 2014) have an effect on the magnitude of EIMD experienced 
following ECC exercise.  
Therefore, if there is potential for MTU behaviour to be altered by a specific exercise 
modality, such as maximal ECC exercise (Penailillo et al., 2015, Lau et al., 2015), 
further investigation is warranted to understand the relationship between MTU 
mechanics and subsequent exercise response. 
2-7.3 Oestrogen as a determinant of exercise induced muscle damage 
2-7.3.1 The structure and function of oestrogen in eumenorrheic females 
Oestrogens are a group of steroid hormones predominantly found within females, 
which primary functions include the development and maintenance of the reproductive 
system, the cyclic production and release of the ovum, and the development of 
secondary sex characteristics (Sherwood, 2016). The actions of oestrogen are 
mediated by binding to specific receptor sites that are localised in tendons, ligaments, 
and skeletal muscle tissue (Hansen, 2018). These tissue receptors include specific 
nuclear oestrogen receptors (OR) α and β, and plasma-membrane OR α and β which 
act as transcription factors once bound to oestrogen (Wiik et al., 2003, Wiik et al., 
2005, Sciore et al., 1998, Hart et al., 1998, Faryniarz et al., 2006).  This expression of 




Oestrogens as a term refers to three hormones that are structurally similar, these are 
estradiol-17β, estrone and estriol. Estradiol-17β has the highest estrogenic properties 
and is the most abundant in humans (Tepperman, 1987, Kendall and Eston, 2002). In 
females, most oestrogens are synthesised in the ovaries. Estradiol-17β is synthesised 
from testosterone and estrone form androstenedione (Thomas and Potter, 2013), with 
estriol being primarily synthesised in the placenta during pregnancy (Tepperman, 
1987). Although predominantly a female hormone, oestrogens are still synthesised in 
small quantities in males via the testes and adrenal glands (Velle, 1966).  
In menstruating females, oestrogen levels fluctuate throughout the menstrual cycle 
(typically lasting ~28 days) which occurs repeatedly from menarche, arising 
approximately at age 13 (Whincup et al., 2001) until post menopause, at approximately 
age 51 (Rosner and Colditz, 2011). The menstrual cycle is divided up into three main 
phases where the ratio of oestrogen and progesterone levels substantially differ: the 
follicular phase, the ovulation phase and the luteal phase (Maki et al., 2002), which 
can be further divided for specificity. During the early follicular phase, oestrogen and 
progesterone levels are low (~150 pmol·L-1 and 0.6 nmol·L-1, respectively). During 
the late follicular phase, oestrogen and levels begin to rise (~450 pmol·L-1) while 
progesterone levels remain low (~0.6 nmol·L-1). At ovulation, oestrogen levels remain 
high (~671 pmol·L-1) whilst progesterone levels begin to rise (~2.5 nmol·L-1). During 
the luteal phase, oestrogen levels are approximately 313, 495 and 327 pmol·L-1 at the 
early, mid and late stages, respectively, while progesterone levels are approximately 
14, 36 and 14 nmol·L-1 at the same respective stages in the luteal phase (Stricker et 
al., 2006). In addition to their role in reproductive function and health, oestrogens have 
unique properties that have been associated with attenuating the magnitude of EIMD 
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following strenuous exercise (Kendall and Eston, 2002), which will be discussed 
further below.  
2-7.3.2 The antioxidant properties of oestrogen 
Earlier in this chapter (section 2-4.2.3) it was discussed that RONS might play a role 
in exacerbating markers of EIMD following ECC exercise, most likely manifesting as 
secondary muscle damage (Zerba et al., 1990). It was suggested within the same 
section that an environment containing compounds with antioxidative properties 
might attenuate these heightened markers of EIMD, compounds such as oestrogen 
(Tiidus et al., 2005, Sugioka et al., 1987). The phenolic ring of oestrogen is similar to 
tocopherol, which displays strong antioxidant behaviour (Tiidus et al., 1999, Bar and 
Amelink, 1997). The structural similarities between oestrogen and tocopherol which 
account for the antioxidative behaviour are a hydroxyl group on their phenolic ring,  
which can terminate peroxidation chain reactions following the donation of hydrogen 
from the hydroxyl group (Tiidus et al., 1999, Tiidus, 1995, Sugioka et al., 1987, Persky 
et al., 2000). From animal studies, Tiidus and Houston (1993) showed that following 
strenuous exercise in female rats with high oestrogen levels, tocopherol levels were 
not depleted in the same way that was seen in male and sexually immature female rats 
from similar research (Sen et al., 1997, Bowles et al., 1991). Kendall and Eston (2002) 
suggested that oestrogen acts as an additional defence against RONS and could protect 
skeletal muscle from EIMD. Although it is not fully understood, this antioxidant action 
of oestrogen has also been suggested to protect cell membranes from lipid 
peroxidation by intercalating into the plasma membrane of a cell, altering the 
membrane fluidity and function (Kendall and Eston, 2002), much like the cell 
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stabilising actions of tocopherol and cholesterol (Wiseman et al., 1993, Tiidus, 1995, 
Persky et al., 2000). This could suggest that a more stable cell membrane could prevent 
membrane related markers of EIMD, such as CK leakage. The potential for oestrogen 
to act as an antioxidant provides a strong rationale that EIMD (particularly secondary 
EIMD) experienced following ECC exercise might be reduced in females. However, 
human studies tend to measure oxidative stress in the blood and not via biopsy 
(common in animal studies). Moreover, the oestrogen levels in animal studies are 
outside the natural fluctuations of oestrogen levels of eumenorrheic human females, 
with methods such hysterectomies commonly employed (Schneider et al., 2012, Le et 
al., 2018, Fulkerson et al., 2015). Therefore, given the methodological difference in 
animal based, sex-difference research, the extrapolation of animal data to a human 
population must be made with caution. 
2-7.3.3 Oestrogen and exercise induced muscle damage 
The notion that oestrogen can confer a protective effect against markers of EIMD has 
been the focus of research for some time. Long term exposure to oestrogen has been 
shown to increase tendon compliance (Hansen, 2016) and therefore might indirectly 
protect against EIMD following ECC exercise, due to an increase in mechanical 
buffering that can reduce muscle lengthening and EIMD markers (Guilhem et al., 
2016), as discussed in section 2-6.2. Additionally, oestrogen can act in a more direct 
manner to alleviate EIMD. Initially, animal studies were used to manipulate 
endogenous levels of oestrogen to investigate the direct protective effect of oestrogen 
against damaging exercise. Several studies have indicated that oestrogen can 
significantly reduce some markers of EIMD, including attenuating strength losses, and 
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particularly, disruption to the muscle membrane (Schneider et al., 1999, Feng et al., 
2004, Enns et al., 2008, Amelink et al., 1990, Amelink and Bar, 1986). For example, 
Bar et al. (1988), reported that following two hours of strenuous exercise, female rats 
that had been ovariectomised displayed a similar response in CK activity as male rats, 
and this CK response could be reduced following the supplementation of oestrogen 
prior to exercise. Moreover, male rats that had been supplemented with oestrogen 
showed a dampened CK response following exercise (Bar et al., 1988). Bar et al. 
(1988) suggested that the membrane stabilising effect of oestrogen was responsible 
for the diminished CK response, although it was also noted that the small ECC 
component of the exercise might explain high CK clearance rates from the  blood, 
something that is not usually present in human studies (Newham et al., 1986). 
Additionally, the age at which female rats are ovariectomised might explain 
differences between studies. This was evidenced by Amelink and Bar (1986) rats that 
were ovariectomised prior to reaching sexual maturity, suffered more EIMD following 
exercise than rats ovariectomised after reaching sexual maturity. This suggests that 
chronic, high levels of oestrogen have a greater protective effect on membrane stability 
than acute doses. Despite these findings, there is data to suggest that there is no effect 
of oestrogen on the EIMD response (Warren et al., 1996, Sotiriadou et al., 2006, 
Moran et al., 2007). Although methodological differences, for example, only 
measuring the acute response to damaging exercise (Moran et al., 2007), might be the 
reason for the different level of protection attributable to oestrogen found between 
studies.  
Most of the aforementioned studies have explored the theory that oestrogen stabilises 
cell membranes following damaging exercise, mainly through measuring blood CK 
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response. This method can be problematic when comparing groups due to the high 
variability in response and high clearance rate from the blood (Warren et al., 1996, 
Hyatt and Clarkson, 1998). More recent research has focussed on the potential anti-
inflammatory actions of oestrogen, with data to date producing discrepant results. 
There is evidence to suggest that oestrogen can reduce the inflammatory response to 
damaging exercise (Tiidus et al., 2001, Stupka and Tiidus, 2001, Schneider et al., 
1999). For example, Enns et al. (2008) reported that leukocyte infiltration was 
attenuated following 90 minutes of downhill running in ovariectomised female rats. 
In contrast, there is similar research that has found that inflammation is actually 
augmented by the presence of oestrogen (Tiidus, 2005, Schneider et al., 2012, 
Fulkerson et al., 2015, Fearing et al., 2016), and research that found contradictory or 
no effect of oestrogen on post exercise inflammation (Velders et al., 2012, McHale et 
al., 2012). A recent study by Le et al., (2018) further investigated this relationship 
between oestrogen and post injury inflammation in female, ovariectomise mice that 
received oestrogen supplementation or placebo. Results showed that the mice 
supplemented with oestrogen displayed augmented markers of muscle inflammation, 
mainly neutrophil infiltration, in comparison to the placebo group. Interestingly, no 
initial differences in strength were present between the two groups yet 2-6 weeks post-
injury, the oestrogen supplemented mice displayed greater strength levels of 13-24%, 
indicating that an enhanced inflammatory response might have augmented the 
regenerative process, leading to faster recovery (Le et al., 2018).  
As previously mentioned, there are discrepancies in the research in relation to the 
effect of oestrogen on post-exercise inflammation. One explanation for this could be 
that oestrogen concentration affects the inflammatory response in an “inverted U” 
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manner, whereby modest or “normal” levels of circulating oestrogen result in the most 
augmented inflammatory response (Straub, 2007). Tiidus (2018) commented that a 
“Goldilocks Zone” might exist where “normal” oestrogen levels might see the highest 
level of inflammation, where levels above or below “normal” might attenuate 
inflammation. Studies reporting an attenuated (Tiidus et al., 2001, Stupka and Tiidus, 
2001, St Pierre Schneider et al., 1999, Enns et al., 2008), or (Tiidus, 2005, Schneider 
et al., 2012, Fulkerson et al., 2015, Fearing et al., 2016) inflammatory response 
following muscle injury did not track muscle strength recovery over the extended time 
period that Le et al. (2018) did, therefore it is uncertain whether this relationship 
between increased inflammation and enhanced strength recovery after 2+ weeks 
would have been present. Nevertheless, the findings by Le et al. (2018) provide a need 
for further understanding of the effect that oestrogen has on post exercise recovery and 
whether suppressing the inflammatory response is beneficial.  
Animal studies used to investigate the relationship between oestrogen and damaging 
exercise provides an excellent theoretical underpinning of the mechanisms of action. 
Unfortunately, the common method of controlling oestrogen levels in these studies is 
via ovariectomy, which is not common practice in human studies. In humans, 
oestrogen levels can be investigated naturally (menstrual cycle fluctuations, post-
menopause) or synthetically (hormone replacement or via the oral OCP). In the sports-
science field, it is common to investigate the OCP and its effect on exercise recovery, 





2-7.3.4 The oral contraceptive pill 
In the United Kingdom, 83% of females of reproductive age were using 
contraceptives, with 42% of women surveyed being hormonal OCP users (NHS, 
2018). Moreover, in a survey of 430 elite female athletes, 50% of women were 
currently using hormonal contraceptives, with 68% of those athletes using an OCP 
(Martin et al., 2018). Hormonal oral contraceptives contain synthetic versions of 
oestrogen and progesterone which inhibit endogenous production of both hormones, 
eliminating the variability of the menstrual cycle (Fleischman et al., 2010). The OCP 
can be taken in a cycle consisting of 21 days ingestion followed by a seven-day 
withdrawal/placebo phase or taken continuously across the 28-day cycle, with both 
methods suppressing oestrogen levels throughout the cycle (Figure 2-7), although 
some rises of oestrogen, to levels similar to those during the early follicular phase, can 
occur in the OCP-free days (Schlaff et al., 2004). The OCP works by altering the 
hypothalamic-pituitary-ovarian feedback loop that prevents ovarian follicles maturing 
(Frye, 2006), preventing ovulation and attenuating the pre-ovulation rise in oestrogen 
(van Heusden and Fauser, 2002). As a result, OCP using females experience 
significantly lower levels of oestrogen and progesterone throughout the menstrual 
cycle in comparison to non-OCP users (Fleischman et al., 2010, Bryant et al., 2008). 
Therefore, these differences in endogenous levels of oestrogen between OCP users 
and eumenorrheic females allow for any potential benefit of oestrogen on markers of 










Figure 2-7 Levels of oestrogen, progesterone, and pituitary hormones, as well as 
depictions of the ovarian follicle and the uterine lining, in normally cycling women, 
pregnant women, and women taking hormonal contraceptives. LH = luteinizing 
hormone; FSH = follicle-stimulating hormone. Adapted from Drife (1996). 
2-7.3.5 Muscle damage response in oral contraceptive pill users and eumenorrheic 
females  
The potential for oestrogen to display a protective effect against damaging exercise 
has sparked an interest within sport science to further investigate this hypothesis. As 
mentioned previously, animal studies that have manipulated oestrogen levels have 
produced conflicting results on the protective effect of oestrogen (Kendall and Eston, 
2002). These conflicting results are also present in human studies that have compared 
OCP using females and eumenorrheic females to measure the effect of circulating 
levels of oestrogen on markers of EIMD. For example, Thompson et al. (1997) 
reported no difference in muscle damage markers between OCP using females and 
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eumenorrheic females following a 50-minute stepping exercise. Likewise, Savage and 
Clarkson (2002) also found no difference in markers of EIMD following ECC exercise 
in the elbow flexors, with the exception of eumenorrheic females recovering more 
isometric strength at 48 and 72 hours than OCP using females, with this difference 
subsiding after 96 hours. Interestingly, Minahan et al. (2015) reported a similar pattern 
of strength loss as Savage and Clarkson (2002). Both OCP using females and 
eumenorrheic females had similar strength losses at 24 hours, but the eumenorrheic 
group had lost less strength at 48 hours than the OCP group. However, Minahan et al. 
(2015) did not measure strength losses past 48 hours, so it is difficult to see if the 
differences between groups would have disappeared at 72 hours, like it did in the study 
by Savage and Clarkson (2002). Recent data by both (Hicks et al., 2016) and Joyce et 
al. (2014) have both reported that eumenorrheic females experienced an attenuated 
CK response compared to OCP using females, following damaging exercise to the 
quadriceps. In addition, there were no differences in maximal strength at any time 
point reported by (Hicks et al., 2016) between groups, whereas strength was not 
measured by Joyce et al. (2014). There is a distinct lack of consistency in the data from 
studies that have investigated whether higher oestrogen levels attenuate EIMD 
markers following damaging exercise. Discrepancies in the data for (Joyce et al., 2014, 
Hicks et al., 2016) or against (Thompson et al., 1997, Savage and Clarkson, 2002) an 
oestrogen induced protective effect might be due to methodological differences 
between studies or the EIMD marker measured. Factors such as study length (number 
of follow up days), damaging protocol (e.g. maximal ECC or stepping) or EIMD 
markers measured (for example, Joyce et al. (2014) did not measure iMVC and 
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Minahan et al. (2015)  only measured iMVC torque loss up until 48 h) make it difficult 
to identify a consistent effect.  
An additional consideration is the variability of which menstrual cycle phase females 
were tested and the reported serum oestrogen levels between studies. For example, 
Thompson et al. (1997) tested eumenorrheic females during the mid-luteal phase and 
OCP users on day 18 of the menstrual with reported oestrogen levels of 116.0  ± 18.4 
pg·ml-1 and 17.4 ± 17.1 pg·ml-1, respectively. Hicks et al. (2016) tested eumenorrheic 
females around ovulation (day 14) and OCP users on the 7th pill taking day, reporting 
oestrogen levels of 433 ± 147 and 209 ± 115 pg·ml-1, respectively. Despite Thompson 
et al. (1997) reporting a 6-fold + difference in oestrogen levels between OCP using 
females and eumenorrheic females, versus an approximate 2-fold increase between 
OCP users and eumenorrheic females in the study by Hicks et al. (2016), no difference 
in EIMD damage markers were reported, which brings into question the acute effects 
of high circulating oestrogen levels on muscle damage protection.  However, it is 
possible that the participants in the study by Thompson et al. (1997) had higher 
progesterone levels than the participants in the study by Hicks et al. (2016), as the 
studies were conducted in the mid-luteal and at ovulation, respectively. The higher 
progesterone levels reported in the mid-luteal phase (Stricker et al., 2006) might have 
produced an antioestrogenic effect (Mester and Baulieu, 1984, Hsueh et al., 1975, 
Hodgen et al., 1994), negating the potential protective effect of oestrogen on EIMD 
markers. However, Thompson et al. (1997) did not report progesterone concentrations, 
so this remains speculative.  A recent study by Anderson et al. (2017) concluded that 
eumenorrheic females completing a muscle damage protocol during the luteal phase 
of the cycle, and females during the active phase of an OCP cycle, experienced a 
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blunted inflammatory response and reported less soreness in comparison to 
eumenorrheic females in the early follicular phase (days 0-6) of the cycle. The 
eumenorrheic females in this study were categorised into having “high” (luteal phase) 
or “low” (menstrual phase) circulating oestrogen levels, as expected during the 
respective cycle phase (Stricker et al., 2006). However, the “high” and “low” groups 
produced oestrogen levels of 140.2 ± 85.7 and 115 ± 82.9 pg·ml-1, respectively in 
comparison to oestrogen levels of 47.5 ± 24.5 pg·ml-1 in the OCP group. With this in 
mind, the differences in EIMD response between groups cannot be easily attributed to 
oestrogen levels for three reasons. Firstly, there were no significant differences in 
oestrogen levels between the “high” and “low” group . Secondly, the OCP group had 
lower circulating oestrogen levels than both non-OCP groups, negating the 
comparison to the ‘low’ eumenorrheic group . Thirdly, progesterone levels were not 
measured, therefore menstrual cycle phase is more difficult to confirm  (Stricker et al., 
2006) and the antioestrogenic effect of progesterone cannot be ruled out (Mester and 
Baulieu, 1984, Hsueh et al., 1975, Hodgen et al., 1994). 
These discrepancies between reported oestrogen levels and EIMD response  in the 
study by Anderson et al. (2017), in addition to the other variables previously 
mentioned, such as methodological differences, highlight a need to explore this area 
further. A more comprehensive and consistent approach to female exercise research 
will provide an ability to make comparisons across studies to help the scientific 
community understand what effects oestrogen has on the muscle and tendon response 
to exercise.  
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2-7 THE REPEATED BOUT EFFECT 
As previously established, unaccustomed exercise, particularly that involv ing active 
muscle lengthening, can result in damage to the structure of skeletal muscle that 
manifests in loss of muscle function, DOMS, CK release, and ultrastructural damage, 
amongst other responses. When performing an identical, subsequent exercise session, 
these markers of EIMD can be dramatically reduced. This phenomenon is known as 
the repeated bout effect (Nosaka and Clarkson, 1995), which can last up to six months 
following the initial exercise bout (Nosaka et al., 2001). Though originally 
investigated following two, high intensity exercise bouts (Nosaka and Clarkson, 
1995), several configurations of an initial exercise bout have been shown to produce 
an RBE on a subsequent exercise session involving maximal ECC exercise.  For 
example, the protective effect of the RBE has been evidenced following maximal 
isometric contractions at long muscle lengths  (Chen et al., 2012b), electrical 
stimulation (Mackey et al., 2011), and low intensity/volume ECC exercise (Chen et 
al., 2013, Chen et al., 2012a). In addition, research has also shown that when a single 
limb is exercised, a protective effect is observed when the non-exercised 
(contralateral) limb performs a damaging bout of ECC exercise (Howatson and van 
Someren, 2007). However, this contralateral RBE confers protection to a lesser extent 
when compared to an ipsilateral condition, with the protective effect no longer evident 
after eight weeks (Chen et al., 2016). 
Though the RBE has been the focus of many EIMD studies in recent years, the 
underlying mechanisms are not fully understood. The factors affecting the RBE, and 




2-7.1 Mechanisms underpinning the repeated bout effect 
As discussed, the magnitude of the RBE is sensitive to numerous factors. The evidence 
suggests that there are most likely numerous underlying mechanisms that contribute 
to the RBE, with reviews on the topic pertaining to four main factors; neural 
adaptations, a modified inflammatory response, ECM remodelling, and changes in 
muscle-tendon unit behaviour (McHugh et al., 1999a, McHugh, 2003, Hyldahl et al., 
2017). The following sections will discuss each mechanism in detail. 
2-7.1.1 Neural adaptations 
Neural adaptations have been suggested to be involved in the adaptive process 
following damaging exercise, resulting in the RBE. Specifically, during a second bout 
of ECC exercise, a shift in motor unit recruitment towards low-threshold motor units 
has been suggested (McHugh et al., 2001). During an initial bout of ECC contractions, 
prior to any repeat bout, unique activation strategies are imposed which might preserve 
the highest threshold motor units (Enoka, 1996). During a study employing 
intramuscular EMG, Dartnall et al. (2011) found that after a single bout of voluntary 
ECC exercise, motor unit synchronisation in the elbow flexors increased by 57% for 
up to seven days, at which point the second exercise bout was performed. Following 
the second bout of exercise an RBE was present, which was supported by the 
attenuation in force loss after the second bout in comparison to the first. Additionally, 
Dartnall et al. (2011) found that following the initial bout of ECC exercise, motor unit 
synchronisation was increased up until the second bout was performed.  Dartnall et al. 
(2011) suggested that the change of motor unit synchronisation after the first bout of 
ECC exercise was an adjustment in the motor neuron pool that resulted in the 
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distribution of force across a larger number of motor units, distributing the force 
experienced in the second bout across more muscle fibres and thus, causing less 
structural damage during the second exercise bout.   
More recent studies have investigated the contribution of altered brain activity to the 
RBE. For example, Goodall et al. (2017) suggested that the RBE might be partly 
explained by changes in motor corticospinal drive. Specifically, a faster recovery of 
voluntary activation [assessed by transcranial magnetic stimulation (TMS)] was 
observed after a repeat bout of ECC exercise in the elbow flexors. Additional research 
into motor cortex adaptations and the RBE found that immediately after exercise, 
short-interval intracortical inhibition (SICI) was reduced following a repeated bout of 
ECC exercise in the dorsiflexors (Skarabot et al., 2019). Although this reduction in 
SICI was correlated with a reduction in iMVC at 24 hours post-exercise (r = ‒0.47, P 
= 0.036), it is likely that the reduction in SICI was due to less muscle damage as no 
other differences in corticospinal or spinal responses were found between bouts. 
Interestingly, the study by Skarabot et al. (2019), compared older and younger 
individuals and found a similar RBE (attenuations in loss of force and CK release) in 
both groups, however the reduction in SICI after the second bout was only present in 
the younger group. As RBE was reported in the older population despite changes in 
SICI, this suggests that the RBE can occur without neural adaptation. Taken together, 
the evidence presented suggests that a neural component to the adaptative process 
following ECC exercise is present and can contribute to the RBE. However, it remains 
unclear to what extent these neural adaptations contribute to the RBE and if these 
contributions are consistent across groups (e.g. old vs young) and muscles involved 
(e.g. elbow flexors vs dorsiflexors). What is clear is that, to an extent, a potent RBE 
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can exist without modulations to the neurophysiological pathway, therefore additional 
mechanisms must exist to explain this.  
2-7.1.2 Modified inflammatory response 
The inflammatory response that follows ECC exercise is essential in the regeneration 
process of skeletal muscle (Tidball, 2005, Chazaud, 2016), though prolonged, excess 
inflammation can exacerbate further degradation of tissue, known as secondary 
muscle damage (see section 2-4.2) (Toumi and Best, 2003, Nguyen and Tidball, 2003, 
Howatson and van Someren, 2008). It would therefore make sense that if excess 
inflammation following ECC exercise was attenuated, further disruption of the 
myofibrils could be avoided, leading to quicker muscle recovery, something which is 
typical of an RBE. Evidence of a modified inflammatory response following repeated 
bouts of ECC exercise was observed by Pizza et al. (1996), where lower circulating 
levels of neutrophils and macrophages following the second bout were recorded. 
However, muscle function was not measured in this study and there was no 
relationship found between neutrophil and macrophage levels and CK activity, leaving 
uncertainty over the role of this modified inflammatory response. Further studies in 
mice have also reported a blunted inflammatory response following ECC exercise 
after prior exposure to a bout of passive stretches, isometric contractions or ECC 
contractions (Pizza et al., 2002). Interestingly, the blunted inflammatory response after 
the ECC contractions was similar, regardless of whether the exercise was preceded by 
passive stretching, isometric contractions or ECC contractions. In addition, passive 
stretching, and isometric contractions did not induce any overt signs of EIMD but did 
induce an inflammatory response approximately half of that induced by ECC 
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contractions, indicating that EIMD is not necessary to induce a protective effect (Pizza 
et al., 2002). 
This hypothesis that the RBE is driven by a blunted inflammatory repose on the second 
bout of exercise has seldom been explored in humans. However, Deyhle et al. (2016) 
employed an RBE protocol in the knee extensors to test this hypothesis. Interestingly, 
there was a greater inflammatory response in the second bout of ECC exercise, 
compared to the first, with marked increases in proinflammatory cytokines, 
macrophage and T-cell infiltration. There was no change in major histocompatibility 
complex class 1 (MHC-1) between bouts, that ruled out the authors hypothesis that 
MHC-1 expression was responsible for the increase in T-cell infiltration. As MHC-1 
can be greatly upregulated in muscle suffering from inflammation (Englund et al., 
2001, Choi et al., 2009) and has a close relationship with CD8+ T-Cells, this was a 
surprising result. 
It has been suggested that this increased inflammatory response in the second bout of 
ECC exercise might increase the rate of recovery, through a more targeted response 
(Hyldahl et al., 2017), akin to the function of anti-bodies when repeatedly exposed to 
a familiar pathogen. For example, Deyhle et al. (2016) noted that although MHC-1 
response did not increase in line with T-cells following a repeated bout of ECC 
exercise, the damaged muscle might have displayed familiar peptide sequences on 
MHC-1 proteins, sensitizing the T-cells to respond to muscle damage and making 
them more readily activatable on exposure to muscle damage (Stefanova et al., 2002). 
This claim, however, remains unsubstantiated and requires further investigation. 
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There remains contrasting evidence on the inflammatory response and the RBE, 
however, altered inflammatory responses following two bouts or ECC exercise have 
been reported. Regardless of whether an attenuated (Pizza et al., 2002, Pizza et al., 
1996) or exacerbated (Deyhle et al., 2016) inflammatory response exists, it is unclear 
if the reduced level of EIMD is caused by these alterations in inflammatory response, 
or driven by them, thus providing a need for further research, particularly in human 
muscle damage studies.   
2-7.2.3 Extracellular matrix remodelling 
Much of the mechanistic research attempting to further understand the mechanisms of 
the RBE has given little attention to the connective tissue surrounding the contractile 
apparatus of the muscle. These structures, collectively known as the extracellular 
matrix, comprise of collagens, predominantly type I and III, glycoproteins and 
proteoglycans, and function to transmit forces from within the myofiber to the tendon, 
both longitudinally and laterally (Grounds et al., 2005). Additionally, a primary 
function of the ECM is to increase levels of passive tension in the MTU, to reduce the 
amount of mechanical strain experienced by the myofibers (Hyldahl et al., 2017). As 
such, this behaviour has led researchers to investigate whether the remodelling of the 
ECM following damaging exercise might provide a mechanistic basis for the RBE. 
Transcriptomic analysis following ECC muscle actions identified that genes 
associated within the ECM network showed upregulated expression from pre to post-
exercise (Hyldahl et al., 2011). Specifically, matricellular proteins tenascin C (TNC), 
cysteine-rich angiogenic inducer 61 (CYR61) and thrombospondin-1 (TSP-1) 
expression was increased 11.6-fold, 33.7-fold and 8.2-fold, respectively, giving a clear 
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indication that ECM adaptation was of significance following contraction induced 
injury (Hyldahl et al., 2011). RBE studies investigating ECM remodelling have found 
significant findings pertinent to these matricellular proteins. For example, Mackey et 
al. (2011), found that TNC expression was increased following a bout of damaging 
electrically stimulated exercise, but expression was attenuated following a repeated 
bout 30 days later, with such TNC behaviour being replicated following ECC exercise 
of the knee extensors (Hyldahl et al., 2015). Tenascin c is a facilitator of the process 
of cell deadhesion, which is characterised by a restructuring focal adhesions and stress 
fibres (Murphy-Ullrich, 2001), shifting a cell from a state of stronger adherence to 
weaker adherence (Schoenwaelder and Burridge, 1999). The state of deadhesion is 
thought to be an important part of tissue regeneration (Murphy-Ullrich, 2001), with a 
deficiency in TNC shown to reduce muscle generation capacity in mice (Fluck et al., 
2008). Tenascin c expression positively correlates with force loss 48 h post ECC 
exercise (Hyldahl et al., 2015), therefore an attenuated TNC response following a 
repeated bout of ECC exercise could explain why attenuated strength loss is 
commonly experienced after ECC exercise is repeated. Although evidence of 
alterations to TNC expression and deadhesion activity has yet to be shown as a 
mechanistic underpinning of the RBE, these occurrences strengthen the hypothesis 
that ECM remodelling might have a prominent part to play in the RBE.  
Remodelling of the ECM following ECC exercise extends beyond the initial post 
EIMD phase where TNC behaviour is altered. Specifically, delayed expression of 
collagen genes indicate that remodelling can occur for up to four weeks (Mackey et 
al., 2011). Following damaging exercise induced by electrical stimulation, Mackey et 
al. (2011) found that the gene expression of types I and III collagen were increased by 
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~6-9 fold, 30 days post-EIMD. Immunohistochemical staining for collagen I and III 
showed more intense staining patterns in the exercised leg, in comparison to the 
control. Taken together, the increased gene expression and intensified staining pattern 
provides evidence that collagen within the ECM is a site of ongoing regeneration, up 
to 30 days after injury. This pattern of early cellular deadhesion activity and delayed 
collagen activity was replicated in the knee extensors by Hyldahl et al. (2015). 
Interestingly, this behaviour of the initial and delayed ECM activity was unaffected 
by a repeated bout of exercise, despite attenuation of EIMD markers (Hyldahl et al., 
2015). This indicates that the adaptation following the first bout of exercise might be 
responsible for the RBE seen after the second bout. Butterfield and Herzog (2006) 
suggest that RBE adaptations occur non-uniformly within the muscle. Therefore, 
another aspect to note is that changes in the collagen content of the ECM might not be 
ubiquitous within the injured muscle, as evidenced by increased collagen expression 
in the superficial but not deep regions of the muscle in animal models (Takagi et al., 
2016). This, however, has yet to be displayed in human studies and warrants further 
investigation.  
Evidence of both immediate and delayed remodelling of the ECM following damaging 
exercise is indicative of this being a mechanistic underpinning of the RBE. However, 
given that the RBE can occur following immediate preconditioning exercise (Chen et 
al., 2012b) non-damaging exercise (Lin et al., 2015), or on the contralateral limb 
(Howatson and van Someren, 2007, Chen et al., 2016) when ECM modelling is 




2-7.2.4 Muscle-tendon unit behaviour 
A high level of fascicle strain, leading to the overstretching of sarcomeres, is presented 
as a key driver of EIMD, which is predominantly explained by the ‘popping sarcomere 
theory’ (Morgan, 1990, Morgan and Proske, 2004). Following a bout of damaging 
ECC exercise, there is speculation that to reduce the amount of strain experienced by 
the muscle fibre, there is an addition of sarcomeres in series, with this presented as a 
possible mechanism for the RBE (Proske and Morgan, 2001). The increased 
sarcomere in series theory was believed to be evidenced by a shift in optimal angle 
towards a longer muscle length (Proske and Morgan, 2001), however this theory 
cannot explain the persistence of the RBE after four weeks when an optimal angle 
shift is no longer present (Chen et al., 2007). Moreover, the RBE has been evidenced 
by completing sub-maximal exercise just two days before a damaging bout of ECC 
exercise (Lavender and Nosaka, 2008), which given the short time between the 
original protective stimulus and the damaging bout, is unlikely to be indicative of 
myofiber remodelling. Although the addition of sarcomeres in series cannot be entirely 
ruled out as a mechanism underpinning the RBE, the evidence presented suggests that 
sarcomere remodelling cannot be solely responsible for the RBE.  
Recent research has focused on muscle fascicle behaviour, with several studies 
unearthing a relationship between the amount of fascicle strain experienced during 
ECC exercise and the magnitude of EIMD experienced (Hicks et al., 2017, Guilhem 
et al., 2016). Moreover, research investigating repeated bouts of ECC exercise have 
shown alterations in MTU behaviour on repeat bouts (Penailillo et al., 2015, Lau et 
al., 2015). Specifically, using ultrasonography, Penailillo et al. (2015) reported a 16% 
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reduction in VL muscle fascicle elongation during a second bout of ECC cycling, 
which was associated with attenuated DOMS. Lau et al., (2015), found that the 
magnitude of MTJ displacement in the elbow flexors was reduced during a second 
bout of ECC exercise and also displayed a lower magnitude of EIMD in the second 
bout. These studies suggest that changes in MTU behaviour, such as an increase in 
tendon compliance, in contrast to the addition of sarcomeres in series (Proske and 
Morgan, 2001), could be responsible for the RBE. Although neither Lau et al., (2015) 
or Penailillo et al. (2015) directly measured tendon properties, recent evidence has 
also shown that the amount of fascicle strain experienced during ECC exercise can be 
attenuated by an increase in tendon compliance (Hicks et al., 2017, Hicks et al., 2013, 
Guilhem et al., 2016), although this is based on studies using a single bout of ECC 
exercise. To further understand the relationship between changes in MTU behaviour 
and the RBE, future studies must incorporate methodologies that track changes in 
tendon and muscle properties between repeated bouts of ECC exercise and where 
possible, during the ECC exercise itself.  
2-7.3 Factors affecting the repeated bout effect 
The repeated bout effect is often expressed by the amount that EIMD markers are 
reduced after the second bout of exercise, often termed the index of protection (IOP) 
(Chen et al., 2014). The IOP is highly sensitive and can be influenced by a number of 
factors pertaining to the initial bout of exercise such as the number (Burt et al., 2015), 
and intensity of contractions (Chen et al., 2017), muscle length (Nosaka et al.,2005a), 
limb involved (Chen et al., 2019), age (Chen et al., 2014), and how accustomed the 
participants are to the activity (Hyldahl et al., 2017). For example, manipulating the 
intensity of the initial bout of ECC exercise produces a proportionate level of 
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protection in a subsequent bout, as evidenced by Chen et al. (2007). Chen et al. (2007) 
compared maximal ECC exercise in the initial bout to three submaximal intensities 
(40%, 60% and 80%) of the elbow flexors. It was found that the protective effect was 
greater after the initial maximal ECC bout and that protection decreased in order of 
initial intensity Chen et al. (2007). Interestingly though, four repeated submaximal 
exercise bouts (40% max iMVC) can confer an equivocal RBE as a single, maximal 
ECC exercise session, thus suggesting that high levels of EIMD do not necessarily 
need to be present initially to induce the RBE (Chen et al., 2010). It is apparent that 
the magnitude of the RBE is sensitive to the intensity of the initial exercise bout, 
however the two studies mentioned by Chen et al. (2007, 2010) both used an equal 
number of repetitions in the high and low intensity protocols and were not matched 
for mechanical work. Recently, Mavropalias et al. (2020), implemented a work 
matched high or low intensity ECC cycling protocol (20% peak power output (PPO) 
and 5% PPO, respectively) for the initial RBE exercise session. Both high and low 
intensity groups repeated the exercise protocol 14 days later at the high intensity (20% 
PPO) and it was found that there were no differences between groups for post-exercise 
muscle function. There were group differences in DOMS, with the group who 
performed low intensity exercise in the first bout reporting higher levels of soreness 
post bout two (Mavropalias et al., 2020). Given the evidence presented, it appears that 
when ECC exercise is matched for the amount of mechanical work performed, 
intensity has no effect on the RBE in relation to muscle function but might attenuate 
soreness when the initial bout is more intense. It should be noted that the study by 
Mavropalias et al. (2020) employed submaximal exercise (ECC cycling), which has 
been shown to induce only modest levels of EIMD Penailillo et al. (2015). Therefore, 
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RBE studies that use maximal ECC protocols compared against work matched 
submaximal ECC exercise should be explored to further understand the effect of 
intensity on the magnitude of the RBE. 
The RBE is also sensitive to contraction type and does not require an ECC action in 
the first exercise bout. For example, 30 iMVCs lasting 5 s with 45 s between 
repetitions, prior to 30 maximal ECCs of the elbow flexors three weeks later, conferred 
a protective effect (Chen et al., 2012a). However, only iMVCs at a long muscle length 
conferred this protection, as in the same study, no protective effect was reported for 
iMVCs at short muscle length (Chen et al., 2012b). This effect of iMVCs at long 
muscle lengths has been seen after just two contractions in the elbow flexors, however 
no RBE was seen after seven days (Chen et al., 2013). An additional factor that can 
influence the magnitude of the RBE is contraction velocity, although mixed evidence 
exists. Chapman et al. (2011) found that a bout of maximal ECC actions of the elbow 
flexors at a slow velocity, conferred protection against EIMD after a bout of fast 
velocity maximal ECC actions in the same arm, three weeks later. In contrast, Barss 
et al. (2014) found that maximal ECC actions of the elbow flexors only produced an 
RBE when contraction velocity was kept constant between the two bouts; fast velocity 
contractions did not reduce markers of EIMD after the second bout consisting of slow 
velocity contractions, and vice versa. Interestingly, a recent study, Barreto et al. (2019) 
combined the use of isometric pre-conditioning (10 iMVCs at long muscle length) two 
days prior to either fast or slow velocity maximal ECC exercise of the elbow flexors. 
This study found that iMVCs two days prior to maximal ECC exercise produced a 
protective effect, irrespective of contraction velocity. These results have important 
implications for the design of research investigating EIMD and the RBE. 
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The data presented suggests that there are several factors that can protect the muscle 
from a damaging bout of ECC exercise. These can be generally summarised to 
conclude a protective effect can be induced by; 1) identical bouts of maximal ECC 
exercise, 2) non- or low-damaging, sub-maximal ECC exercise, 3) isometric exercises 
at long muscle lengths, 4) maximal ECC on the contralateral limb and 5) low volume, 
maximal ECC exercise. It is likely that many combinations of these exercises might 
induce an RBE. 
2-8 SEX DIFFERENCES IN EXERCISE INDUCED MUSCLE 
DAMAGE AND THE REPEATED BOUT EFFECT 
Study of the varying responses of men and women to ECC exercise has increased over 
the last decade, however there is still no definitive answer to whether a sex difference 
exists. Early animal studies reported that males display a higher susceptibility to 
EIMD (St Pierre Schneider et al., 1999, Komulainen et al., 1999, Clarkson and Hubal, 
2002). In human studies, there is less clarity as to whether there is a sex difference in 
EIMD response between the sexes. Evidence exists supporting (Wolf et al., 2012, 
Sewright et al., 2008, Oosthuyse and Bosch, 2017, Joyce et al., 2014, Hicks et al., 
2016, Fredsted et al., 2008, Amorim et al., 2014) or refuting (Stupka et al., 2000, 
Sayers and Clarkson, 2001, Rinard et al., 2000, Dannecker et al., 2012) a sex 
difference in EIMD response.   
2-8.1 Sex differences in exercise induced muscle damage following a single bout of 
eccentric exercise 
Studies investigating sex differences that use direct measures of EIMD are uncommon, 
with only Stupka et al. (2000) presenting such data, reporting no sex difference in Z-
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line streaming following ECC exercise in the lower limb. Therefore, the use of indirect 
markers of EIMD are generally implemented to detect sex differences in the muscle 
damage response, which can produce varying results dependent on the measure used. 
Strength loss, as measured by iMVC, is a valid marker of EIMD (Warren et al., 1999, 
Nosaka et al., 2006) and when implemented, has produced contrasting results in the 
EIMD sex-difference literature. For example, following an ECC step protocol, 
Fredsted et al. (2008), reported that females experienced greater losses in knee 
extensor strength at 24, 48 and 72 hours post-exercise than males. Moreover, Sewright 
et al. (2008) reported a greater loss in iMVC force immediately after ECC exercise of 
the elbow flexors but not at any other timepoint, which could be an indicator of fatigue 
and not EIMD (Walsh et al., 2004). Minahan et al. (2015) reported losses in quadricep 
iMVC force immediately after and 24 h post exercise in males, OCP-using females 
and eumenorrheic females. However, after 48 hours, only eumenorrheic females 
showed no further decline in strength loss whereas the males and OCP using females 
did, with the authors suggesting that oestrogen facilitated the enhanced recovery. 
Other studies have shown no sex differences in strength loss following ECC exercise 
of the elbow flexors (Sayers and Clarkson 2001, Savage and Clarkson 2002) or knee 
extensors (Hicks et al., 2016). The contrasting evidence in relation to sex differences 
in strength loss is difficult to explain when different limbs are being tested, especially 
when upper limbs are more susceptible to damage than lower limbs (Saka et al., 2009, 
Chen et al., 2019, Chen et al., 2011). Nevertheless, in contrast to the animal data, the 
larger strength loss reported by Fredsted et al. (2008) was attributed to the female 
participants exercising at a higher relative intensity than males. Although this cannot 
be confirmed due to total work not being reported, a recent meta-analysis suggests that 
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when strength loss in normalised for ECC work, no sex differences in strength losses 
are present (Morawetz et al., 2019). Overall, it appears that a distinct conclusion 
cannot be drawn as to whether a consistent difference in strength loss exists following 
ECC exercise between males and females.  
Compared to males, females have higher circulating levels of oestrogen (Velle, 1966, 
Tepperman, 1987, Kendall and Eston, 2002) and with oestrogen reported to have a 
predominant cell membrane stabilising effect (Kendall and Eston, 2002), it would be 
prudent to include measures of membrane stability in sex related EIMD studies. 
Indeed, several studies have reported the CK response to ECC exercise, with strong 
evidence suggesting that females demonstrate an attenuated CK response in 
comparison to males in the knee extensors (Joyce et al., 2014, Hicke et al., 2016) and 
the elbow flexors (Sewright et al., 2008). In contrast, Stupka et al. (2000) did not report 
a sex difference in CK following ECC knee extensor exercise, but did report an 
attenuated inflammatory response, determined by circulating leukocyte concentration, 
in females, which they attributed to the membrane stabilising effect of oestrogen. This 
is surprising considering that the membrane stabilising effect of oestrogen is also 
thought to be the mechanism of attenuated CK release following ECC exercise 
(Kendall and Eston, 2002). This anomaly could potentially be explained by the time 
course of sampling as Stupka et al. (2000) measured CK at 48 and 144 hours post-
exercise, when CK reportedly peaks at 72-96 hours (Saka et al., 2009, Clarkson et al., 
1992), thereby giving a false account of true CK peak values. It might be considered 
that higher CK values in males is due to higher volumes of exercised muscle, however, 
in a recent meta-analysis, Morawetz et al. (2019) reported that despite normalising CK 
data to muscle CSA, males still reported higher peak levels of CK, giving weight to 
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the theory that oestrogen acts to stabilise cell membranes and attenuates CK release 
(Kendall and Eston, 2002). Moreover, after CK response being normalised to 
quadricep CSA, Hicks et al. (2016) found that males exhibited a greater CK response 
than females following 6 sets of  12 maximal ECC knee extensions. Despite this 
difference in CK, no sex differences in strength loss were found (Hicks et al., 2016) 
making it difficult to draw any solid EIMD sex-difference conclusions based on this 
evidence.  
The evidence presented shows that there is contrasting evidence of a differing EIMD 
response between males and females when using post-exercise strength loss as a 
measure. There appears to be more consistent evidence that shows an attenuated CK 
response in females compared to males, however, given that a direct relationship 
between CK and EIMD is lacking (Stupka et al., 2000, Stupka and Tiidus, 2001) and 
CK sex differences can be present in the absence of strength loss differences (Hicks et 
al., 2016), it remains unclear whether males and females respond differently to 
damaging ECC exercise.  
2-8.2 Sex differences in exercise induced muscle damage following repeated bouts 
of eccentric exercise 
Repeated bouts of ECC exercise typically result in reduced markers of EIMD after the 
second bout (Nosaka and Clarkson, 1995). The magnitude of RBE is determined by a 
number of factors (contraction intensity, muscle length, contraction velocity etc.) as 
discussed earlier (section 2-6). However, much less is known on how sex influences 
the magnitude of the RBE. Although several RBE studies have included a mix of male 
and female participants (McHugh and Pasiakos, 2004, Deyhle et al., 2016, Cleary et 
al., 2002, Black and McCully, 2008), to our knowledge, only Stupka et al. (2001) 
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directly assessed sex differences in the magnitude of the RBE. Eight males and eight 
females performed three sets of 12 unilateral leg press exercises followed by 100 ECC 
leg extensions. No RBE differences between males and females were found with the 
exception of an increase in neutrophil infiltration in women, 24 hours after the second 
bout. As neutrophil infiltration is relatively rapid following damaging exercise 
(Fielding et al., 2000), it is possible that neutrophil levels in male participants had 
returned to baseline levels after the second exercise bout. Additionally, alterations to 
the time course of the inflammatory response have been observed in males following 
repeated exercise bouts (Smith et al., 1998), which makes it plausible that peak 
neutrophil infiltration in the male participants might have been missed. Whether a time 
course difference following repeated bouts of exercise exists for females remains 
unclear.  
Typically, studies investigating the RBE in female only populations (Nikolaidis et al., 
2007, Muanjai et al., 2019, Lin et al., 2017, Brown et al., 2016) have observed 
responses typical of the RBE (attenuated strength loss, CK release and DOMS) 
demonstrated in male populations. However, given the heterogeneity of 
methodologies between studies, it is difficult to ascertain whether the RBE response 
of males and females is equivalent. Even Stupka et al. (2001), who implemented the 
same methodology between male and female groups, acknowledged that due to the 
small group numbers (n = 8 per group), the lack of statistical power meant that the sex 
difference in the inflammatory response should be interpreted with caution. Therefore, 
to understand the RBE response following repeated ECC exercise, studies need to be 
conducted that implement the same study protocol between males and females. 
Moreover, no study to date has investigated the effect of the OCP on the magnitude of 
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the RBE. Given the potential for oestrogen to influence the muscle damage response 
(Kendall and Eston, 2002), it would be prudent to implement OCP use as factor into 
future study design.  
2-9 AIMS 
In light of the aforementioned research, the main aim of this thesis was to use 2D B-
mode ultrasonography to further understand the properties and behaviour of the patella 
tendon and vastus lateralis in males and females and how these properties contribute 
to the EIMD response to ECC exercise and the magnitude of the repeated bout effect. 
To achieve this aim, the thesis will consist of three studies, the aims of which are 
outlined below.  
Study 1: The reliability and validity of measuring patellar tendon cross‐sectional 
area using 2D B-mode ultrasonography and magnetic resonance imaging. 
Aims: 1) Determine the agreement between US and magnetic resonance imaging 
(MRI) measures of PT CSA for two independent raters 2) determine the within-day, 
inter- and intra-rater reliability for US and MRI measures of PT CSA and, 3) determine 
the between-day, intra-rater reliability of US measures of PT CSA. 
Study 2: Test-retest reliability of measuring patella tendon properties and muscle 
fascicle length changes in the vastus lateralis during maximal eccentric exercise, 
using 2d b-mode ultrasonography. 
Aims: Determine the reliability of using US to quantify PT properties at rest and 




Study 3: Sex differences in exercise induced muscle damage and the repeated 
bout effect following maximum, single limb, knee extension exercise 
Aims: To assess whether adaptations in MTU behaviour during maximal lengthening 
contractions can explain the RBE, and whether these adaptations differ between males, 
eumenorrheic females, and females taking the OCP. Additionally, to investigate the 




CHAPTER 3 THE RELIABILITY AND VALIDITY OF 
MEASURING PATELLAR TENDON CROSS‐SECTIONAL 





The human patellar tendon (PT) plays a crucial role in locomotion by transmitting 
force from the quadriceps muscle group to the tibia. Tendon is a viscoelastic tissue 
and will deform under loading (Magnusson et al., 2008), with the degree of loading 
corresponding to the structural properties of the tissue (Maganaris and Paul, 1999). 
These structural properties, such as tendon stiffness and YM, determine the 
compliance of the tendon, which in turn might mediate the magnitude of EIMD 
experienced during ECC exercise. Specifically, tendons can act as a mechanical buffer 
during high force ECC contractions, reducing the amount of muscle fascicle strain 
during such movements (Hicks et al., 2013) and potentially alleviating the magnitude 
of EIMD experienced (Guilhem et al., 2016, Hicks et al., 2017).  
To determine the role of the PT and its compliance in the mechanical buffering of 
force, accurate and reliable measurements of these properties and behaviours must be 
performed. Specifically, tendon CSA is an important measure needed to estimate the 
material properties of the PT, such as YM.  
Magnetic resonance imaging is a technique that uses the chemical and magnetic 
environment surrounding unpaired hydrogens, and their magnetic properties, to 
produce tissue images (Berger, 2002). The strong magnetic environment produced by 
an MRI machine forces the protons in the body to behave like bar magnets and align 
with the magnetic field (Read and Peduto, 2000). The protons are then excited to a 
higher energy state by an electromagnetic pulse at the natural or radio frequency (RFr) 
of the proton, which when terminated, causes the proton to return to alignment and 
emit a lower RFr. This contrasting RFr energy can be detected and built to form an 
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image, with the different tissues (lipid, bone, tendon etc.) detectable by altered proton 
relaxation rates, which is what produces excellent image contrasting (Read and 
Peduto, 2000). Several studies have validated the accuracy of MRI in measuring 
tendon properties (Sonin et al., 1996, Carrino et al., 1997, Berthoty et al., 1989), with 
MRI considered the ‘gold standard’ of tendon property measurement and routinely 
used as a validation tool against other measurement techniques (Kruse et al., 2017, 
Bohm et al., 2016).  
Another form of in vivo measurement technique for tendon properties is 2D B-mode 
ultrasound imaging, which is an imaging technique that builds up a cross-sectional 
display of soft tissue using the SONAR principle. Throughout this thesis, 2D B-mode 
ultrasound imaging will be referred to solely as “ultrasound imaging”, unless stated 
otherwise. For tendon imaging, this process requires a transducer (typically 5-12 
MHz) placed on the skin, which transmits ultrasonic waves into the tissue before 
returning to the same transducer, where the depth and the brightness are determined 
and plotted (Read and Peduto, 2000). The ultrasound image is constructed based on 
numerous acoustic and structural interactions, with specific effects on beam 
interference, attenuation, refraction, and reflection, resulting in the possibility of 
distinction between tissue (Read and Peduto, 2000). Ultrasound technology is 
commonly used in research settings to assess tendon size and to measure the tendon’s 
response to loading and healing (Thoirs and Childs, 2018). Ultrasound is an 
affordable, time efficient, portable and non-invasive imaging technique, which makes 
it an attractive tool in musculoskeletal research. As with all diagnostic tools, US is not 
without its limitations and a number of considerations need to be taken into account 
when the method is used. For example, US accuracy and reliability are dependent on 
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a number of factors such as operator experience (Wallwork et al., 2007), non-
standardised imaging protocols, and slight variations in transducer positioning 
(Gellhorn and Carlson, 2013). To have confidence in the values of tendon properties 
calculated from US derived dimensions, measurement error must be understood. 
The reliability and accuracy of US tendon measures is conflicted within the literature 
(McAuliffe et al., 2017, Gellhorn and Carlson, 2013). For example, Reeves et al. 
(2003), reported that between-day, intra-rater reliability showed strong agreement 
between measures of PT CSA. In addition, Gellhorn and Carlson (2013) found that 
both experienced and inexperienced US operators showed high levels of inter- and 
intra-rater reliability, and inter-machine reliability for measuring PT CSA, when strict 
scanning protocols were used. In contrast, Bohm et al., (2016) and Ekizos et al. (2013) 
found that US measures of AT CSA and PT CSA, respectively, were unreliable, with 
Ekizos et al. (2013) attributing this to poor definition of tendon borders. Interestingly, 
Kruse et al. (2017) reported that intra-rater US measures of AT were reliable but not 
interchangeable with MRI measures, as US underestimated AT CSA by ~5.5%. The 
agreement of US and MRI measures of tendon CSA has also produced contrasting 
results in the literature. Similar to Kruse et al. (2017), Bohm et al., (2016) found that 
US measures of the AT underestimated CSA by ~19%. In contrast, recent research by 
Stenroth et al. (2019) found that when highly standardized measurement protocols are 
implemented and an experienced rater is used, agreement between US and MRI 
measures of both the AT and PT is high. One factor that might explain the 
discrepancies between MRI and US tendon analysis might be that MRI analysis 
overestimates CSA because of the inclusion of the paratenon, the areolar tissue 
between the tendon and its sheath, which is commonly excluded during US analysis 
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(Kruse et al., 2017). Additionally, the method used to digitise and analyse images 
might affect the agreement between US and MRI tendon analysis. For example, Kruse 
et al. (2017) employed a manual tracing technique for US images of the AT and a 
threshold cut-off method for MRI analysis and found poor agreement between the two 
measurement methods. Stenroth et al. (2019) used the same method of image 
digitisation and analysis for both US and MRI images and reported good agreement 
between the methods, but only when the rater was experienced (> five years of 
musculoskeletal imaging and segmentation (Stenroth et al., 2019). Collectively, these 
data suggested that the reliability and accuracy of US and MRI measures of tendon 
CSA are inconsistent and require further investigation. Of particular importance to this 
project, one key factor appears to be the experience of the US operator (McAuliffe et 
al., 2017, Hayes et al., 2019), and therefore it is prudent to assess the accuracy and 
reliability of the US operators in the present study and the subsequent studies in this 
thesis. Therefore the aims of this present study are threefold: 1) determine the 
agreement between US and MRI measures of PT CSA for two independent raters, 2) 
determine the within-day, inter- and intra-rater reliability for US and MRI measures 
of PT CSA, and 3) determine the between-day, intra-rater reliability of US measures 
of PT CSA. In relation to the overall aim of this thesis, this study will provide 
confidence that the calculations used to determine patella tendon properties, and any 
changes in such properties resulting from exercise intervention, are based on accurate 





Nineteen participants, ten females and nine males, participated in the study (age: 25 ± 
6 years; stature: 1.71 ± 0.10 m; mass: 71.3 ± 12.5 kg). Participants completed a pre-
test questionnaire and were only included in the study if they had no neuromuscular  
or musculoskeletal impairments in the lower limbs within the last six months. 
Contraindications for MRI included cardiac pacemaker, metal objects in the body 
(such as aneurysm clips or a programmable shunt in the brain), joint prosthesis, bone 
fixation devices, and pregnancy. Institutional ethical approval was received from the 
Northumbria University Faculty of Health & Life Sciences Ethics committee in 
accordance with the Declaration of Helsinki. Participants were supplied with a 
participant information sheet, detailing the purpose of the study and provided written 
consent before participating (Appendix 1).  
3-2.2 Experimental design 
Participants were requested to visit the laboratory on three occasions. The first session 
was the imaging of the PT using MRI, the second and third visits were the imaging of 
the PT using US, separated by three days, with the second session one week after the 
first. In session one, two MRI scans of the PT were performed, separated by a short 
interval, where the participant was removed from the MRI scanner before being 
repositioned within the MRI scanner and scanned again. In sessions two and three, 
two raters each performed two US scans of the PT on the same leg. The participant 
was then removed from the scanning position, before being repositioned and US scans 
performed again, resulting in four US scans per rater, per visit (eight US scans in total). 
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Rater 1 was considered less experienced, however, training in image acquisition using 
US, and image digitisation and analysis was provided in depth  before the study by 
Rater 2, who was experienced over a five-year period in musculoskeletal radiography. 
Imaging was performed at the same time of day in each session to remove diurnal 
effects on tendon size (Stenroth et al., 2019). Prior to each visit, participants were 
asked to refrain from strenuous lower body exercise for 48 hours to reduce possible 
deformations in the PT structure due to fluid ecchymosis.  
3-2.3 Procedures 
MRI Examinations 
Participants attended Newcastle Clinic for the MRI examinations. Prior to scanning, 
measures of stature and mass were recorded using a portable stadiometer (Seca model 
213; Seca, Hamburg, Germany) and digital scales (Seca model 813; Seca, Hamburg, 
Germany) respectively. Participants were placed in an open MRI device (GE Ovation 
0.35 T open MRI scanner, GE Healthcare, Little Chalfont, UK) in a left decubitus 
position, with the hip and knee flexed to 85° and 90° (0° = full extension), respectively 
(Figure 3-1a), confirmed using a goniometer (Idass 360° goniometer; Idass, Cornwall, 
UK). This positioning was chosen to mirror the hip and knee angles of participants 
during the US measurements in sessions two and three. The right knee was scanned 
for all participants. The scan procedure was performed by a qualified radiographer at 
Newcastle Clinic after positioning of the knee had been confirmed by the researcher.  
The MRI scan procedure was divided into three sections; a localiser scan to confirm 
correct field of view, a sagittal plane scan (spin echo T1, TR/TE 500/24, field of view 
20 ×15 cm, slice thickness 4 mm, spacing between slices 0 mm, 03:45 mins scan time) 
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followed by an axial scan  (spin echo T1, TR/TE 450/24, field of view 20 x 15cm, 
slice thickness 4 mm, spacing between slices 0 mm, 05:31 mins scan time). The 







Figure 3-1 Scanning position prior to the MRI scan (A) and scanning position for US imaging 
(B).  
Ultrasound Examinations 
Participants were positioned in an isokinetic dynamometer (System 4 Pro, Biodex 
Medical Systems Inc., NY, USA) in a seated position, with the hip and knee flexed to 
85° and 90° (0° = full extension), respectively (Figure 3-1b). A real-time B-mode 
ultrasound (HDI 5000 SonoCT, Philips, Amsterdam, Netherlands) was used to assess 
PT CSA and PT length. Sagittal images of the PT were obtained using an US probe 
(7.5 MHz linear array probe, 55 mm width) to locate the apex of the patellar and the 
tibial tuberosity, with marks placed on the skin at each site. US images were enhanced 
using a conductive gel (Aquasonic 100, Parker Laboratories Inc., Fairfield, NJ, USA). 
The distance between the two sites was measured via an inextensible anthropometric 
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tape measure and taken as PT length. PT CSA was measured in the axial plane at 25% 
(proximal), 50% (mid) and 75% (distal) of PT length, with the scan locations clearly 
marked on the skin. Ultrasound images were captured live using image acquisition 
software (AVer Media Capture Studio, AVer Media Technologies, New Taipei City, 
Taiwan) and analysed offline. PT CSA images were obtained by two US operators. 
Within each US session, the participant was removed from the dynamometer and the 
scan location marks were removed from the skin before being repositioned. The 
procedure was then repeated to allow for within session reliability to be assessed. 
MRI image analysis 
Sagittal MRI images were used to locate the apex of the patellar and the tibial 
tuberosity, to ensure consistency of anatomical landmarks used to determine PT length 
during US examinations. From the sagittal MRI images, the corresponding axial image 
could be identified. The number of images between the axial image for the apex of the 
patellar and the tibial tuberosity was used to determine the PT CSA image at 25, 50 
and 75% of PT length. For example, if 12 images lay between the apex of the patellar 
and the tibial tuberosity, images 3, 6 and 9 would be analysed for 25, 50 and 75% PT 
length, respectively. Should the appropriate point lay between two images, the image 
towards the proximal region of the PT was analysed.  
MRI images were exported and analysed by digitising software (ImageJ 1.45; National 
Institutes of Health, Bethesda, MD, USA). Images were firstly converted to 32-bit 
greyscale. An adjustable threshold cut-off method was used to determine PT borders 
(Kruse et al.,2017). The threshold was adjusted until the smallest natural appearance 
of the PT was achieved (Figure 3-2a). Patellar tendon CSA was then calculated by the 
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software. Both raters performed this sequence twice for each image with the mean PT 
CSA recorded for further analysis. All images were independently blinded and 




Figure 3-2 Axial MRI image showing the automatically outlined PT CSA (A) and the 
corresponding axial US image showing the manually outlined PT CSA (B) using imageJ 
software (ImageJ 1.45; National Institutes of Health, Bethesda, MD, USA).  
Ultrasound image analysis 
Ultrasound videos were exported to video editing software (Adobe Premier Elements 
version 15, Adobe, CA, USA) for frame-by-frame analysis. The images at the 
appropriate PT CSA location were manually assessed, before being exported for 
analysis in imageJ software. The tendon border was then manually outlined, and the 
CSA was calculated (Figure 3-2b). Each rater manually analysed each image twice, 
with the mean PT CSA used for further analysis. All US images were independently 
blinded before both raters analysed all images in a randomised order to prevent the 
possibility of systematic error due to recalling previous analysis. 
3-2.4 Statistical analysis  
Data are presented as mean ± SD. The level of significance was set to α = 0.05. Data 
were analysed using a published spreadsheet (Hopkins, 2015) in Microsoft Excel 
(Microsoft Excel 2016, Microsoft, Washington D.C., USA) as follows: 
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MRI vs US comparison. Agreement between MRI and US was assessed via linear 
regression for each rater individually, and the collapsed scores between both raters. 
Pearson correlation coefficients and the standard error of the estimate (SEE) were 
calculated for PT CSA values. Additionally, paired sample t-tests were used to assess 
for systematic error.  
MRI and US reliability. Relative reliability of MRI and US measurements was 
assessed using intraclass correlation coefficients (ICC3,1), while absolute reliability 
was assessed by calculating typical error (TE) (95% confidence intervals) expressed 
as raw units and as a coefficient of variation (CV, %). The standard error of 
measurement (SEM) was calculated as the square root of the mean square error from 
a one-way analysis of variance (ANOVA) (Stenroth et al., 2019). Paired sample t-tests 
were implemented to assess for systematic error (Dragiev et al., 2011). Reliability via 
ICC was interpreted by the following: ICC 0.5 – 0.75, moderately reliable, ICC 0.75-
0.9, good reliability, ICC > 0.9, excellent reliability (Koo and Li, 2016). Reliability 
was assessed for the proximal, mid and distal PT CSA images individually, in addition 
to the mean of all three PT CSA scores. 
Inter- Intra-rater reliability. Within-day, intra-rater reliability was assessed for MRI 
and US images by comparing the PT CSA scores between the first and second image 
in each session. Between-day, intra-rater reliability was assessed for US images by 
comparing the PT CSA scores of the first scan for each rater (before the participant 
was repositioned) for each visit. Within-day, inter-rater reliability for MRI and US 
images was assessed by comparing the PT CSA scores of rater 1 and rater 2 (before 
the participant was repositioned) during visit 1. Relative reliability of MRI and US 
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measurements was assessed using ICC3,1, while absolute reliability was assessed by 
calculating SEM (described earlier) and calculating TE (95% confidence intervals) 
expressed as raw units and as a coefficient of variation (CV, %). Paired sample t-tests 
were implemented to assess for systematic error (Dragiev et al., 2011). 
3-3 RESULTS 
Magnetic resonance imaging vs Ultrasonography 
Mean ± SD PT CSA scores are presented in Table 3-1. Individual data points for MRI 
and US measures of PT CSA are displayed in Figure 3-3. No systematic differences 
were present when proximal, mid and distal values were averaged for both raters 
individually and when values were averaged across both raters.  For rater 1, there was 
evidence of a small systematic bias, as US underestimated MRI PT CSA by 2.6 mm2 
(p = 0.017) and 5.3 mm2 (p = 0.008) for proximal and distal measurements, 
respectively, compared to MRI. For rater 1, SEE (raw units) ranged from 4.0 - 8.1 
mm2 for proximal, mid and distal measures and 3.3 mm2 when scores were combined. 
Pearson’s r ranged from 0.88 – 0.96 for location specific measures and 0.97 for 
combined scores. For rater 2, SEE ranged from 4.6 – 7.3 mm2 for location specific 
measures and 2.6 mm2 when scores were combined. Pearson’s r ranged from 0.89 - 
0.95 for location specific measures and 0.98 when scores were combined. Collapsed 
scores for raters 1 and 2 produced SEEs that ranged from 3.8 – 4.7 mm2 for location 
specific measures and 2.4 mm2 when scores were combined. Pearson’s r ranged from 




Within-day intra-rater reliability 
Mean ± SD PT CSA scores for within-day, MRI and US analysis are presented in 
Table 3-2. The individual within-day PT CSA scores for rater 1 and rater 2 are 
displayed in Figure 3-4a and Figure 3-4b for US and MRI measurements, respectively. 
For rater 2, US analysis overestimated PT CSA by 1.4 mm2 in measure two compared 
with measure one (p = 0.028) for the proximal PT CSA. No other systematic 
differences between the first and second measure were found for US or MRI analysis. 
TE (raw units) for rater 1 US analysis ranged from 1.5 - 2.7 mm2 for location specific 
measures and 1.4 mm2 for combined scores. In comparison, TE for rater 1 MRI 
analysis range from 4.6 – 6.7 mm2 for location specific measures and was 3.6 mm2 for 
combined scores. TE for rater 2 US analysis ranged from 1.8 – 3.0 mm2 for location 
specific analysis and 1.3 mm2 for combined scores. In comparison, TE for rater 2 MRI 
analysis ranged from 4.5 – 6.7 mm2 for location specific analysis and 3.0 mm2 for 
combined scores. Within-day measures were good (ICC ≥ 0.81) for rater 1 distal MRI, 
rater 2 proximal MRI and distal MRI analysis. All other within-day measures were 








Table 3-1 Agreement between US and MRI measures of patellar tendon cross-
sectional area 
 MRI (mm2) US (mm2) Bias (95% CI) P SEE PCC 
Rater 1           
   Proximal 84.0 ± 14.7 81.4 ± 12.5 –2.6 (–4.6 - –0.5) 0.017* 4.0 0.96 
   Mid 87.8 ± 14.9 82.6 ± 14.0 –5.3 (–9.0 - –1.5) 0.008* 7.9 0.86 
   Distal 91.1 ± 16.6 91.3 ± 14.2 0.2 (–3.6 - 4.0) 0.905 8.1 0.88 
   Mean† 87.6 ± 14.3 86.7 ± 12.6 –0.9 (–2.6 - 0.8) 0.278 3.3 0.97 
Rater 2           
   Proximal 84.5 ± 14.0 83.5 ± 14.3 –0.9 (–3.1 - 1.3) 0.395 4.6 0.95 
   Mid 88.3 ± 16.2 89.3 ± 14.7 1.1 (–1.8 - 3.9) 0.431 6.1 0.93 
   Distal 90.8 ± 15.4 91.1 ± 14.1 0.3 (–3.1 - 3.7) 0.863 7.3 0.89 
   Mean† 87.8 ± 13.9 88.0 ± 14.0 0.2 (–1.1 - 1.4) 0.793 2.6 0.98 
Combined           
   Proximal 84.2 ± 14.3 82.5 ± 13.2 –1.7 (–3.5 - 0.1) 0.055 3.8 0.97 
   Mid 88.0 ± 15.5 88.4 ± 13.8 0.4 (–1.5 - 2.3) 0.673 3.9 0.97 
   Distal 91.5 ± 14.6 91.2 ± 13.9 –0.3 (–2.5 - 1.9) 0.785 4.7 0.95 
   Mean† 87.4 ± 13.2 87.7 ± 14.0 0.4 (–0.9 - 1.6) 0.541 2.4 0.98 
Data are presented as mean ± SD. MRI = magnetic resonance imaging; US = ultrasound 
imaging; CI = confidence interval; P = paired samples t-test; SEE = standard error of the 
estimate; PCC = Pearson correlation coefficient; † = mean score of the proximal, mid and 



























Figure 3-3. Individual data points for the agreement between estimations of patellar tendon 
cross-sectional area using ultrasound and MRI. Panel A = Rater 1, Panel B = Rater 2, Panel B 
= Rater 1 and 2 combined. The solid line represents the line of equality. The dashed red line 
denotes the regression line with corresponding 95% CIs represented in the grey hashed area. 
CSA = cross sectional area. MRI = magnetic resonance imaging. 
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Between-day intra-rater reliability 
The PT CSA scores for between-day US analysis are presented in Table 3-3. The 
individual, between-day PT CSA scores for rater 1 and rater 2 are displayed in Figure 
3-4c for US measurements. No systematic differences were present between visits for 
either rater. TE for rater 1 ranged from 3.2 – 3.5 mm2 for location specific measures 
and was 2.3 mm2 for combined scores. TE for rater 2 ranged from 2.6 – 3.7mm2 for 
location specific measures and was 1.6 mm2 for combined scores. All between-day 
measures were considered excellent (ICC ≥ 0.94).   
Within-day inter-rater reliability 
Patella tendon CSA scores for within-day US and MRI analysis are presented in Table 
3-4. The individual, within-day PT CSA inter-rater scores are displayed in Figure 3-
4d for MRI and US measurements. No systematic differences were found between 
raters for MRI or US analysis. Typical error for US analysis ranged from 3.3 - 4.3 
mm2 for location specific measures and was 2.4 mm2 for combined scores. Typical 
error for MRI analysis ranged from 2.2 - 2.8 mm2 for location specific measures and 
was 1.5 mm2 for combined scores. All within-day, inter-rater scores were considered 














Table 3-2 Within-day intra-rater reliability for estimates of patellar tendon cross-sectional area using US and MRI 
 Measure 1 (mm2)  Measure 2 (mm2) Bias (95% CI) P TE (95% CI) CV (95% CI) ICC SEM SEM% 
Rater 1 US            
   Proximal 81.4 ± 12.5  82.6 ± 14.0 1.2 (–0.5 - 2.9) 0.158 2.5 (1.9 - 3.7) 2.6 (1.9 - 3.8) 0.97 3.6 4.2 
   Mid 87.5 ± 13.5  87.8 ± 14.1 0.3 (–0.8 - 1.2) 0.606 1.5 (1.1 - 2.2) 1.7 (1.3 - 2.5) 0.99 0.8 0.8 
   Distal 91.3 ± 14.2  92.0 ± 13.1 0.7 (–1.1 - 2.5) 0.407 2.7 (2.0 - 3.9) 3.0 (2.3 - 4.5) 0.97 2.3 2.3 
   Mean# 86.7 ± 12.6  87.5 ± 13.1 0.7 (–0.2 - 1.6) 0.117 1.4 (1.0 - 2.0) 1.6 (1.2 - 2.4) 0.99 2.2 2.5 
Rater 1 MRI            
   Proximal 84.0 ± 14.7  82.4 ± 14.0 –1.6 (–4.7 - 1.6) 0.318 4.6 (3.5 - 6.9) 6.0 (4.5 - 8.9) 0.91 4.8 5.3 
   Mid 87.8 ± 14.9  88.7 ± 15.3 0.9 (–2.3 - 4.1) 0.560 4.6 (3.5 - 6.9) 5.8 (4.3 - 8.7) 0.92 2.8 2.9 
   Distal 91.1 ± 16.6  90.4 ± 13.8 –0.6 (–5.2 - 4.0) 0.778 6.7 (5.1 - 9.9) 7.6 (5.7 - 11.4) 0.82 1.9 1.9 
   Mean# 87.6 ± 14.3  87.2 ± 13.5 –0.4 (–2.7 - 1.9) 0.700 3.6 (2.5 - 5.0) 4.1 (3.1 - 6.1) 0.95 1.3 1.4 
Rater 2 US            
   Proximal 83.5 ± 14.3  84.9 ± 14.2 1.4 (0.2 - 2.5) 0.028* 1.8 (1.3 - 2.6) 2.1 (1.6 - 3.1) 0.99 4.2 4.6 
   Mid 89.3 ± 14.7  89.0 ± 14.2 –0.4 (–1.8 - 1.0) 0.574 2.0 (1.5 - 3.0) 2.3 (1.7 - 3.4) 0.98 1.2 1.2 
   Distal 91.1 ± 14.1  91.2 ± 13.6 0.1 (–1.9 - 2.2) 0.894 3.0 (2.3 - 4.4) 3.2 (2.4 - 4.8) 0.96 0.4 0.4 
   Mean# 88.0 ± 14.0  88.4 ± 13.5 0.4 (–0.5 - 1.3) 0.400 1.3 (1.0 - 2.0) 1.5 (1.1 - 2.2) 0.99 1.1 1.2 
Rater 2 MRI            
   Proximal 84.5 ± 14.0  83.1 ± 13.0 –1.3 (–4.8 - 2.1) 0.423 5.1 (3.8 - 7.5) 6.4 (4.8 - 9.6) 0.87 4.1 4.6 
   Mid 88.3 ± 16.2  88.3 ± 15.4 0.0 (–3.1 - 3.1) 0.997 4.5 (3.4 - 6.7) 5.5 (4.1 - 8.2) 0.93 0.0 0.0 
   Distal 90.8 ± 15.4  91.9 ± 13.9 1.1 (–3.5 - 5.7) 0.626 6.7 (5.1 - 9.9) 8.0 (6.0 - 12.0) 0.81 3.3 3.4 
   Mean# 87.8 ± 13.9  87.8 ± 13.1 –0.1 (–2.1 - 2.0) 0.931 3.0 (2.3 - 4.5) 3.7 (2.8 - 5.6) 0.96 0.3 0.3 
Data are presented as mean ± SD. CI = confidence interval; P = paired sample t-test; TE = typical error; CV = coefficient of variation expressed 
as a percentage; ICC = intraclass correlation coefficient; SEM = standard error of measurement (mm2); SEM% = standard error of measurement 
expressed as a percentage of the mean; US = ultrasound imaging; MRI = magnetic resonance imaging; * = significantly different between 






Table 3-3 Between-day intra-rater reliability for estimates of patellar tendon cross-sectional area using US imaging 
 Visit 1 (mm2) Visit 2 (mm2) Bias (95% CI) P TE (95% CI) CV (95% CI) ICC SEM SEM% 
Rater 1              
   Proximal 81.4 ± 12.5 83.3 ± 14.7 2.0 (–0.4 - 4.3) 0.096 3.4 (5.6 - 5.0) 4.1 (3.1 - 6.1) 0.94 6.0 6.9 
   Mid 87.5 ± 13.5 88.4 ± 14.2 0.9 (–1.5 - 3.4) 0.426 3.5 (2.7 - 5.2) 4.1 (3.1 - 6.2) 0.94 2.9 3.1 
   Distal 91.3 ± 14.2 90.9 ± 14.8 –0.4 (–2.5 - 1.8) 0.737 3.2 (2.4 - 4.7) 3.4 (2.6 - 5.1) 0.96 1.1 1.1 
   Mean# 86.7 ± 12.6 87.6 ± 13.9 0.9 (–0.7 - 2.4) 0.278 2.3 (1.8 - 3.5) 2.7 (2.0 - 4.0) 0.97 2.6 2.9 
Rater 2              
   Proximal 83.5 ± 14.3 84.1 ± 14.1 0.5 (–1.5 - 2.6) 0.599 3.0 (2.3 - 4.5) 3.8 (2.9 - 5.7) 0.96 1.6 1.8 
   Mid 89.3 ± 14.7 88.2 ± 14.3 –1.2 (–3.7 - 1.3) 0.335 3.7 (2.8 – 5.5) 4.2 (3.2 – 6.3) 1.00 3.7 4.2 
   Distal 91.1 ± 14.1 90.3 ± 14.5 –0.8 (–2.6 - 1.0) 0.339 2.6 (2.0 - 3.9) 3.0 (2.2 - 4.4) 0.97 2.6 2.7 
   Mean# 88.0 ± 14.0 87.5 ± 13.8 1.6 (1.2 - 2.3) 0.344 1.6 (1.2 - 2.3) 1.8 (1.4 – 2.7) 1.00 1.5 1.6 
Data are presented as mean ± SD. CI = confidence interval; P = paired sample t-test; TE = typical error; CV = coefficient of variation expressed as 
a percentage; ICC = intraclass correlation coefficient; SEM = standard error of measurement (mm2) ; SEM% = standard error of measurement 
expressed as a percentage of the mean; US = ultrasound imaging; * = significantly different between visit 1 and visit 2; # = mean score of the 
proximal, mid and distal scores 
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Table 3-4 Within-day inter-rater reliability for estimates of patellar tendon cross-sectional area using US and MRI 
 Rater 1 (mm2) Rater 2 (mm2) Bias (95% CI) P TE (95% CI) CV (95% CI) ICC SEM SEM% 
Ultrasound              
   Proximal 81.4 ± 12.5 83.5 ± 14.3 2.2 (–0.4 - 4.7) 0.890 3.7 (2.8 - 5.5) 4.6 (3.4 - 6.8) 0.93 6.6 7.6 
   Mid 87.5 ± 13.5 89.3 ± 14.7 1.8 (–1.0 - 4.8) 0.203 4.3 (3.2 - 6.3) 4.8 (3.6 - 7.2) 0.92 5.7 6.0 
   Distal 91.3 ± 14.2 91.1 ± 14.1 –0.2 (–2.4 - 2.0) 0.858 3.3 (2.5 - 4.8) 3.9 (3.0 - 5.9) 0.95 0.6 0.6 
   Mean# 86.7 ± 12.6 88.0 ± 14.0 1.3 (–0.4 - 2.9) 0.127 2.4 (1.8 - 3.6) 3.0 (2.3 - 4.5) 0.97 3.9 4.3 
MRI              
   Proximal 84.0 ± 14.7 84.5 ± 14.0 0.5 (–1.0 - 2.0) 0.503 2.2 (1.7 - 3.3) 3.0 (2.3 - 4.5) 0.98 1.5 1.7 
   Mid 87.8 ± 14.9 88.3 ± 16.2 0.4 (–1.5 - 2.4) 0.649 2.8 (2.2 - 4.2) 3.2 (2.4 - 4.8) 0.97 1.3 1.4 
   Distal 91.1 ± 16.6 90.8 ± 15.4 –0.3 (–1.6 - 1.1) 0.691 2.0 (1.5 - 2.9) 2.1 (1.6 - 3.1) 0.99 0.8 0.8 
   Mean# 87.6 ± 14.3 87.8 ± 13.9 0.2 (–0.8 - 1.2) 0.653 1.5 (1.1 - 2.2) 1.6 (1.2 - 2.4) 0.99 0.7 0.8 
Data are presented as mean ± SD. CI = confidence interval; P = paired sample t-test; TE = typical error; CV = coefficient of variation expressed as 
a percentage; ICC = intraclass correlation coefficient; SEM = standard error of measurement (mm2); SEM% = standard error of measurement 














Figure 3-4.  Panel A = Within-day, intra-rater reliability of estimates of PT CSA using US, Panel B = Within-day, intra-rater reliability of estimates of PT CSA using MRI, 
Panel C = Between-day, intra-rater reliability of estimates of PT CSA using US Panel D = Within-day inter-rater reliability of estimates of PT CSA using US and MRI. The 
solid black line represents the line of equality. In panels A, B and C, the dashed red line denotes the regression line for rater 1, and the dashed blue line denotes the regression 
line for rater 2. In panel D, the dashed red line denotes the regression line for US, and the dashed blue line denotes the regression line for MRI. The white dots represent 
individual data points for rater 1. The black dots represent individual data po ints for rater 2. The white diamond represents data points for US. The black diamond represents 




The aims of this study were to 1) determine the agreement between US and MRI measures of 
PT CSA for two independent raters 2) determine the within-day, inter- and intra-rater reliability 
for US and MRI measures of PT CSA and, 3) determine the between-day, intra-rater reliability 
of US measures of PT CSA. This study has demonstrated that there are high levels of agreement 
between US and MRI derived measures of PT CSA. Moreover, both US and MRI provide 
reliable within-day inter- and intra-rater measures of PT CSA. Finally, US provides reliable 
between-day, intra-rater measures of PT CSA. The results of this study are of particular 
importance as rater 1 will conduct measures of PT dimensions in the studies in chapters 4 and 
5. As tendon dimensions will be used to calculate the mechanical properties of the tendon 
during exercise in the subsequent studies in this thesis, the high reliability of PT CSA measures 
by rater 1 in the current study can provide confidence that any changes discovered over time 
are unlikely to be due to variability in the measurement technique.  
Agreement between MRI and US measures 
Patellar tendon CSA values measured using US were systematically smaller compared with 
MRI for rater 1 at the proximal and mid regions of the PT (‒2.6 mm2, and ‒5.3 mm2, 
respectively) but no systematic differences were found for the more experienced rater 2. In 
agreement with the present study, Stenroth et al. (2019) found that US derived measures of the 
AT were smaller than MRI measures, when the rater was inexperienced. However, for the PT, 
the more experienced rater underestimated CSA (mean of proximal mid and distal CSA) values 
derived from US measures in comparison to MRI, though the inexperienced rater showed no 
systematic difference between the two methods for the PT. In contrast, Kruse et al. (2017) 
reported consistent underestimation of AT CSA by US in comparison to MRI for both raters, 
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although their experience was not specified. Given the contrasting results, there appears to be 
no consistent link between rater experience and US vs MRI tendon CSA comparison.  
Though there was systematic underreporting of proximal and mid PT CSA measures by US, 
compared to MRI in the present study, there were no systematic differences between US and 
MRI for either rater when all three sites (proximal, mid and distal) were combined and averaged 
for each participant. This is an important finding, as the mean score is commonly used to 
estimate average tendon CSA and subsequently calculate tendon stiffness and YM (Onambele 
et al., 2007, Murtagh et al., 2018, Maganaris and Paul, 1999, Kongsgaard et al., 2007, Hicks et 
al., 2013, Couppe et al., 2016, Couppe et al., 2008). Stenroth et al. (2019), who also used the 
method of measuring tendon CSA by averaging the proximal, mid and distal CSA values, 
reported that agreement between MRI and US measures of PT CSA was greater for the 
experienced rater (Pearson’s r = 0.87), who had experience of musculoskeletal imaging (similar 
to the experienced rater in the current study)  in comparison to the inexperienced rater 
(Pearson’s r = 0.44). In comparison, the present study found similar agreement between the 
experienced (Pearson’s r = 0.44). In comparison, the present study found similar agreement 
between the experienced (r = 0.97, SEE = 3.3 mm2) and less experienced rater (r = 0.98, SEE 
= 2.6 mm2), providing evidence that rater experience was not essential to levels of agreement. 
Additionally, agreement between MRI and US measures of PT CSA for both raters in the 
present study was higher than that for the experienced rater in the study by Stenroth et al. 
(2019). One potential reason for the difference between the studies could be due to the present 
study using a stronger magnet (0.35 T) in the MRI machine than the study by Stenroth et al. 
(2019) (0.18 T), with higher magnetic fields having better signal to noise ratios, typically 
producing higher quality images, though this does not necessarily result in more reliable images 
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(Trattnig et al., 1997). To date, no studies have directly assessed the effect of MRI magnet 
strength on estimating tendon dimensions, and the relationship between the two remain unclear.  
Within-day intra-rater reliability 
Rater 1 reported no systematic differences for within-day measures of US or MRI at any of the 
location specific measures or for combined PT CSA. Rater 2 overestimated PT CSA on 
measure two in comparison to measure one (1.4 mm2) for US, whereas no systematic 
differences between measures for MRI were reported. The overestimation of PT CSA by US 
at the proximal site might be explained by two reasons. Firstly, in an attempt to sharpen the 
image quality, rater 2 might have re-positioned the probe distally, during the second measure. 
Although exploratory, this explanation is supported by a greater CSA reported at the mid-
tendon, therefore any distal movement in US probe could explain the inflated estimation of PT 
CSA at the proximal site. The second reason might be attributed to a slight adjustment in probe 
orientation whilst scanning. Slight adjustments in probe angle can result in an increased 
diameter when positioned slightly askew (Gellhorn and Carlson, 2013), much like cutting into 
a cucumber at a bias. Nevertheless, the systematic difference in the present study was confined 
to the proximal site of the PT, with no difference occurring when the three locations were 
combined, which, as mentioned previously, is the measure used to further calculate Young’s 
modulus (Murtagh et al., 2018, Kongsgaard et al., 2007, Hicks et al., 2013, Couppe et al., 2016, 
Couppe et al., 2008).   
Within-day, intra-rater reliability of PT CSA estimations has received little study, with the 
available literature producing differing results. In the present study, relative reliability for US 
derived estimation of PT CSA, when proximal, mid and distal sites are averaged, was 
considered excellent, with an ICC of 0.99 for both raters which, in comparison to Gellhorn and 
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Carlson (2013) and Ekizos et al. (2013), who reported ICCs of 0.87-0.96 and 0.79, respectively, 
suggests a higher level of reliability, thus giving confidence that rater 1 can produce highly 
reliable measures of PT CSA, which will be used to assess Young’s modulus in studies 2 and 
3.  
To the best of my knowledge the present study is the first to investigate the within-day, intra-
rater reliability of MRI estimates of  PT CSA, making comparison to other literature difficult. 
Two comparisons that can be made are from the studies by Kubo et al. (2001) and Stenroth et 
al. (2019) who assessed PT CSA estimations by MRI over two separate days. KUBO (2001) 
reported a CV of 1.6% where as Stenroth et al. (2019) reported CVs of 4.1% and 6.0% for 
experienced and inexperienced raters, respectively. The CVs of 4.1% and 3.7% in the present 
study for rater 1 and rater 2, respectively, are more in line with Stenroth et al. (2019) than Kubo 
et al. (2001). It is possible that the higher reliability displayed by Kubo et al. (2001) is due to 
the small sample size of six participants which can affect estimates of error (Springate, 2011), 
in comparison to 19 and 15 participants in the present study and the study by Stenroth et al. 
(2019), respectively. Moreover, it is unclear if the reliability figure presented by Kubo et al. 
(2001) is obtained from a single, experienced rater or not. If so, it would be possible that this 
is the reason for the high reliability presented, as it has been suggested that reliability can be 
optimised by using one experienced rater (Thoirs and Childs, 2018).   
An unexpected finding in the present study was that for both raters, both relative reliability and 
absolute reliability was higher for US in comparison to MRI for all locations and mean PT 
CSA estimations, though reliability for all mean estimations for US and MRI PT CSA were 
considered excellent (ICC = ≥ 0.95). The most likely estimation for this is the technique used 
to determine the examination positions. The US examinations in the present study determined 
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the three measurement locations (proximal, mid and distal) prior to the scan being performed. 
In the MRI examinations, the image chosen for CSA analysis was chosen post-test, using the 
sagittal scan as a guide. Though anatomical landmarks were still used to determine 
measurement locations, slight variation in the positioning of the participant might have led to 
the images being analysed being slightly biased towards the proximal or distal insertion of the 
PT. Most likely, this was a combination of both, which would explain the lower reliability but 
a lack of a systematic difference between measures. 
Between-day intra-rater reliability 
Due to MRI availability, between day reliability, assessed by two visits, three days apart, was 
assessed for US measures only. In comparison to Stenroth et al. (2019), who also estimated PT 
CSA on two separate occasions using US, the present study showed higher reliability. Relative 
reliability was higher for both raters within the present study (ICCs 0.97 and 0.99, rater 1 and 
rater 2, respectively) in comparison to both raters (ICCs 0.85 and 0.50, respectively) in the 
study by Stenroth et al. (2019), with their second rater being less experienced than the first. 
Raters 1 and 2 in the present study also displayed higher absolute reliability in comparison to 
the two raters in the study by Stenroth et al. (2019), with SEMs of 2.6 and 1.5 mm2 vs 5.0 and 
8.9 mm2, respectively. Consistent with the lower reliability reported for within-day, intra-rater 
US measures of PT CSA, Ekizos et al. (2013) reported lower reliability (mean ICC 0.60) than 
the present study and Stenroth et al. (2019). Ekizos et al. (2013) attributed the low levels of 
reliability to low image quality obtained from US, making the distinction of the tendon borders 
difficult. This appears to not be the case both in the present study and the reliability reported 
by Stenroth et al. (2019). One explanation for this could be the US machine used by Ekizos et 
al. (2013), as research has suggested that differences in equipment can affect intra-rater 
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reliability (Gellhorn and Carlson, 2013). Although, Ekizos et al. (2013) and the current study 
both used 7.5 Hz linear array probes, therefore and differences in reliability due to the 
equipment might be due to differences in manufacturer specifications, though this needs further 
investigation. Additionally, the technique used to define PT measurement sites by Ekizos et al. 
(2013) was to use the first image below the patellar bone and above the tibia as the location for 
the proximal and distal measurement, respectively. This therefore might open some subjectivity 
between raters as to where the proximal and distal regions are located , which could have 
differed between visits via slightly different probe orientation, for example. In the present 
study, and the study by Stenroth et al. (2019), anatomical landmarks (apex of the patellar and 
the tibia tuberosity) were used to define the origin and insertion of the PT, the proximal, mid 
and distal examination sites were then mathematically calculated based on these measurements. 
As this process was repeated on both visits, it would appear that this process might account for 
the higher reliability recorded in the present study and the study by Stenroth et al. (2019), in 
comparison to Ekizos et al. (2013), hence validating the importance of a consistent examination 
protocol which in turn, might improve reliability (Thoirs and Childs, 2018).  
Inter-rater reliability 
For both US and MRI, intra-rater reliability was considered excellent (ICC = ≥ 0.92), with MRI 
slightly higher in terms of relative and absolute reliability and no systematic differences present 
for any measures. Inter-rater reliability was considerably higher in the present study compared 
to Stenroth et al. (2019) for both relative (US ICCs 0.97 vs 0.56, MRI ICCs 0.99 vs 0.62) and 
absolute (US SEM 0.7 mm2 vs 6.0 mm2) reliability. The large inter-rater differences between 
the two studies can be attributed to the large difference in experience of the raters in the study 
by Stenroth et al. (2019), with the inexperienced rater having no prior experience in 
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musculoskeletal radiography. In the present study, although rater 1 was less experienced than 
rater 2, a substantial level of practice with the digitisation process was undertaken before the 
study. Research has shown that increased experience can improve the reliability of US 
measures (Dudley-Javoroski et al., 2010) although it remains to be determined exactly what 
level of experience is needed to produce high levels of reliability.  
Limitations 
 The present study provides important methodological evidence which will allow the 
interchangeable use of US and MRI in estimating PT CSA. However, this study is not without 
its limitations. Specifically, the estimation of PT CSA for both US and MRI were based on the 
judgements of the raters and their interpretation of the tendon borders. Although agreement 
between the two studies was excellent, it cannot be ruled out that the true CSA is what was 
measured by MRI analysis. It is difficult to ascertain if both the US and MRI images included 
the paratenon, due to it not being clearly identifiable (Bohm et al., 2016). This gross over- or 
under-estimation might have consequences for subsequent mechanical calculations pertaining 
to PT CSA (e.g. Young’s Modulus), and whilst within study comparisons would not be 
affected, extrapolation to other populations might be difficult. In addition, despite the 
procedures within the study being of high consistency, they do differ to other PT CSA 
estimation studies (e.g. examination location).  
Another limitation is the time period between the test days of the US measurements. With only 
three days in between each measure, the test-retest reliability of scores over longer time 
periods, is not known. Whilst this approach ensures that the US measures are comparable, it 
does not consider the potential change in diameter of tendons that can occur over time with 
exercise (Tardioli et al., 2012). With the subsequent chapters in this thesis including an 
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exercising population, and studying responses over longer time periods (i.e. the RBE), these 
physiological considerations must be considered. Finally, caution must be taken if future 
research utilises equipment that is different to that used in the present study or uses raters of 
different musculoskeletal radiography experience, as this might affect the reliability of any 
subsequent results.  
Conclusion 
This present study shows that PT CSA obtained via the use of US is a reliable tool both within 
and between operators. Moreover, US and MRI can be used interchangeably to assess PT CSA; 
this would not be recommended within the same study but could be used as a way of comparing 
studies with different means of image acquisition. Although this study contradicts reports of 
reliability from earlier research, this is most likely dependent on the strictness of scanning 
protocol and operator experience. In subsequent chapters in this thesis, rater 1 will be 
performing all US scanning procedures. Therefore, it is with confidence that the PT CSA 
measures obtained by the rater will be accurate and reliable. As such, the subsequent chapter 
will measure tendon forces during exercise, with the PT CSA measure being used to calculate 
YM. In the wider context of the thesis, this measure of YM will be used to determine changes 
in the behaviour of the PT following maximal ECC exercise, with this change in tendon 




CHAPTER 4 TEST-RETEST RELIABILITY OF MEASURING 
PATELLA TENDON PROPERTIES AND MUSCLE FASCICLE 
LENGTH CHANGES IN THE VASTUS LATERALIS DURING 





Chapter 3 confirmed that US is a valid and reliable method of measuring PT CSA which is 
important due to PT CSA being part of the equation used to calculate YM (Onambele et al., 
2007). However, PT CSA is a resting measure and can only partially account for the 
behavioural properties of tendon during dynamic exercise. During maximal isometric knee 
extension exercise, PT properties such as stiffness and YM can also be measured using US 
(Onambele et al., 2007, Hicks et al., 2013, Fukunaga et al., 1996). Moreover, US can also be 
used to measure muscle behaviour during maximal knee extension exercise (Penailillo et al., 
2015, Hicks et al., 2017, Hicks et al., 2013, Guilhem et al., 2016). The ability to measure both 
tendon and muscle behaviour in real time during exercise makes US an attractive prospect for 
researchers, given that there is evidence to suggest that the behaviour of the muscle is mediated 
by properties of the tendon (Hicks et al., 2013, Guilhem et al., 2016). 
Magnetic resonance imaging is an alternative method of measuring muscle and tendon 
properties and has some advantages over US, such as the ability to measure large areas of 
muscle simultaneously (Lieber and Ward, 2011, Finni, 2006) and has high spatial resolution, 
leading to high image quality  (Lieber and Ward, 2011). However, MRI is expensive and unlike 
US, usually requires participants to remain stationary (Narici, 1999), limiting the dynamic 
measurement of muscle and tendon properties. This typically leads to researchers using US to 
measure muscle and tendon behaviour when movement is involved. An immediate advantage 
of the use of US in dynamic movements is that US allows the quantification of the independent 
contribution of muscle and tendon to total MTU behaviour (Reeves and Narici, 2003, Fukunaga 
et al., 1997), which is important so that the relationship between muscle and tendon properties 
and their behaviour during movement can be investigated.  
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Many variables can be quantified by US during dynamic activity; however, muscle fascicle  
behaviour has received attention in the literature for a number of reasons. Firstly, muscle 
fascicles are closely related to sarcomere length (Lichtwark et al., 2018), which has been shown 
to have an indirect relationship with muscle energetics and force production (Bohm et al., 
2018). Moreover, during ECC exercise, the magnitude of muscle fascicle lengthening has been 
shown to influence the muscle damage response (Guilhem et al., 2016, Hicks et al., 2017). 
Additionally, reduced muscle fascicle lengthening during the second of two identical bouts of 
ECC exercise has been associated with a reduced magnitude of EIMD (Penailillo et al., 2015). 
There is also evidence that muscle fascicle lengthening during maximal ECC exercise is greater 
for males in comparison to eumenorrheic females, and that this leads to a higher amount of 
circulating CK levels in the blood (Hicks et al., 2016), though no fascicle lengthening 
differences have been shown between eumenorrheic females and OCP using females. 
Nevertheless, given the evidence that the degree of fascicle lengthening can be related to EIMD 
magnitude, it is important that fascicle lengthening is measured as accurately and reliably as 
possible to confirm this relationship. 
The reliability of any measurement tool must be established before there can be confidence in 
any result obtained from the measure, with US being no exception. A systematic review by 
Kwah et al. (2013) assessed the use of US to measure muscle fascicle length and pennation 
angle (PA) and concluded that US generally provides valid and reliable measures. However, 
the majority of studies in this review were based on resting, passive or isometric conditions, 
making it difficult to extrapolate those findings to studies that investigate dynamic actions; 
specifically, maximal ECC exercise. Unlike isometric contractions, there is substantial 
lengthening of the MTU during ECC contractions, which can be altered by lengthening of the 
tendon (Lichtwark and Wilson, 2007, Joseph et al., 2016), the muscle fascicles (Hicks et al., 
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2013, (Penailillo et al., 2015), or a combination of both (Guilhem et al., 2016). Additionally, it 
has been reported that MTU behaviour is different between males and females (Hicks et al., 
2013). More recently, Van Hooren et al. (2020) concluded that US was a reliable method of 
determining fascicle length and PA during movement, including ECC exercise, if certain 
recommendations were incorporated. These included using probe holders to minimise 
alterations in probe orientation, using probes with a large field of view, and to maximize 
sampling frequency by minimising image depth. Therefore, as reliability is potentially 
dependent on one or more of these factors, further research implementing these 
recommendations by Van Hooren et al. (2020) is warranted.   
Obtaining US measurements of fascicle behaviour during lengthening actions is challenging, 
and it is essential to ensure high test-retest reliability. The systematic review by Van Hooren et 
al. (2020) included only one study that investigated the reliability of measuring VL fascicle 
lengthening during maximal ECC exercise. This study by Guilhem et al., (2011) reported ICCs 
of 0.82, 0.75 for VL fascicle lengthening and pennation angle, respectively. Additionally, this 
study was conducted on just five participants, over two visits  separated by one day. In a 
subpopulation of five males, Hicks et al. (2013) investigated the reliability of VL fascicle 
lengthening during maximal ECC exercise across two visits, separated by four days, where an 
ICC of 0.998 was reported. These two studies reported excellent reliability [ICC ≥ 0.9 (Koo 
and Li, 2016)] but the short test-retest period does not account for any fluctuations in muscle 
fascicle architecture that might happen over time. In this thesis, the final study will be 
measuring PT and VL fascicle properties using US with ~ four weeks in between visits. 
Therefore, reliability of these US measures of PT and VL properties needs to be assessed with 
a four-week test-retest period, to give confidence that any findings in the final study between 
visits are due to the exercise intervention and not measurement error. Therefore, the aim of this 
121 
 
study was to determine the reliability of using US to quantify PT properties at rest and during 
maximal isometric exercise, and VL properties at rest and during maximal ECC exercise. This 
is to be completed with a large participant number, over three visits, which has been suggested 
as a minimum requirement for reliability studies (Hopkins, 2000). Moreover, no reliability 
studies investigating VL properties during maximal ECC exercise and tendon properties during 
maximal ISO exercise have included a female population, despite reported sex differences in 
patella tendon (Onambele et al., 2007) and VL fascicle lengthening (Hicks et al., 2013) during 
maximal exercise. Therefore, a subgroup analysis will be performed to determine the reliability 
of the same measures for males, females using the oral contraceptive pill and eumenorrheic 
females to reflect the participant groups to be used in the final study.  
4-2 METHODS 
4-2.1 Participants 
A total of 36 participants were recruited for the study, and divided into three groups; 1) twelve 
males (age: 23 ± 4 years; stature: 1.79 ± 0.11 m; mass: 87.1 ± 10.8 kg); 2) 12 females (age: 22 
± 6 years; stature: 1.68 ± 0.08 m; mass: 62.3 ± 11.7 kg) taking a monophasic OCP; and 3) 12 
eumenorrheic females (age: 24 ± 4 years; stature: 1.69 ± 0.06 m; mass: 69.1 ± 10.4 kg) who 
had not used any form of hormonal contraception for the past 12 months  (self-reported). 
Participants completed a pre-test questionnaire (Appendix 2) and were included in the study 
only if they had no neuromuscular or musculoskeletal impairments in the lower limbs within 
the last six months. Female participants completed an additional menstrual health questionnaire 
(Appendix 2). All participants self-reported as being physically active, participating in at least 
one lower body resistance session per week. Females in the OCP group reported taking a 
combined monophasic OCP, with estradiol doses between 20-30 µg, for an average of 4 ± 2 
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years. The types of monophasic OCP used in this study were taken daily for 21 days, followed 
by a 7-day, withdrawal phase. Females in the eumenorrheic group reported a regular menstrual 
cycle (mean length 27 ± 2 days). A regular menstrual cycle was defined as 24-36 days 
(Landgren et al., 1980, Cole et al., 2009). Female participants with menstrual cycles outside of 
this regular range, or females who were pregnant in the year preceding the study were excluded. 
Institutional ethical approval was received from the Northumbria University Faculty of Health 
& Life Sciences Ethics committee in accordance with the Declaration of Helsinki. Participants 
were supplied with a participant information sheet, detailing the purpose of the study and gave 
written consent before participating (Appendix 1). 
4-2.2 Experimental design 
Participants were asked to visit the laboratory on four occasions; one practice session and three 
experimental visits. The practice visit included measures of anthropometrics, PTMA and 
dynamometer familiarisation. The three experimental trials consisted of resting measures of 
VL architecture and PT dimensions using US. Additionally, measures of PT stiffness and 
optimal angle of force production of force production (OA) during iMVCs were recorded. 
Following that, VL fascicle lengthening was recorded using US during maximal ECC knee 
extension exercise. The first and second experimental visit were separated by one week. The 
first and third experimental visits were separated by four weeks for males and OCP taking 
females. For eumenorrheic females, to ensure consistency in the menstrual cycle phase between 
two consecutive cycles, and to reflect the menstrual cycle phase in which the eumenorrheic 
females in chapter 5 were to be tested, the first and third experimental visits were during the 
mid-luteal phase of the menstrual cycle (~four weeks apart), calculated from a positive 




The practice session began with the collection of stature and mass, measured using a portable 
stadiometer (Seca model 213; Seca, Hamburg, Germany) and digital scales (Seca model 813; 
Seca, Hamburg, Germany) respectively. This was followed by a dual‐energy X‐ray 
absorptiometry scan (DXA) to measure the PTMA of the non‐ dominant leg (defined as the leg 
used to provide stability during movements e.g. kicking) at a 90° knee angle (0° = full 
extension). The participant was then familiarised with the physical requirements of the testing 
procedure. This involved sitting in an isokinetic dynamometer (System 4 Pro, Biodex Medical 
Systems Inc., NY, USA) and taking the non‐dominant leg passively through a pre -determined 
range of motion (30°‐110° knee extension). Following three sub-maximal efforts, participants 
then performed iMVCs of the knee extensors against the lever arm of the dynamometer at 70° 
and 80° knee angles to practice contractions at different knee angles. This was followed by a 
ramped iMVC at 80° knee angle, with the aim of reaching their previous iMVC torque in a 
time of 4‐6 seconds, as linear as possible, as this was the contraction type used to assess tendon 
stiffness (see below). The knee angle used in the practice session was reduced by 10° in 
comparison to the experimental visits as iMVCs at long muscle lengths can confer a protective 
effect against EIMD in subsequent exercise sessions (Chen et al., 2012b). Participants received 
a demonstration of maximal ECC contractions of the knee extensors to familiarise the 
participant with the action of the dynamometer. No ECC knee extensor exercise was included 
in the practice trial, as previous research has demonstrated that even very small volumes of 






Visit 1 began with the collection of resting measures of VL length, width , thickness, CSA, 
fascicle length (FL), and PA using US, in a supine position to control for changes in 
intramuscular fluid between lying and standing and to enhance US image quality (Berg et al., 
1993). Participants then transferred to the dynamometer where they were seated in an upright 
position and the non-dominant leg positioned at 90°. Patella tendon length and CSA were then 
recorded (described in section 3-2.2). Following three sub-maximal warm up attempts, 
participants then performed two ramped iMVCs whilst patella and tibia tuberosity 
displacement was measured to assess tendon elongation, which was subsequently used to 
calculate tendon stiffness (described below). Following this, the OA of force production was 
determined by a series of iMVC contractions at different knee angles (described below). 
Following this, two sets of five maximal ECC contractions of the knee extensors, through a 
range of motion between 30°‐ 110° knee angle (0° = full extension) , were performed  in the 
isokinetic dynamometer at an angular velocity of 30°·s‐1 during the ECC phase, and an 
automatic passive return to full extension at 60°·s‐1 in the CON phase, with 120 s between sets. 
Visits 2 and 3 followed the same protocol as visit 1, one week and four weeks later, 
respectively, and data obtained were assessed for reliability. One ‐week retest reliability (visit 
1 to 2) was used to assess the reliability of all ultrasound-based measures with minimal 
biological variability. Four‐week retest reliability (visit 1 to 3) was assessed as the variability 
across this time period was considered important as it replicated the proposed intervention 
duration of the subsequent experimental chapter (chapter five) of this thesis. In between visits, 
participants were instructed to live habitually, with the exception of avoiding lower body 
exercise for 24 h prior to each visit. 
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For the initial experimental visit, females taking the OCP were tested on the day of the 14 th pill 
ingestion (self-reported). Eumenorrheic females were tested during the mid-luteal phase of the 
menstrual cycle. This was achieved by confirming ovulation and testing these participants 
approximately seven days (± one day) after. This procedure was implemented before 
experimental visits one and three for this population. For eumenorrheic females, experimental 
visit one will take place in the mid-luteal phase of the menstrual cycle and visit two, that will 
assess the seven-day reliability, will take place in the late luteal or early follicular phase of the 
menstrual cycle. Although visits one and two will be in slightly different stages of the menstrual 
cycle and therefore might have differences in circulating levels of oestrogen and progesterone, 
the strength of evidence suggests that short term fluctuations in these hormones across the 
menstrual cycle does not influence the mechanical properties of human muscle and tendon 
(Kubo et al., 2009). A detailed description of all experimental procedures can be found below. 
4-2.3 Procedures 
Anthropometric measurements 
Stature and mass were measured as described in section 3-2.3. Mid-thigh circumference (MTC) 
was defined as the mid-point between the Trochanterion and Tibiale laterale and measured 
using a standard anthropometric tape. 
Vastus Lateralis fascicle length and pennation angle 
A real-time B-mode ultrasound (HDI 5000 SonoCT, Philips, Amsterdam, Netherlands) was 
used to obtain resting measures of VL FL, and CSA of the non-dominant leg. With the 
participant laying in a supine position with the leg fully extended, an ultrasound probe (7.5 
MHz linear array probe, 50 mm wide) was used to identify the distal and proximal insertion 
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sites of the VL, where marks were placed on the skin, with the distance between the two marks 
recorded as VL length. At 50% VL muscle length, the border where the VL meets the rectus 
femoris (RF) and biceps femoris (BF) was located using the ultrasound probe and marked on 
the skin. The distance between the VL-RF and VL-BF boundaries indicated VL muscle width. 
The location where 50% muscle length and width met was denoted by a cross in permanent 
marker. This was the location of the ultrasound probe during all measures of VL muscle fascicle 
length. Additionally, this process of determining the location of the ultrasound probe was 
repeated for each individual visit. An echo absorptive marker was placed on the skin at the 
measurement location to provide a visual baseline of the internal VL structure and to ensure 
that there was no movement artefact confounding the measurement of FL. Resting VL FL was 
taken at this location by placing the ultrasound probe perpendicular to  the skin in the mid-
sagittal plane and orienting the probe as precisely as possible with the fascicle. Ultrasound 
images were recorded in real time at 25 frames per second using image acquisition software 
(AVer Media Capture Studio, AVer Media Technologies, New Taipei City, Taiwan) and 
analysed offline using imaging software (ImageJ 1.45; National Institutes of Health, Bethesda, 
MD, USA). Fascicle length was measured from the visible insertion of the fibre into the deep 
or superficial aponeurosis. If the fascicle extended beyond the width of the ultrasound image, 
linear continuation to calculate FL was applied (Figure 4-1), with this method of measuring FL 
typically yielding an error of 2-7% (Finni et al., 2003, Finni et al., 2001). To reduce error using 
the linear continuation method, an average of three fascicles was assessed for each image. In 
each image where VL FL was determined, PA for the corresponding fascicle was measured 
(Figure 4-1). The PA was determined as the angle between the deep aponeurosis and the muscle 

















Figure 4-1 An example of the linear continuation method used to estimate VL fascicle length at rest 
and measures of muscle thickness and pennation angle (PA). A) 30° knee angle (0° = full extension) B) 






Vastus lateralis anatomical cross-sectional area and muscle thickness 
To measure anatomical VL CSA, at 50% VL length, echo-absorptive markers were placed at 
30 mm intervals from the medial to the lateral edge of the VL muscle. The ultrasound probe 
was placed in the axial plane, perpendicular to the VL muscle and moved slowly across the 
echo-absorptive markers. The images obtained were aligned using the shadows cast by the 
echo-absorptive markers and the contour of the muscle. This allowed the entire VL cross -
sectional area to be re-created using imaging software (Adobe Photoshop Elements, version 
15, Adobe). The VL cross-sectional area was then measured using the imaging software 
described previously.  
Vastus lateralis muscle thickness was measured by placing the US probe in the transverse plane 
perpendicular to the skin. The site of measurement was the same as where VL FL was 
measured, at 50% VL length and width. Thickness of the VL was measured as the distance 
between the adipose tissue-VL interface and the VL-vastus intermedius interface (Kubo et al., 
2001) which is displayed in Figure 4-1. 
Tendon length and cross-sectional area 
Patella tendon length and CSA were assessed using the methods described in section 3-2.3.  
Patella tendon stiffness 
To measure PT stiffness, participants performed isometric actions in an isokinetic 
dynamometer (System 4 Pro, Biodex Medical Systems Inc., NY, USA). The dynamometer 
settings and 0° knee extension (full extension) used during the initial experimental visit were 
recorded and standardised throughout all subsequent visits. Prior to performing any actions, 
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the knee was fixed by inextensible straps at 90° and inextensible straps were placed over the 
hips and shoulders to minimise any extraneous movement.  
The participant was instructed to perform a ramped iMVC lasting approximately six seconds 
in the isokinetic dynamometer. Patella tendon displacement was assessed in the sagittal plane 
via ultrasound at both the apex of the patella and the tibial tuberosity. This was recorded over 
two contractions, separated by 90 s, consistent with Onambele et al. (2007) as a means of 
measuring PT displacement. The combined displacement of the two sites was taken as total 
tendon displacement. Images were captured at approximately 10% increments of the ramped 
iMVC, synchronised with the torque acquisition system (Spike 2, Cambridge Electronic 
Design, Cambridge, UK) by an external square wave pulse. Patella tendon stiffness was 
calculated at every 10% of iMVC torque using the following formula: iMVC torque + 
antagonist co-activation torque / PTMA (see below).  
Patella tendon moment arm of the non- dominant leg was measured at 90° using a DXA 
(HorizonTM DXA System, Hologic Inc, MA, USA), scan (IVAHD Image type), in order to 
calculate tendon forces. A goniometer was used to ensure a knee angle of 90°. Patella tendon 
moment arm was determined as the perpendicular distance between the centre point of the 
patella tendon and the tibio-femoral contact point (Figure 4-2) quantified using digitising 
software (MIPAV v8, NIH, MD, USA). This method of measuring PTMA has been shown to 
be valid and reliable when compared to MRI (Erskine, 2014). 
The force × elongation curve derived from data at every 10% of maximal ramped iMVC was 
fitted with a second order polynomial function forced through zero (Onambele et al., 2007). 
The tangential slope at discreet sections of the curve, relative to maximal ramped iMVC force, 
was calculated by differentiating the curve at every 10% PT force interval.  To account for 
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force differences between visits, the slope of the tangential line was computed for the weakest 
iMVC across the three visits. This standardised the comparison of PT stiffness and YM at a 









Figure 4-2 A) a participant positioned in the DXA scanner with the knee positioned at 90° B) scanning 
location identified using a target C) an example image of a DXA scan used to assess patella tendon 
moment arm. P = patella, F = femur, PT = patella tendon, PTMA = patella tendon moment arm, T = 
tibia, CP = tibio-femoral contact point 
 
Antagonist co-activation 
Surface electromyography EMG activity was recorded from the BF, semitendinosus (ST) and 
semimembranosus (SM) muscles during all contractions. To minimise interference and to 
ensure that electrode placement was over the belly of each muscle, US was used to define the 
medial and lateral borders of each muscle and marked with permanent marker. Electrode 
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placement was halfway between each marked site for each muscle. Site areas were shaved and 
cleaned prior to the placement of electrodes to reduce skin impedance below 5000 Ω (Hermens 
et al., 2000). Surface EMG bipolar electrodes (Delsys Trigno, Delsys, Boston, MA, USA) were 
placed on the muscle bellies and root-mean-square (RMS) amplitude was recorded during all 
contractions. EMG data was collected (2000 Hz), filtered (20-450 Hz), and acquired for off-
line analysis (Spike 2, Cambridge Electronic Design, Cambridge, UK). Electrodes measuring 
EMG activity in the BF, SM and ST were surrounded by a protective sheath to minimise any 
potential interference caused by compression against the electrode from the seat of the 
dynamometer.  
To determine antagonist co-activation during the ramped iMVC exercise, maximum EMG of 
the BF (long head), ST and SM during knee flexion iMVC was measured. Following three sub-
maximal warm up attempts, participants performed two iMVC knee flexions at a 90° knee 
angle against the lever arm of the dynamometer, producing as much force as fast as possible, 
holding for 3-5 s before relaxing. The integral of the RMS was calculated, 500 ms either side 
of peak torque. During the ramped iMVCs of the knee extensors, at every 10% of peak torque, 
the absolute integral of the BF, ST and SM EMG were taken over 250 ms. The mean EMG of 
the knee flexor muscles was used to calculate co-activation torque. Co-activation torque was 
calculated as (KF EMG during ramped maximal voluntary isometric knee extension / knee 
flexor EMG during maximal voluntary isometric knee flexion) × peak maximal voluntary 
isometric knee flexion torque at 90° knee angle (Onambele et al., 2007). This equation assumes 
that a linear relationship exists between knee flexor EMG and iMVC knee flexion torque and 





Young’s modulus was calculated using the formula; PT stiffness × (PT length (mm) / PT CSA 
(mm2) at ramped iMVC (Onambele et al., 2007). Young’s modulus was standardised to the 
weakest iMVC across the three visits as previously explained in the patella tendon stiffness 
section. 
Measures of maximal isometric force and optimal angle 
After performing the isometric contractions required to calculate tendon stiffness and YM, 
participants then performed two iMVCs at seven different knee angles (60, 65, 70, 75, 80, 85 
and 90°) in a randomised order, with 60 s between repetitions. Participants were asked to push 
against the lever arm of the dynamometer as fast and as forcefully as possible, holding the 
contraction for 3-5 s. The highest torque produced at each knee angle was taken as maximal 
isometric voluntary contraction. The angle at which the highest torque was produced was 
recorded as the optimum angle for force production. 
Measurements of VL fascicle length during eccentric exercise 
To measure VL fascicle behaviour during ECC knee extensions, the ultrasound probe was 
placed at 50% of VL muscle length and width (as previously defined), in the mid-sagittal plane 
of the non-dominant leg and fixed in position using a customised bracket (Figure 4-3). During 
ECC contractions from 30 to 110° knee angle, ultrasound images were recorded in real time at 
25 frames per second using image acquisition software (AVer Media Capture Studio, AVer 
Media Technologies, New Taipei City, Taiwan). An externally generated square wave pulse 
was used to synchronise the images with the torque acquisition system that simultaneously 
recorded knee joint angle. An echo-absorptive marker was placed on the skin to ensure that 
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any probe movements during contraction could be identified during analysis (Figure 4-1). 
Images were analysed offline (at every 10° during eccentric contractions) using imaging 
software (ImageJ 1.45; National Institutes of Health, Bethesda, MD, USA). Fascicle lengths 
from the still images were analysed as previously described (Figure 4-2). Fascicle length 
changes were measured as absolute change (FL at 110° knee angle ‒ FL at 30° knee angle) and 
relative change (percentage increase in FL from 30° (0%) knee angle to 110° (100%) knee 
angle). Three ECC contractions were analysed per visit. These were the fifth repetition of the 
first set and the second and fifth repetition of the second set. This allowed comparisons across 
visits of each individual repetition in turn (e.g. set one repetition five, compared across all three 
visits). Additionally, to measure within set reliability of VL fascicle lengthening, the second 
and fifth repetitions of the second set were compared. To measure the between-set reliability 
of VL fascicle lengthening, the fifth repetition of set one and set two were compared. For both 
within- and between-set reliability, the mean of all three visits per respective repetition was 




















Figure 4-3 An example of probe placement during ECC exercise using a custom-made bracket. 
Confirmation of ovulation in eumenorrheic females 
Prior to any testing, eumenorrheic females were required to confirm they were within the mid-
luteal phase (~day 21) of the menstrual cycle. To achieve this, prior to visits 2 and 4, 
participants determined ovulation via the use of a home ovulation kit that detected surges in 
luteinising hormone (LH) (Clearblue digital, Swiss Precision Diagnostics Gmbh, Geneva, 
Switzerland). Participants were required to test their urine from day nine of the menstrual cycle, 
with day one being the first day of bleed. A surge of LH on two consecutive days confirmed 
that eumenorrheic females were ovulatory (Su et al., 2017). Following the confirmation of 
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ovulation, participants visited the laboratory seven days later, to ensure they were in the mid-
luteal phase of the menstrual cycle (Mihm et al., 2011). On the day of experimental visits 2 and 
4, prior to any of the experimental procedures described above, a 10 mL venous blood sample 
was collected from the antecubital fossa region of the arm (BD Vacutainer, Beckton Dickenson, 
Oxford, UK), to measure serum concentrations of estradiol and progesterone. For the samples 
to be analysed for estradiol, the collected blood was allowed to clot at room temperature for 30 
minutes before being centrifuged at 1000 × g at 5 ˚C for 15 minutes. For the samples to be 
analysed for progesterone, the collected blood was allowed to clot at room temperature for two 
hours before being centrifuged at 1000 × g at 5 ̊ C for 15 minutes. 50 µL of serum was pipetted 
into four separate aliquots and analysed for concentrations of estradiol and progesterone using 
commercially available ELISA kits (ELISA; Bio-techne, MN, USA), following manufacturer’s 
instructions.  
Data analysis 
All ultrasound videos taken were exported to video editing software (Adobe Premier Elements 
version 15, Adobe, CA, USA) for frame-by-frame analysis. For resting measures of VL and 
PT, the required images were selected by the researchers for further analysis. For measures of 
VL and PT during exercise, the images that corresponded to the specific time point 
(synchronised with the data acquisition software) were selected for further analysis. All images 
were analysed using the imageJ software. 
4-2.3 Statistical analysis 
Data are presented as mean ± SD. The level of significance was set to α = 0.05. Statistical 
analysis was performed using the statistical software package SPSS (v.19; Chicago, IL, USA) 
and using a published spreadsheet (Hopkins, 2015) in Microsoft Excel (Microsoft Excel 2016, 
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Microsoft, Washington D.C., USA). One‐way repeated measures ANOVA were employed to 
assess for differences between visits, with the exception of within- and between-set VL fascicle 
lengthening, where a paired sample t-test was used to test for differences. Where a difference 
was found following the one-way repeated measures ANOVA, least significant post hoc tests 
were performed. Typical error (raw units), typical error as a coefficient of variation (CV, %), 
and intra‐class correlations were calculated for all variables for the assessment of random error. 
Reliability via ICC was interpreted by the following: ICC 0.5 – 0.75, moderately reliable, ICC 
0.75-0.9, good reliability, ICC > 0.9, excellent reliability (Koo and Li, 2016). Statistical 
significance was accepted at P < 0.05. Analyses were performed for all participants combined 
(n = 36) and within each experimental group (n = 12 for each group).  
4-4 RESULTS 
Vastus lateralis properties 
Mean ± SD VL properties for all participants are presented in Table 4-1. Individual data points 
for VL architecture measures in visit 1 vs visit 2 and visit 1 vs visit 3 are displayed in Figure 
4-4. CVs were 2.3%, 2.6%, 2.5% and 2.3% for VL CSA, FL PA and thickness, respectively. 
All measures of VL properties showed excellent reliability (ICC ≥ 0.97). Results from the 
ANOVA revealed that resting measures of VL FL and PA were different between visits. Post 
hoc analysis showed that US overestimated VL FL by 0.4 ± 0.9 mm in visit 1 in comparison to 
visit 3 (p = 0.034) and VL PA was 0.1 ± 0.3° greater in visit 1 in comparison to visit 3 (p = 
0.042). No other systematic differences were present. Optimal angle of force production 




Patella tendon properties 
Mean ± SD PT properties are presented in Table 4-2. Individual data points for PT property 
measures in visit 1 vs visit 2 and visit 1 vs visit 3 are displayed in Figure 4-5. CVs ranged from 
1.0% to 11.5% for all measures. PT CSA, PT length, knee extension MVC, knee extension 
antagonist co-activation, PT force, PT stiffness and PT YM all displayed excellent reliability 
(ICC ≥ 0.94), whilst PT elongation displayed good reliability (ICC = 0.86). No systematic 






Table 4-1 The reliability of using B-mode ultrasound to measure VL properties at rest and the reliability of the optimal angle of force 
production derived from maximal isometric voluntary contraction in males and females (n = 36).  
 Visit 1 Visit 2 Visit 3 P TE (95% CI) CV (95% CI) ICC 
VL CSA (cm2) 29.0 ± 6.4 29.2 ± 6.0 29.1 ± 6.1 0.529 0.5 (0.5 – 0.7) 2.3 (1.9 – 2.8) 0.99 
VL FL (mm) 60.7 ± 9.8 61.2 ± 9.6 60.3 ± 9.6 0.034* 1.6 (1.4 – 2.0) 2.6 (2.2 – 3.2) 0.97 
VL PA (deg) 19.7 ± 3.2 19.9 ± 3.1 19.6 ± 3.2 0.042* 0.5 (0.4 – 0.6) 2.5 (2.1 – 3.1) 0.98 
VL Thickness (mm) 20.0 ± 3.5 20.1 ± 3.4 19.9 ± 3.4 0.056 0.5 (0.4 – 0.6) 2.3 (1.9 – 2.9) 0.98 
Optimal Angle (deg) 74.9 ± 9.7 74.6 ± 7.3 75.6 ± 7.3 0.749 5.4 (4.6 - 6.7) 7.7 (6.5 - 9.7) 0.57 
Data are presented as mean ± SD. VL = vastus lateralis; CSA = cross-sectional area; FL = fascicle length; PA = pennation angle; CI = confidence 
interval; P = repeated measures ANOVA; TE = typical error; CV = coefficient of variation; ICC = intraclass correlation coefficient; * P < 0.05 
from ANOVA. 
Table 4-2 The reliability of using B-mode ultrasound to measure patella tendon properties at rest and during maximal isometric voluntary 
contraction in males and females (n = 36). 
 Visit 1 Visit 2 Visit 3 P TE (95% CI) CV (95% CI) ICC 
PT CSA (mm2) 85.0 ± 12.3 85.2 ± 12.2 84.9 ± 12.4 0.267 0.8 (0.7 – 1.0) 1.0 (0.9 – 1.2) 1.00 
PT Length (mm) 65.5 ± 7.1 65.6 ± 6.9 65.2 ± 6.9 0.397 1.3 (1.1 – 1.6) 2.0 (1.7 – 2.5) 0.97 
Knee Extension MVC (N∙m) 167.9 ± 79.0 174.7 ± 83.4 176.5 ± 80.4 0.068 16.2 (13.7 – 20.1) 9.1 (7.7 – 11.4) 0.96 
Antagonist Co-activation (N∙m) 9.4 ± 6.1 9.3 ± 5.9 9.2 ± 5.7 0.526 0.7 (0.6 – 0.9) 11.5 (9.7 – 14.5) 0.99 
PT Elongation (mm) 7.4 ± 1.0 7.6 ± 1.2 7.6 ± 1.3 0.164 0.4 (0.4 – 0.6) 6.0 (5.0 – 7.4) 0.86 
PT Force (N) 4436 ± 1602 4618 ± 1757 4664 ± 1768 0.087 432 (365 – 535) 9.8 (8.2 – 12.2) 0.94 
PT Stiffness (N∙mm-1) 1134.1 ± 410.5 1139.4 ± 413.8 1140.9 ± 433.8 0.830 46.5 (39.3 – 57.6) 4.2 (3.5 – 5.2) 0.99 
PT YM (MPa) 786.0 ± 248.6 789.7 ± 264.8 784.3 ± 258.0 0.204 38.2 (32.3 – 47.3) 4.4 (3.7 – 5.5) 0.98 
Data are presented as mean ± SD. PT = patella tendon; CSA = cross-sectional area; YM = Young’s modulus; CI = confidence interval; P = repeated measures 















Figure 4-4 Reliability of using US to estimate resting measures of VL CSA (A), VL fascicle length (B), pennation angle (C) and VL thickness (D). The dashed 
line represents the line of equality. The solid red line denotes the regression line for visit 1 vs visit 2 and the solid blue line denotes the regression line for visit 
1 vs visit 3. The black dots represent individual data points for visit 1 vs visit 2 and the white dots represent individual data points for visit 1 vs visit 3.VL = 
vastus lateralis, CSA = cross sectional area, US = ultrasound imaging. n = 36.  
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Vastus lateralis behaviour during eccentric exercise by repetition 
Table 4-3 presents mean ± SD for each individual ECC repetition analysed. Individual data for 
absolute VL fascicle lengthening (FL at 110° knee angle ‒ FL at 30° knee angle) are displayed 
in Figure 4-6, and relative VL fascicle lengthening (% increase from 30° (0%) to 110° (100%) 
knee angle) are displayed in Figure 4-7. CVs ranged from 2.7% to 3.5% and 2.9% to 3.7% for 
absolute and relative VL fascicle lengthening, respectively. Reliability for the three repetitions 
analysed were considered excellent (ICC ≥ 0.97) for both absolute and relative fascicle 
lengthening. Absolute fascicle lengthening for set 1 rep 5 was greater in visit 3 compared to 
visit 1 (0.9 ± 1.4 mm) and visit 2 (0.9 ± 1.7 mm). No other systematic differences were present 
for set 2 repetitions. CVs for ECC torque for each repetition ranged from 10.1% to 11.9%. 
Reliability was considered good (ICC ≥ 0.86) for set 2 reps 2 and 5, and excellent (ICC = 0.90) 
for set 1 rep 5.  
Within- and between-set vastus lateralis behaviour 
Table 4-4 presents mean ± SD for within and between set repetitions. Individual data points for 
within and between set fascicle lengthening values are presented in Figure 4-8. CVs for 
absolute fascicle lengthening were 1.2% and 1.1% for within and between set, respectively. 
CVs for relative fascicle lengthening were 1.2% for both within and between set. Reliability 
for both absolute and relative fascicle lengthening was considered excellent for both within and 
between set (ICC ≥ 0.99). No systematic differences were present for any with in or between 
set measure. CVs for ECC torque were 8.3% and 9.0% for within and between set, respectively. 













Figure 4-5 Reliability of estimating PT length at rest using US (A). Reliability of estimating PT elongation during a ramped iMVC using US (B). Reliability 
of estimating PT stiffness (C) and Young’s modulus (D) during a ramped iMVC. The dashed line represents the line of equality. The solid red line denotes the 
regression line for visit 1 vs visit 2 and the solid blue line denotes the regression line for visit 1 vs visit 3. The black dots represent individual data points for 















Table 4-3 The reliability of using B-mode ultrasound to measure VL fascicle lengthening during maximal ECC exercise in males and 
females (n = 36).  
 Visit 1 Visit 2 Visit 3 P TE (95% CI) CV (95% CI) ICC 
Set 1 Rep 5              
    Absolute FL (mm) 44.2 ± 7.7 44.2 ± 7.8 45.1 ± 7.3 0.002* 1.2 (1.0 - 1.5) 3.1 (2.6 - 3.8) 0.98 
    Relative FL (%) 59.9 ± 14.5 59.5 ± 14.9 60.5 ± 14.4 0.059 1.9 (1.6 - 2.3) 3.7 (3.1 - 4.6) 0.97 
    ECC Torque (N∙m) 1481.3 ± 456.8 1466.8 ± 437.6 1487.5 ± 475.5 0.838 149.8 (126.8 - 185.5) 10.1 (8.4 - 12.6) 0.90 
Set 2 Rep 2              
    Absolute FL (mm) 44.3 ± 7.5 44.5 ± 7.8 44.8 ± 7.2 0.360 1.4 (1.2 - 1.8) 3.5 (2.9 - 4.3) 0.97 
    Relative FL (%) 59.9 ± 14.7 59.9 ± 14.7 60.4 ± 14.4 0.448 1.9 (1.6 - 2.4) 3.6 (3.0 - 4.5) 0.98 
    ECC Torque (N∙m) 1474.8 ± 450.7 1455.3 ± 446.4 1424.6 ± 446.6 0.405 156.7 (132.6 - 194.1) 11.3 (9.5 - 14.2) 0.88 
Set 2 Rep 5              
    Absolute FL (mm) 44.5 ± 7.7 44.6 ± 7.6 45.0 ± 7.1 0.198 1.1 (1.0 - 1.4) 2.7 (2.3 - 3.4) 0.98 
    Relative FL (%) 59.9 ± 14.8 60.0 ± 14.6 60.7 ± 14.4 0.147 1.5 (1.3 - 1.9) 2.9 (2.4 - 3.6) 0.99 
    ECC Torque (N∙m) 1480.1 ± 473.1 1475.0 ± 463.8 1394.9 ± 401.0 0.143 172.9 (146.3 - 214.1) 11.9 (10.0 - 15.0) 0.86 
Data are presented as mean ± SD. FL = fascicle lengthening; ECC = eccentric; YM = Young’s modulus; CI = confidence interval; P = repeated 





Table 4-4 The reliability of using B-mode ultrasound to measure within- and between-set VL fascicle lengthening 
during maximal ECC exercise in males and females (n = 36). 
   P TE (95% CI) CV (95% CI) ICC 
Within Set Set 2 Rep 2 Set 2 Rep 5     
   Absolute FL (mm) 44.6 ± 7.4 44.7 ± 7.4 0.311 0.5 (0.4 - 0.6) 1.2 (1.0 - 1.5) 0.99 
   Relative FL (%) 60.1 ± 14.5 60.2 ± 14.5 0.652 0.7 (0.5 - 0.8) 1.2 (0.9 - 1.5) 1.00 
   ECC Torque (N∙m) 1465.7 ± 439.8 1435.7 ± 419.0 0.330 128.9 (104.6 - 168.2) 8.3 (6.7 - 10.9) 0.91 
           
Between Set Set 1 Rep 5 Set 2 Rep 5     
   Absolute FL (mm) 44.5 ± 7.5 44.7 ± 7.4 0.058 0.4 (0.4 - 0.6) 1.1 (0.9 - 1.4) 1.00 
   Relative FL (%) 60.0 ± 14.5 60.2 ± 14.5 0.175 0.6 (0.5 - 0.8) 1.2 (1.0 - 1.6) 1.00 
   ECC Torque (N∙m) 1478.7 ± 450.4 1435.7 ± 419.0 0.206 141.6 (114.9 - 184.8) 9.0 (7.2 - 11.9) 0.90 
Data are presented as mean ± SD. FL = fascicle lengthening; ECC = eccentric; CI = confidence interval; P = paired sample t-


















Figure 4-6 Reliability of measuring absolute fascicle lengthening during ECC exercise using US in set 
1 rep 5 (A) Set 2 rep 2 (B) and set 2 rep 5 (C). The dashed line represents the line of equality. The solid 
red line denotes the regression line for visit 1 vs visit 2 and the solid blue line denotes the regression 
line for visit 1 vs visit 3. The black dots represent individual data points for visit 1 vs visit 2 and the 
white dots represent individual data points for visit 1 vs visit 3. VL = vastus lateralis, US = ultrasound 


















Figure 4-7. Reliability of measuring relative fascicle lengthening during ECC exercise using US in set 
1 rep 5 (A) Set 2 rep 2 (B) and set 2 rep 5 (C). The dashed line represents the line of equality. The solid 
red line denotes the regression line for visit 1 vs visit 2 and the solid blue line denotes the regression 
line for visit 1 vs visit 3. The black dots represent individual data points for visit 1 vs visit 2 and the 
white dots represent individual data points for visit 1 vs visit 3. VL = vastus lateralis, US = ultrasound 













Figure 4-8 Reliability of estimating absolute VL fascicle lengthening during ECC exercise using US within- (A) and between-set (B). Reliability of estimating 
relative VL fascicle lengthening during ECC exercise using US within- (C) and between-set (D). The dashed line represents the line of equality. The solid red 
line denotes the regression line. VL = vastus lateralis, US = ultrasound imaging. n = 36.
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Patella tendon property reliability by group 
Table 4-5 presents the mean ± SD for patella properties by group. Figure 4-9 displays the 
individual data points for PT stiffness and Young’s modulus by group. For all PT property 
measures, CVs ranged from 0.9% to 15.3% in the male group, 0.7% to 12.4% in the OCP group 
and 0.9% to 8.3% in the eumenorrheic group. For the male group, PT CSA, PT length, knee 
extension MVC, knee extension antagonist co-activation, PT stiffness and PT YM all showed 
excellent reliability (ICC ≥ 0.94) whilst PT elongation showed good reliability (ICC = 0.86). 
For the OCP group, PT CSA, knee extension MVC, knee extension antagonist co-activation, 
PT stiffness and PT YM showed excellent reliability (ICC ≥ 0.94) whilst PT length and PT 
elongation showed good reliability (ICC ≥ 0.84). For the eumenorrheic group, all measures 
showed excellent reliability (ICC ≥ 0.91). No systematic differences were present. 
Vastus lateralis behaviour during eccentric exercise by repetition, by group 
Table 4-6 presents mean ± SD for VL behaviour lengthening during ECC exercise. All 
measures, for all groups, showed excellent reliability (ICC ≥ 0.95). For the male group, CVs 
ranged from 4.2% to 4.7% for absolute fascicle lengthening and 4.6% to 5.6% for relative 
fascicle lengthening. For the OCP group, CVs ranged from 1.3% to 2.8% for absolute fascicle 
lengthening and 0.7% to 2.3% for relative fascicle lengthening. For the eumenorrheic group, 
CVs ranged from 2.0% to 2.6% for absolute fascicle lengthening and 2.0% to 2.7% for relative 
fascicle lengthening. No systematic differences were present for the male and OCP groups. In 
the eumenorrheic group, results from the ANOVA revealed a difference between visits for set 
one repetition five. Post hoc analysis showed that fascicle lengthening for set one repetition 
five was 1.5 ± 1.6 mm (absolute, P = 0.007) and 1.9 ± 2.0% (relative, P = 0.009) greater in 
visit three in comparison to visit one, and 1.3 ± 1.2 mm (absolute, P = 0.003) greater in visit 
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three in comparison to visit two, with no difference in relative fascicle lengthening between 
visit three and visit two.  
Within- and between-set vastus lateralis behaviour by group 
Figure 4-10 displays the individual data points for within- and between-day, absolute and 
relative fascicle lengthening by group.  For within- and between-set fascicle lengthening, all 
measures for all groups showed excellent reliability (ICC ≥ 0.98) and CVs remained ≤ 1.6%. 
For the eumenorrheic group, between set fascicle lengthening was greater in set 2 than set 1 
for both absolute (0.5 ± 0.7 mm, P = 0.024) and relative (0.8 ± 1.0%, P = 0.021) measures. No 
other systematic differences between measures were present. 
Serum levels of estradiol and progesterone 
There were no differences in estradiol levels in eumenorrheic females between visit 1 and visit 
3 (124.9 ± 42.7 vs 118.0 ± 35.4 pg·ml-1, respectively, P = 0.197). There were no differences in 
progesterone levels in eumenorrheic females between visit 1 and visit 3 (57.3 ± 20.9 vs 55.0 ± 





Table 4-5 The reliability of using B-mode ultrasound to measure patella tendon properties at rest and during maximal isometric voluntary contraction by group (males, 
n = 12; OCP females n = 12, eumenorrheic females, n = 12). 
  Visit 1 Visit 2 Visit 3 P TE (95% CI) CV (95% CI) ICC 
PT CSA (mm2) Males 97.1 ± 11.9 97.2 ± 11.7 97.1 ± 11.8 0.718 0.9 (0.7 - 1.4) 0.9 (0.7 - 1.4) 1.00 
 OCP 79.5 ± 8.5 79.6 ± 8.6 79.3 ± 8.8 0.645 0.7 (0.5 - 1.0) 0.9 (0.7 - 1.4) 1.00 
 Eumenorrheic 78.4 ± 5.1 78.8 ± 5.1 78.2 ± 5.3 0.287 0.9 (0.7 - 1.4) 1.2 (0.9 - 0.8) 0.98 
               
PT Length (mm) Males 68.6 ± 8.5 68.7 ± 8.5 68.1 ± 8.5 0.082 0.7 (0.5 - 1.0) 1.0 (0.8 - 1.6) 0.99 
 OCP 63.8 ± 5.0 64.0 ± 4.5 63.4 ± 4.6 0.778 2.1 (1.6 - 3.1) 3.2 (2.4 - 4.9) 0.84 
 Eumenorrheic 64.1 ± 6.7 64.0 ± 6.5 64.1 ± 6.7 0.998 0.6 (0.4 - 0.9) 0.9 (0.7 - 1.4) 0.99 
               
KE MVC (N∙m) Males 250.0 ± 77.2 260.5 ± 78.8 251.1 ± 74.4 0.382 21.6 (16.3 – 32.5) 8.2 (6.1 – 12.6) 0.94 
 OCP 138.8 ± 41.9 141.4 ± 47.3 151.8 ± 62.3 0.138 13.7 (10.3 – 20.1) 11.0 (8.2 – 17.1) 0.94 
 Eumenorrheic 114.8 ± 28.2 122.3 ± 38.2 126.6 ± 41.3 0.065 10.8 (8.2 – 16.3) 8.0 (6.0 - 12.4) 0.93 
               
KE Antagonist CoA (N∙m) Males 10.6 ± 7.6 10.2 ± 7.4 10.4 ± 7.3 0.405 0.7 (0.6 – 1.1) 15.3 (11.4 – 24.0) 0.99 
 OCP 8.9 ± 5.5 8.9 ± 5.2 8.9 ± 5.0 0.943 0.8 (0.6 – 1.2) 11.2 (8.3 – 17.4) 0.98 
 Eumenorrheic 8.7 ± 5.1 8.7 ± 5.2 8.4 ± 4.8 0.289 0.6 (0.4 – 0.9) 7.1 (5.3 – 10.8) 0.99 
               
PT Elongation (mm) Males 7.3 ± 1.1 7.6 ± 1.3 7.5 ± 1.3 0.337 0.5 (0.4 - 0.8) 6.8 (5.1 - 10.6) 0.86 
 OCP 7.6 ± 1.2 7.8 ± 1.4 7.8 ± 1.6 0.414 0.5 (0.4 - 0.8) 7.2 (5.4 - 11.0) 0.89 
 Eumenorrheic 7.4 ± 0.8 7.5 ± 0.8 7.6 ± 0.9 0.301 0.3 (0.2 - 0.4) 3.5 (2.7 - 5.4) 0.91 
               
PT Force (N) Males 5915 ± 1499 6198 ± 1498 5994 ± 1558 0.374 491 (370 – 740) 8.3 (6.2 – 12.8) 0.92 
 OCP 4161 ± 1164 4304 ± 1417 4527 ± 1742 0.255 476 (359 – 716) 12.4 (9.2 – 19.3) 0.91 
 Eumenorrheic 3232 ± 713 3353 ± 1000 3471 ± 990 0.209 307 (232 – 463) 8.3 (6.2 – 12.7) 0.91 
               
PT Stiffness (N∙mm-1) Males 1575.3 ± 330.3 1574.0 ± 345.9 1605.8 ± 343.4 0.343 59.0(44.5 - 88.8) 3.8 (2.9 - 5.8) 0.98 
 OCP 1005.9 ± 215.3 1021.6 ± 225.0 1011.4 ± 236.1 0.651 40.1 (30.6 - 61.2) 3.8 (2.8 - 5.7) 0.97 
 Eumenorrheic 821.0 ± 208.8 822.5 ± 209.4 805.6 ± 219.7 0.487 36.3 (27.4 – 54.7) 4.8 (3.6 – 7.4) 0.98 
               
PT YM (MPa) Males 1014.8 ± 207.5 1014.1 ± 246.2 1026.3 ± 210.6 0.242 50.2 (37.8 - 75.7) 4.5 (3.4 - 6.9) 0.96 
 OCP 732.9 ± 159.8 747.1 ± 188.2 728.6 ± 164.6 0.368 35.3 (26.7 - 53.3) 4.0 (3.0 - 6.1) 0.97 
 Eumenorrheic 610.3 ± 184.9 607.9 ± 184.9 597.9 ± 187.5 0.501 26.0 (19.6 – 39.1) 4.6 (3.5 – 7.0) 0.98 
Data are presented as mean ± SD. PT = patella tendon; CSA = cross-sectional area; YM = Young’s modulus; OCP = oral contraceptive pill; CI = confidence interval; 













Figure 4-9 Reliability of estimating PT stiffness during a ramped iMVC by group (males, n = 12; OCP females n = 12, eumenorrheic females, n = 12) for visit 
1 vs visit 2 (A) and visit 1 vs visit 3 (B). Reliability of estimating Young’s modulus during a ramped iMVC for visit 1 vs visit 2 (C) and visit 1 vs visit 3 (D). 
The dashed line represents the line of equality. The solid red line denotes the regression line for males, the solid blue line denotes the regression line for OCP 
users, and the solid grey line denotes the regression line for eumenorrheic females. The black dots represent individual data points for males, the white dots 
represent individual data points for OCP users, and the white diamonds represent the individual data points for eumenorrheic females. PT = patella tendon, US 
= ultrasound imaging, OCP = oral contraceptive pill.  
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Table 4-6 The reliability of using B-mode ultrasound to measure VL fascicle lengthening during maximal ECC exercise by group  (males, n = 12; 
OCP females n = 12, eumenorrheic females, n = 12). 
  Visit 1 Visit 2 Visit 3 P TE (95% CI) CV (95% CI) ICC 
Set 1 Rep 5               
    Absolute FL (mm) Males 45.6 ± 7.3 45.6 ± 7.9 46.6 ± 6.8 0.252 1.8 (1.4 - 2.8) 4.7 (3.5 - 7.2) 0.95 
 OCP 42.5 ± 7.9 42.3 ± 7.8 42.6 ± 7.7 0.477 0.7 (0.5 - 1.0) 1.5 (1.1 - 2.3) 0.99 
 Eumenorrheic 44.5 ± 8.3 44.7 ± 8.0 46.0 ± 7.3 0.002* 0.9 (0.7 - 1.3) 2.3 (1.7 - 3.5) 0.99 
               
    Relative FL (%) Males 59.2 ± 13.9 58.1 ± 14.5 59.5 ± 13.6 0.296 2.7 (2.0 - 4.1) 5.6 (4.2 - 8.5) 0.97 
 OCP 56.8 ± 14.7 56.2 ± 14.4 56.6 ± 14.7 0.325 1.0 (0.7 - 1.5) 1.6 (1.2 - 2.5) 1.00 
 Eumenorrheic 63.6 ± 15.4 64.2 ± 15.8 65.5 ± 14.5 0.020* 1.6 (1.2 - 2.4) 2.8 (2.1 - 4.2) 0.99 
Set 2 Rep 2               
    Absolute FL (mm) Males 45.6 ± 7.2 45.9 ± 7.9 45.9 ± 6.9 0.891 1.9 (1.4 - 2.9) 4.8 (3.6 - 7.3) 0.95 
 OCP 42.7 ± 7.9 42.6 ± 8.1 42.5 ± 7.5 0.897 1.2 (0.9 - 1.8) 2.8 (2.1 - 4.3) 0.98 
 Eumenorrheic 44.7 ± 7.8 45.2 ± 7.7 46.1 ± 7.2 0.069 1.1 (0.8 - 1.7) 2.6 (1.9 - 3.9) 0.98 
               
    Relative FL (%) Males 58.6 ± 13.9 58.3 ± 14.4 59.1 ± 14.2 0.357 2.6 (1.9 - 3.8) 5.2 (3.9 - 8.0) 0.97 
 OCP 57.1 ± 14.8 56.6 ± 14.7 56.3 ± 14.3 0.416 1.3 (1.0 - 2.0) 2.3 (1.7 - 3.4) 0.99 
 Eumenorrheic 63.9 ± 15.7 64.8 ± 15.1 65.8 ± 14.3 0.142 1.7 (1.2 - 2.5) 2.7 (2.0 - 4.1) 0.99 
Set 2 Rep 5               
    Absolute FL (mm) Males 45.8 ± 7.7 46.0 ± 7.8 46.1 ± 6.5 0.771 1.7 (1.3 - 2.6) 4.2 (3.2 - 6.5) 0.96 
 OCP 42.3 ± 7.9 42.4 ± 7.8 42.7 ± 7.7 0.298 0.5 (0.4 - 0.8) 1.3 (1.0 - 1.9) 1.00 
 Eumenorrheic 45.3 ± 7.9 45.4 ± 7.5 46.1 ± 7.1 0.077 0.9 (0.7 - 1.4) 2.0 (1.5 - 3.1) 0.99 
               
    Relative FL (%) Males 58.4 ± 14.3 58.3 ± 14.4 59.6 ± 13.6 0.377 2.3 (1.8 - 3.5) 4.6 (3.5 - 7.0) 0.98 
 OCP 56.6 ± 14.7 56.6 ± 14.7 56.6 ± 14.7 0.866 0.4 (0.3 - 0.5) 0.7 (0.5 - 1.1) 1.00 
 Eumenorrheic 64.7 ± 15.4 65.1 ± 14.6 65.8 ± 14.4 0.129 1.2 (0.9 - 1.8) 2.0 (1.5 - 3.0) 1.00 
Data are presented as mean ± SD. FL = fascicle lengthening; OCP = oral contraceptive pill; CI = confidence interval; P = repeated measures ANOVA; TE = 














Table 4-7 The reliability of using B-mode ultrasound to measure within- and between-set VL fascicle lengthening during maximal 
ECC exercise by group (males, n = 12; OCP females n = 12, eumenorrheic females, n = 12).  
  Set 2 Rep 2 Set 2 Rep 5 P TE (95% CI) CV (95% CI) ICC 
Within Set        
   Absolute FL (mm) Males 45.8 ± 7.2 46.0 ± 7.2 0.471 0.6 (0.4 - 1.0) 1.4 (1.0 - 2.3) 0.98 
 OCP 42.6 ± 7.8 42.5 ± 7.8 0.830 0.5 (0.3 - 0.8) 1.2 (0.8 - 2.0) 1.00 
 Eumenorrheic 45.3 ± 7.5 45.6 ± 7.5 0.130 0.4 (0.3 - 0.7) 1.0 (0.7 - 1.7) 1.00 
            
   Relative FL (%) Males 57.8 ± 14.0 57.8 ± 13.9 0.374 0.6 (0.4 - 0.9) 1.2 (0.9 - 2.1) 1.00 
 OCP 56.7 ± 14.6 56.6 ± 14.7 0.822 0.7 (0.5 - 1.1) 1.2 (0.8 - 2.0) 1.00 
 Eumenorrheic 64.8 ± 15.0 65.2 ± 14.7 0.225 0.7 (0.5 - 1.2) 1.1 (0.8 - 1.9) 1.00 
            
Between Set  Set 1 Rep 5 Set 2 Rep 5     
   Absolute FL (mm) Males 46.0 ± 7.2 46.0 ± 7.2 0.919 0.4 (0.3 - 0.6) 0.9 (0.6 - 1.5) 0.99 
 OCP 42.5 ± 7.8 42.5 ± 7.8 0.273 0.3(0.2 - 0.5) 0.7 (0.5 - 1.2) 1.00 
 Eumenorrheic 45.1 ± 7.8 45.6 ± 7.5 0.024* 0.5 (0.4 - 0.9) 1.3 (0.9 - 2.3) 1.00 
            
   Relative FL (%) Males 57.8 ± 13.9 58.8 ± 13.9 0.192 0.7 (0.5 - 1.1) 1.3 (0.9 - 2.2) 1.00 
 OCP 56.5 ± 14.5 56.6 ± 14.7 0.686 0.3 (0.2 - 0.6) 0.6 (0.4 - 1.0) 1.00 
 Eumenorrheic 64.4 ± 15.2 65.2 ± 14.7 0.021* 0.7 (0.5 - 1.2) 1.4 (1.0 - 2.4) 1.00 
Data are presented as mean ± SD. FL = fascicle lengthening; OCP = oral contraceptive pill; CI = confidence interval; P = repeated measures 













Figure 4-10 Reliability of estimating absolute VL fascicle lengthening during ECC exercise using US by group (males, n = 12; OCP females n = 12, 
eumenorrheic females, n = 12) within- (A) and between-set (B). Reliability of estimating relative VL fascicle lengthening during ECC exercise using US by 
group within- (C) and between-set (D). The dashed line represents the line of equality. The solid red line denotes the regression line for males, the solid blue 
line denotes the regression line for OCP users, and the solid grey line denotes the regression line for eumenorrheic females. The black dots represent individual 
data points for males, the white dots represent individual data points for OCP users, and the white diamonds represent the individual data points for eumenorrheic 




The results from chapter three in this thesis showed that US is a valid and reliable tool for 
measuring PT CSA. Additionally, chapter three showed that the operator who was to perform 
all subsequent US analysis in the thesis could produce reliable estimates of PT CSA at rest. 
These findings from chapter three supported the use of US as a measurement tool in the current 
study. One of the main aims of this thesis was to determine the difference in patella tendon 
stiffness, VL muscle fascicle lengthening, and indirect markers of muscle damage over two 
bouts of maximal ECC exercise of the knee extensors, separated by four weeks. Therefore, the 
use of US needed to be expanded from measuring PT CSA at rest, to measures of the VL at 
rest and measures of the PT and VL during dynamic activity, across time. Therefore, the main 
aim of chapter 4 was to determine whether 2D B-mode ultrasound is a reliable imaging method 
for estimating PT properties both at rest and during maximal isometric exercise, and VL 
properties both at rest and during maximal ECC exercise, across a seven-day and four-week 
period. Additionally, another aim of the thesis was to compare the responses of males, OCP 
using females, and eumenorrheic females to maximal ECC knee extension exercise. By 
extension, a secondary aim of this study was to assess the reliability of US imaging as method 
for estimating PT and VL properties both at rest and during maximal exercise in males, OCP 
using females, and eumenorrheic females. One of the main findings from this study is that US 
is a reliable technique for measuring resting properties of the PT and VL at rest and du ring 
exercise with both one and four weeks between measures. The current study also showed that 
both PT and VL properties can be reliably measured using US for males, OCP users and 




Resting patella tendon properties 
As concluded from chapter three in this thesis, and from previous research, US was found to 
be a valid and reliable measure of PT CSA (Stenroth et al., 2019, Gellhorn and Carlson, 2013). 
Additionally, chapter three showed that there was excellent inter-rater reliability in measuring 
PT CSA using US, highlighting the competence of the rater who subsequently performed the 
US analysis in the current study. One difference between the current study and the previous 
chapter was the length of time between measurements. In chapter 3, only a three-day period 
was observed between measures, ensuring minimal physiological variation between visits. In 
the present study, a one- and four-week time period was allowed between measures, to account 
for the fact that four weeks would be the test-re-test period between experimental visits in 
chapter five, and the follow-up measures will persist for one week following exercise. Despite 
a longer period between retest occasions the results of the present study, in comparison to 
chapter three, displayed slightly better absolute (TE 0.8 mm vs 1.4 mm) and relative (CV 1.0% 
vs 1.6%) reliability, with both studies displaying similar ICCs (1.00 vs 0.99). The high 
reliability of using US to estimate PT CSA in chapter three in relation to the previous studies 
(Stenroth et al., 2019, Ekizos et al., 2013) was discussed in detail in section 3-4. The slightly 
improved reliability in the present study could be due to the examiner performing the 
measurement and analysis becoming more experienced over time, which has been shown to 
increase reliability (Dudley-Javoroski et al., 2010), which could explain why the mean TE and 
CVs in the current study were lower than the 95% confidence intervals present for rater 1 in 





Patella tendon length and elongation during exercise 
Patella tendon CSA typically consists of measuring the tendon at 25%, 50% and 75% of tendon 
length, with the mean of all three sites used to estimate whole tendon CSA (Hicks et al., 2013, 
Kongsgaard et al., 2007, Couppe et al., 2008, Couppe et al., 2016, Murtagh et al., 2018). It is 
therefore important that estimation of PT length is accurate so that these sites can be identified 
consistently. Gellhorn and Carlson (2013) reported an ICC of 0.96 for repeated measurements 
of PT length, which corroborated findings from the present study, which found an ICC of 0.97 
for PT length, giving confidence in the correct identification of CSA measurement sites. In 
addition to resting measures, the correct quantification of tendon properties during exercise is 
required to properly estimate tendon stiffness and Young’s Modulus, specifically, PT 
elongation. Onambele et al. (2007) reported excellent reliability (ICC = 0.91) for measuring 
PT elongation using US, which was slightly higher than the present study which displayed 
good reliability (ICC = 0.86). One reason why PT elongation might not be as reliable as the 
study by Onambele et al. (2007) is due to the variation in PT force during the ramped iMVC 
(CV 9.8%). As tendon elongation is dependent on the amount of force applied (Hansen et al., 
2006), this variation in tendon force might have affected the amount of PT elongation 
experienced between each trial. Alternatively, there is a possibility that the ultrasound was 
slightly misaligned longitudinally during ramped iMVC, which has been shown to produce an 
overestimation of tendon elongation (Magnusson et al., 2001). However, as tendon elongation 
is a precursor to tendon stiffness and YM calculation (Onambele et al., 2007) as well as being 
sensitive to the amount of force applied, the reliability of this measure should not receive as 
much focus as the downstream calculations, which, in the present study, were deemed 
excellent, as discussed in the next section.  
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Patella tendon stiffness and Young’s modulus 
Despite the fluctuations in knee extension MVC, antagonist co-activation, PT force and 
elongation, reliability of PT stiffness and YM was excellent (ICC ≥ 0.98). The main reason for 
this is most likely that for each participant, each measure of stiffness and YM was made relative 
to the visit that produced the lowest force. Whilst no between participant comparisons were 
made during this study, this method of using force corresponding to the weakest contraction 
has been used in the literature to account for differences in force production between 
participants and allow comparisons to be made (Onambele et al., 2007, Hicks et al., 2013, 
Hicks et al. 2017). As PT stiffness and YM was standardised to the iMVC of the weakest 
contraction per participant, it is unsurprising that reliability was excellent, once PT elongations 
and force fluctuations had been eliminated. Chapter five will investigate measures of PT 
stiffness and YM prior to two bouts of maximum ECC exercise. The results of the current study 
show that these measures of tendon properties do not change following exposure to low 
volumes of ECC contractions. This provides confidence that any changes detected in PT 
stiffness and YM in chapter five are not due to normal biological variation or measurement 
error.   
Resting measures of the vastus lateralis 
Ultrasound measurements of VL dimensions (CSA and thickness) in the present study were 
shown to have excellent reliability (ICC ≥ 0.98) which corroborates findings from Reeves et 
al. (2004), who reported ICCs of 0.997 – 0.999 and TE ranging from 0.15 cm2 to 0.40 cm2, 
which equated to 1.0% and 3.3%, when presented as a percentage, similar to the present study 
(2.3%). This finding is of particular importance when conducting sex differences research on 
the muscle damage response to exercise. For example, CK has been normalised to VL CSA 
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when comparing the response of males and females to ECC exercise (Hicks et al., 2016), to 
account for large differences in muscle volume and force production between groups. 
Moreover, normalising ECC torque during exercise to VL CSA is also a method utilised in sex 
differences research (Morawetz et al., 2019). Therefore, the high reliability of measuring VL 
CSA shown in the current study allows these ‘normalising’ techniques to be employed with 
confidence in future studies. 
Vastus lateralis muscle architecture at rest (FL, PA and thickness) in the current study showed 
excellent reliability between measures taken one and four weeks apart (ICCs, ≥ 0.97), which is 
similar to that reported by Alegre et al. (2006), who reported ICCs of 0.95, 0.96 and 0.96 for 
FL, PA, and thickness, respectively. Changes in resting muscle architecture are commonly used 
to measure training adaptations, such as increases in FL following 12 weeks of ECC based 
training (Baroni et al., 2013). It is therefore crucial that highly reliable imaging techniques are 
used to suitably quantify these architectural measures, avoiding inaccurate estimation of 
changes in these measures as a result of an exercise intervention (Klimstra et al., 2007). In the 
present study, both FL and PA were systematically different between visits 1 and 3, despite the 
small CVs (2.6% and 2.5%, respectively) and excellent reliability (ICC ≥ 0.97). Although the 
differences for FL and PA were small (0.4 ± 0.9 mm and 0.1 ± 0.3°, respectively), an 
explanation for this difference might be due to slight probe rotation in one or both visits, 
affecting the quantification of each measure (Klimstra et al., 2007, Kawakami et al., 1995). It 
is also possible that in the four-week time period between measures, some training-induced 
architectural differences might have occurred, as the participants were actively involved in 
training between visits. However, as FL was shorter on the four-week follow up, this is unlikely 
as resistance training tends to increase, not shorten FL (Baroni et al., 2013, Blazevich, 2006, 
Alegre et al., 2006). Nevertheless, the systematic differences between visits one and three were 
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small and although this will have increased TE (Hopkins, 2000), the systematic bias and CV 
were low. Overall, it can be concluded that US provides a highly reliable method of estimating 
VL properties at rest. 
Optimal angle of force production 
In the present study, the reliability of OA measurements was moderate (ICC = 0.57), with a TE 
of 5.4° and CV of 7.7%. Shifts in OA towards a longer muscle length are indicative of EIMD 
(Hicks et al., 2016, Chen et al., 2013), most commonly attributed to an addition of sarcomeres 
in series following a remodelling of the muscle from damage elicited by ECC exercise (Proske 
and Morgan, 2001). However, little data on the reliability of OA is present in the literature. 
Recently, Oranchuk et al. (2020) investigated OA in the knee extensors over three occasions 
and reported a CV of 8.0% and ICC of 0.58 between visits one and two and a CV of 7.3% and 
ICC of 0.64 between visits two and three, which is similar to the current study. Chen et al. 
(2013) reported a CV of 6.7% and an r value of 0.96 for the test-retest reliability of OA 
measures in the upper arm, although it was not stated how many participants or contractions 
this was derived from.  
However, despite the differences in muscle architecture between the upper arm and VL, the 
similar CVs in the studies by Chen et al. (2013) and Oranchuk et al. (2020) to the present study 
indicates some consistency between the literature. It must be noted that both Chen et al. (2013) 
and Oranchuk et al. (2020) used concentric contractions to determine OA to the nearest degree, 
in contrast to repeated isometric contractions in the present study. As the current study used 5° 
intervals in a range of 60 - 90°, the precise OA could not be measured. No literature currently 
exists comparing isometric and concentric methods of obtaining OA, so it is difficult to say 
which is the superior method, but the similar reliability between isometric and concentric 
160 
 
measures of OA indicate that either method can be used. However, the ICC of 0.57 and the TE 
of 5.4° in the present study requires some caution when interpreting shifts in OA as a marker 
of EIMD, specifically when compared over multiple time-points. 
Vastus lateralis fascicle lengthening during maximal ECC exercise 
Although the present study is the first comprehensive study on the reliability of US derived VL 
fascicle lengthening during maximal isokinetic ECC exercise, similar reliability analyses were 
reported by Hicks et al. (2013) and Guilhem et al. (2011). These analyses were conducted on a 
sub-sample of five people, where ICCs of 0.99 and 0.82 were reported, respectively.  It must be 
noted that the high reliability displayed by Hicks et al. (2013) might be due to the small sample 
size in comparison to the present study, which can affect estimates of error (Springate, 2011). 
Nevertheless, US derived VL fascicle lengthening reliability has twice been investigated by 
Penailillo et al. (2015, 2016), although these studies were conducted using a sub-maximal, ECC 
cycling protocol. Nonetheless, an ICC range of 0.97 to 0.98 (absolute fascicle lengthening) and 
0.97 to 0.99 (relative fascicle lengthening) in the present study was similar to Penailillo et al. 
(2015), who reported an ICC of 0.99. Penailillo et al. (2016) reported a CV of 5.6% for fascicle 
lengthening, which was larger than the CV range of 2.7% to 3.5% reported in the present study. 
Both studies by Penailillo et al. (2015, 2016), the study by Hicks et al. (2013), and the present 
study used the linear extrapolation (Reeves and Narici, 2003) to partially estimate FL, which 
typically is associated with a 2-7% error (Finni et al., 2001, Finni et al., 2003). With this taken 
into consideration, it would appear that the greater proportion of the fascicle that needs to be 
estimated would lead to a greater chance for the error reported by Finni et al. (2003) to occur. 
Whilst the present study would be minimally affected by this estimation error, due to the range 
of motion being consistent between visits and therefore requiring similar levels of linear 
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extrapolation, FL comparisons between studies might be subject to this error, depending on the 
range of motion around the joint utilised in the procedure and the muscle architecture of the 
participants. For example, the high ICC reported by Hicks et al. (2013) in comparison to the 
present study and the studies by Penailillo et al. (2015, 2016), might be due to the estimations 
of FL at longer muscle lengths. Hicks et al. (2013) used a maximum knee angle of 90° in 
comparison to ~120° in the studies by Penailillo et al. (2015, 2016) and 110° in the present 
study, meaning that less of the fascicle length might have been estimated, therefore minimising 
the error associated with the linear continuation method (Finni et al., 2001, Finni et al., 2003). 
Although, the level of FL estimation is dependent on starting FL and the behaviour of the 
fascicle during exercise, which has been shown to differs between groups, specifically, males 
and females (Hicks et al., 2013, Hicks et al., 2016). However, due to different probe lengths 
(38 mm) used by Hicks et al. (2013) and the present study (50 mm), the increased range of 
motion might have been absorbed by the increased field of view, meaning a similar amount of 
FL was estimated for both studies, despite the differences in range of motion, leading to the 
similar reports of reliability. 
An important feature of this study was to determine VL behaviour both within and between 
sets of ECC contractions. Typically, motor output is more variable during ECC contractions 
than CON contractions, as ECC contractions are likely more unaccustomed movements 
requiring different neural control (Christou and Carlton, 2002). Therefore, this study was 
designed so that participants could perform enough ECC contractions to be able to produce 
consistent force outputs and allow consistent measurement of fascicle behaviour, without 
performing too many ECC contractions that might cause excessive EIMD and alter MTU 
behaviour (Lau et al., 2015). Although CVs for ECC torque were 8.3% and 9.0% for within- 
and between-set, respectively, reliability was still considered excellent. This stable force output 
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during ECC exercise resulted in CVs ≤ 1.2% and ICCs ≥ 0.99, with no systematic bias present 
for both absolute and relative changes in FL, within- and between sets. This study therefore 
confirms that US is a reliable tool for estimating fascicle lengthening during maximal ECC 
exercise. 
Measures of patella tendon and vastus lateralis properties for males, OCP using females 
and eumenorrheic females 
Finally, the last aim of this study was to determine whether the reliability of US measures of 
PT and VL properties at rest and during maximal exercise were different between males, OCP 
users and eumenorrheic females, as these experimental groups will be investigated in chapter 
five. Reliability for PT CSA measures was excellent for all groups (ICC ≥ 0.98) with all CVs 
≤ 1.2%. The main discrepancy discovered was the high CV (12.4%) presented in the OCP 
group for tendon elongation, although both males and eumenorrheic females displayed higher 
CVs (both 8.3%) than for other measures. However, ICCs ≥ 0.91 for all groups still indicate 
excellent reliability. Of particular importance is the similar reliability scores for relative PT 
stiffness and YM between groups. As the elastic properties of tendon can be a determinant of 
EIMD, acting as a mechanical buffer and reducing the length of muscle fascicle lengthening 
and subsequent EIMD magnitude (Hicks et al., 2017, Guilhem et al., 2016), and changes in 
tendon compliance might be a mechanism of the RBE (Hyldahl et al., 2017, Lau et al. 2015), 
the reliability of tendon properties in the absence of EIMD is important when implementing 
interventions that might alter these properties.  
Reliability of fascicle lengthening was excellent for all groups (ICC ≥ 0.95) with CVs ≤ 5.6%. 
The only systematic difference was in the eumenorrheic group, where both absolute and 
relative fascicle lengthening was greater in visit 3 in comparison to visit 1. Similarly, only 
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eumenorrheic females produced a systematic difference for absolute and relative fascicle 
lengthening between-sets, despite very similar measures of reliability. One possible 
explanation for this is that, as the weakest group, as determined by PT force (Table 4-5), 
eumenorrheic females might be less trained than participants in the other group. As strength 
training reduces force fluctuations during maximal contractions (Tracy et al., 2004, González 
et al., 2007) and fascicle lengthening can be affected by contraction force (Fukunaga et al., 
1997), the inability to maintain a consistent force at specific time points might account for the 
reported changes in fascicle lengthening. Nevertheless, the systematic differences in the 
eumenorrheic group were small (≤ 1.8%) and reliability measures remained high. 
Conclusion  
The present study can conclude that using US to measure PT and VL properties at rest and 
during maximal ECC exercise of the knee extensors is highly reliable and can be implemented 
when other imaging modalities are not available. Furthermore, there are minimal differences 
of the reliability of these measures between males, OCP users and eumenorrheic females.  The 
overall aim of this thesis is to use 2D B-mode ultrasonography to further understand the 
properties and behaviour of the patella tendon and vastus lateralis in males and females and 
how these properties contribute to the EIMD response to ECC exercise and the magnitude of 
the RBE. The findings in the present study, and those from chapter three, are key to progressing 
to the next chapter. In chapter five, the US measures used in chapters three and four will be 
used to assess VL and PT properties at rest and during maximal knee extension exercise. 
Therefore, establishing the reliability of these US measures of MTU properties, along with 
understanding the measurement error relating to these techniques, is imperative to ensure that 
any changes that occur between the two exercise visits in chapter five results are not 
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misconstrued. An additional aim of this thesis is to compare the VL and PT behaviour during 
maximal ECC exercise and the magnitude of EIMD responses of males, OCP using females, 
and eumenorrheic females. The current study has established that the reliability of the US 
measures used to assess VL and PT behaviour during maximal ECC knee extension exercise 
does not differ between groups, thereby allowing comparisons between groups in chapter five 
to be completed with confidence.
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CHAPTER 5 SEX DIFFERENCES IN EXERCISE INDUCED 
MUSCLE DAMAGE AND THE REPEATED BOUT EFFECT 





Humans produce an adaptive response to a single bout of maximal ECC exercise that reduces 
muscle damage markers in an identical bout performed a second time, known as the RBE 
(Nosaka and Clarkson, 1995). A number of mechanisms, including neural adaptations, 
remodelling of the ECM, changes in the inflammatory response and mechanical adaptations, 
such as a change in MTU behaviour, have been proposed to mediate the RBE, however these 
are not fully understood (Hyldahl et al., 2017, McHugh, 2003).  
The mechanical behaviour of the MTU during contraction can be measured using 
ultrasonography. Chapter 4 established that US is a reliable, valid tool to measure MTU 
properties, specifically PT and VL properties at rest and during maximal isometric and 
lengthening exercise. Ultrasonography has previously been used to assess both tendon 
properties and muscle fascicle behaviour during iMVCs, passive movement, and a single bout 
of maximal eccentric contractions of the knee extensors, in both males and females (Finni et 
al., 2003, Guilhem et al., 2011, Hicks et al., 2013, Hicks et al., 2016). In recent years, US has 
been used to assess adaptations in the behaviour of the MTU of the VL during repeated bouts 
of ECC cycling (Penailillo et al., 2015) and MTJ displacement during repeated bouts of 
maximal ECC exercise of the elbow flexors (Lau et al., 2015). These studies found that men 
exhibit lower fascicle lengthening (Penailillo et al., 2015) and reduced muscle lengthening (Lau 
et al., 2015) on the repeated bouts of exercise. In a recent review of the mechanisms 
underpinning the RBE, Hyldahl et al. (2017) stated that this evidence of reduced muscle 
lengthening during a repeated bout of ECC exercise from Penailillo et al. (2015) and Lau et al 
(2015), suggests that there might be a possibility of an increase in tendon compliance, though 
direct evidence of this tendon adaptation has not been presented. Furthermore, the reduced 
amount of muscle lengthening displayed in the second bout of ECC exercise in the studies by 
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Penailillo et al. (2015) and Lau et al. (2015) were also accompanied by a lower magnitude of 
EIMD markers. Should the theory of tendon adaptation suggested by Hyldahl et al. (2017) be 
correct, this could explain the reduction in EIMD markers seen following a repeated bout of 
exercise in the studies by Penailillo et al. (2015) and Lau et al (2015) as a greater tendon 
compliance has been theorised to reduce the amount of fascicle lengthening during ECC 
exercise via a mechanical buffering action (Guilhem et al., 2016, Hicks et al., 2013). Therefore, 
it is possible that reduced muscle lengthening during a second bout of ECC exercise, via an 
increase in compliance of the tendon, could be a mechanism that explains the RBE. However, 
no study to date has measured tendon properties between two bouts of maximal ECC exercise, 
therefore it is unclear if this tendon adaptation exists.  
The measurement of muscle lengthening during repeated bouts of ECC exercise has provided 
some insight into the role that MTU adaptations might play in reducing markers of EIMD (Lau 
et al., 2015, Penailillo et al., 2015), however, these studies only involved male participants and 
therefore do not take into account the differences in MTU behaviour that has been displayed in 
females. For example, in a single bout of maximal ECC exercise of the knee extensors, females 
have exhibited a lower magnitude of VL fascicle lengthening and higher PT compliance in 
comparison to males (Hicks et al. 2013, Hicks et al., 2016). As this observation is based on a 
single bout of ECC exercise, two pertinent questions require answering; 1) does the difference 
in MTU behaviour between males and females remain after repeated bouts of ECC exercise? 
and 2) does fascicle lengthening and the associated EIMD response reduce with the RBE, as 
seen in males (Penailillo et al., 2015)? Examining MTU behaviour and the EIMD response in 
males and females would give insight into whether MTU adaptations mediate the RBE, and 
whether these changes are consistent across sexes.  
168 
 
The baseline differences in the behaviour of MTU properties between males and females might 
be attributed to differences in sex hormones, specifically, oestrogen. For example, α and β 
oestrogen receptors are localised and expressed within tendon tissue and the increased action  
of these receptors in the presence of high circulating oestrogen levels might be responsible for 
the higher tendon compliance observed in females compared to males (Faryniarz et al., 2006, 
Hart et al., 1998, Wiik et al., 2003 Wiik et al., 2005, Sciore et al., 1998). This increased 
compliance, or lower tendon stiffness, is thought to be due to the chronic effects of oestrogen 
on collagenous tissue, which include decreased total collagen and protein content, tendon 
fascicle diameter and density (Belanger et al., 2004, Baltzopoulos, 1995, Abubaker et al., 
1996), increased collagen degradation and decreased collagen synthesis (Neugarten et al., 
2000, Fischer, 1973, Dyer et al., 1980), a reduction in tensile strength (Slauterbeck et al., 1999, 
Booth and Tipton, 1970), and an increase in elastic content (Shikata et al., 1979, Fischer and 
Swain, 1977). Due to these effects of oestrogen on tendon properties, it would be logical to 
suggest that lower levels  of oestrogen would have the opposing effect, leading to higher tissue 
stiffness, which has indeed been evidenced by the lower compliance of tendons in males 
compared to eumenorrheic females (Hicks et al., 2013, Kubo et al., 2003).  As lower levels of 
oestrogen can lead to differences in tendon properties (Kubo et al., 2003), it would make sense 
to hypothesise that supressing oestrogen, through such means as using the OCP (van Heusden 
and Fauser, 2002, Elliott-Sale et al., 2013), could result in decreased tendon stiffness. However, 
although OCP administration has been shown to reduce the stimulating effect of exercise on 
tendon collagen synthesis through the suppression of collagen fractional synthetic rate (Hansen 
et al., 2009a), differences in mechanical tendon properties, such as stiffness and Young’s 
modulus, are not different between OCP users and eumenorrheic females (Hansen et al., 2013, 
Hicks et al., 2017). However, there is evidence to suggest that OCP use might augment the CK 
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response (Hicks et al., 2017, Joyce et al., 2014) and result in prolonged losses in iMVC strength 
(Minahan et al., 2015) in response to ECC exercise. Though far from conclusive, this evidence 
suggests that differences in the EIMD response to ECC exercise might differ between OCP 
users and eumenorrheic females. Moreover, this dif ference in EIMD response is only evident 
after a single bout of ECC exercise, so it remains unanswered if OCP users will respond 
differently to a repeated bout of ECC exercise compared to eumenorrheic females.  
Chapters 3 and 4 of this thesis showed that US can be used to measure PT and VL properties 
at rest and during maximal exercise both accurately and reliably, over multiple visits. Chapter 
4 showed specifically that the mechanical behaviour of the MTU did not differ during three 
visits over a 28-day time period, consisting of 10 maximal ECC contractions of the knee 
extensors per visit. This would suggest that if differences in MTU behaviour were present 
following a high-volume bout of maximal ECC exercise, these differences could be attributed 
to MTU adaptation, rather than measurement error. The aim of this study was to assess whether 
adaptations in MTU behaviour during maximal lengthening contractions could explain the 
RBE, and whether these adaptations differed between males, eumenorrheic females, and  
females taking the OCP. Moreover, an additional aim of this study was to investigate the 
potential relationships between MTU behaviour and the magnitude of EIMD and the RBE.  
5-2 METHODS 
5-2.1 Participants 
A total of 36 participants were recruited for the study and divided into three groups (12 per 
group), males, OCP using females, and eumenorrheic females. Baseline characteristics are 
presented in Table 5-1. Participants completed a pre-test questionnaire and were included in 
the study if they had no neuromuscular or musculoskeletal impairments in the lower limbs 
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within the last six months. All participants self -reported being physically active, participating 
in no less than one lower body resistance training session per week. Females in the OCP group 
reported taking a combined monophasic OCP, with estradiol doses between 20-30 µg, for an 
average of 3 ± 2 years. The types of monophasic OCP used in this study were taken daily for 
21 days, followed by a 7-day, withdrawal phase. Females in the eumenorrheic group reported 
a regular menstrual cycle (mean length 27 ± 3 days). A regular menstrual cycle was defined as 
24-36 days (Landgren et al., 1980, Cole et al., 2009). Female participants with menstrual cycles 
outside of this regular range, or females who were pregnant in the year preceding the study 
were excluded. Institutional ethical approval was received from the Northumbria University 
Faculty of Health & Life Sciences Ethics committee in accordance with the Declaration of 
Helsinki. Participants were supplied with a participant information sheet, detailing the purpose 
of the study before giving written consent before participating (Appendix 1). 
 
 
Table 5-1 Baseline participant characteristics. 
 Male (n = 12) OCP (n = 12) Eumenorrheic (n = 12) P 
Age (years) 22 ± 4 23 ± 2 22 ± 3 0.557 
Stature (m) 1.81 ± 0.06 1.71 ± 0.09 1.66 ± 0.06 0.002*# 
Mass (kg) 83.9 ± 13.3 70.4 ± 15.0 64.3 ± 15.0 <0.001*# 
VL CSA (cm2) 34.0 ± 5.8 26.5 ± 5.2 28.2 ± 6.5 0.004*# 
VL FL (mm) 69.6 ± 7.7 70.1 ± 14.2 62.3 ± 11.9 0.200 
VL PA (degs) 19.4 ± 3.2 18.5 ± 2.2 20.2 ± 3.4 0.356 
PTMA (cm) 4.3 ± 0.4 3.8 ± 0.4 3.8 ± 0.3 <0.001*# 
Data are presented as mean ± SD. VL = vastus lateralis, CSA = cross-sectional area, FL = fascicle 
length, PA = pennation angle, PTMA = patella tendon moment arm, OCP = oral contraceptive pill 





Participants visited the laboratory on 13 occasions throughout the course of the study for one 
practice trial (single visit), followed by two experimental trials, each consisting of six visits. 
On the first day of the first experimental trial (referred to as Bout 1, or B1) participants 
completed baseline assessment of resting VL and PT properties, followed by assessment of 
baseline markers of EIMD, PT properties, and OA of force production during a concentric 
contraction. This was then followed by a bout of maximal ECC exercise. Follow up 
assessments of EIMD markers were performed at 24, 48, 72, 96 and 168  hours post‐exercise. 
Approximately four weeks later, participants completed a second experimental trial that was 
identical to the first, to study the RBE referred to as Bout 2, or B2). Participants were instructed 
to refrain from exercise for 24 hours prior to baseline testing, and throughout the remainder of 
the seven-day testing period during both B1 and B2. Participants were instructed to refrain 
from the consumption of caffeine for 12 hours prior to testing, and to continue their habitual 
diet throughout the study.  Participants were also instructed to avoid non‐steroidal anti‐
inflammatory drugs or other stimulants for the duration of the experimental period. During the 
4-week period between experimental trials participants were instructed to resume and maintain 
their habitual physical activity. For both muscle damage sessions, eumenorrheic females were 
tested during the mid‐luteal phase of the menstrual cycle, seven days (± one day) after 
confirming ovulation, where both oestrogen and progesterone are high (Stricker et al., 2006).  
Follow up sessions were measured over the remainder of the luteal phase, into the early 
follicular phase, where oestrogen and progesterone gradually decline (Stricker et al., 2006). 
Female participants taking a monophasic OCP were tested on the 14th day (self -reported) of 
pill ingestion, equivalent to day 21 of the menstrual cycle, due to the initial seven pill‐free days 
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(Elliott et al., 2005). This time‐point is equivalent to the mid‐luteal phase of eumenorrheic 
females taking no form of hormone influencing contraceptives.  
Practice trial overview 
The practice trial began with a DXA scan to measure the PTMA of the non‐dominant leg 
(defined as the leg used to provide stability during movements e.g. kicking) at a 90° knee angle 
(0° = full extension). The participant was then permitted practice with the physical 
requirements of the testing procedure, which involved sitting in an isokinetic dynamometer 
(System 4 Pro, Biodex Medical Systems Inc., NY, USA) and taking the non‐dominant leg 
passively through a pre‐determined range of motion (30°‐110° knee extension (full extension 
= 0°). The participant then performed iMVCs of the knee extensors against the lever arm of the 
dynamometer at 70° and 80° knee angles, followed by a ramped iMVC at 80°, with the aim of 
reaching maximum iMVC torque in a time of 4‐6 seconds, as linear as possible. A knee angle 
of 80° was selected for the ramped iMVC in the practical trial to avoid isometric contractions 
at long muscle lengths, as this has been shown to confer a protective effect against markers of 
EIMD in subsequent damaging exercise (Chen et al. 2012b). The ramped iMVC in the practice 
trial was a manoeuvre that participants were required to execute during experimental visits to 
measure tendon stiffness and YM. Participants received a demonstration of maximal eccentric 
contractions of the knee extensors by the researcher, to habituate the participant with the action 
of the dynamometer. The participant did not perform any ECC knee extensor exercise in the 
practice trial, as previous research has demonstrated that even very small volumes o f ECC 





Experimental trials overview 
A schematic of the experimental trials is illustrated in Figure 5-1.  At baseline, anthropometric 
measurements (stature, mass, mid‐thigh circumference (MTC) of the non-dominant leg) were 
recorded. B-mode ultrasound was then used to measure resting fascicle length and CSA of the 
VL, and length and CSA of the PT. Creatine kinase levels were measured via capillary blood 
sampling. Participants then completed ratings of muscle soreness, followed by isometric and 
concentric muscle actions of the knee extensors to measure PT stiffness, and to determine the 
optimum angle of force production respectively. Isometric MVCs of the knee flexors were 
performed to estimate co‐activation force, which was used when calculating PT stiffness. 
Surface electromyography of hamstring muscle groups were recorded throughout measures of 
PT stiffness to measure co-activation (Onambele et al., 2007). Subsequent to baseline 
measures, participants then performed a bout of muscle damaging exercise consisting of 100 
maximal isokinetic ECC knee extensions (20 sets of 5 repetitions, with one minute of rest 
between sets), during which fascicle lengthening was tracked at 50% of VL length and width 
using ultrasonography. Post exercise assessments of MTC, soreness, CK, iMVC and cMVC 
were measured after the ECC protocol at 24, 48, 72, 96 and 168 h (Figure 5-1). The 
experimental trials (B1 and B2) were identical.  
Procedures for anthropometric measurements, PTMA, VL fascicle length and CSA, PT length 
and CSA, measures of iMVC and OA, measurements of VL fascicle lengthening during ECC 
exercise, ultrasound image analysis and confirmation of ovulation in eumenorrheic f emales 
were identical to the techniques used in Chapter 4; a detailed description can be found in section 
4-2.3. The additional methods implemented in the current chapter are detailed below.  
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Figure 5-1 Schematic illustration of the experimental trial. The procedure was repeated ~4 weeks later. US = ultrasound; PT = patella tendon; CSA = cross-




Mid-thigh circumference was measured using a standard anthropometric tape, at the point 
marked at 50% VL length and width as outlined in section 4-2. 
Delayed onset of muscle soreness 
Delayed onset of muscle soreness was quantified via VAS, which involved asking participants 
to mark on a scale of 0‐200 mm (0 = no pain, 100 = very, very sore) their feeling of muscle 
soreness, when a 60 N pressure was applied at the same point marked for VL fascicle length 
analysis. The force applied was determined by a digital algometer (FDX 50 Force Ten digital 
force gauge, Wagner Instruments, CT, USA).  
Creatine kinase 
Fingertip capillary blood samples (20 μL) were taken using standard aseptic techniques. 
Samples were analysed using commercial CK analysis kit (Reflotron®, Roche Diagnostics, 
Risch‐Rotkreuz, Switzerland), which has been shown to have excellent agreement with CK 
values obtained via venepuncture (Knoblauch et al., 2010). The resting normal expected values 
for CK when using this equipment are between 50 and 200 IU·L-1; the CV for this instrument 
was < 3% (Keane et al., 2015).  
Measures of concentric force and optimal angle 
Maximal concentric voluntary contraction (cMVC) torque (N·m) was assessed during 
isokinetic contractions performed at 60°·s‐1 angular velocity from 110‐30° knee angle. Three 
efforts were performed with one‐minute rest between repetitions. The repetition with the 
highest peak torque was used for further analysis, with the knee angle at which peak torque 
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occurred being recorded as the OA of force production. This procedure has been shown to be 
reliable and suitable for measuring OA in the knee extensors (Oranchuk et al., 2020). This 
procedure was repeated in all follow up sessions after both eccentric exercise protocols to 
monitor any changes in the length‐tension relationship. Changes in OA have been shown 
following damaging bouts of exercise and the use of cMVC has been shown to be sensitive in 
detecting changes in OA (Chen et al., 2007, Chen et al., 2013).  
Patella tendon stiffness and Young’s modulus 
A detailed description of the method used to calculate PT stiffness and YM and the methods 
used to measure surface EMG and antagonist co-activation during ramped iMVC, can be found 
in section 4-2.3. In the current study, both PT stiffness and YM were standardised using two 
methods, to allow specific comparisons. For each participant, the slope of the tangential line 
was computed for the weakest PT force recorded for each individual participant, across the two 
bouts and used to calculate PT stiffness and YM. This is referred to as “within participant” 
stiffness or YM and is used to allow the comparison of PT properties at an individual level. 
This standardised the comparison of PT stiffness and YM at a consistent load within each 
participant, across bouts. Additionally, for each participant, the slope of the tangential line was 
computed for the weakest PT force recorded by all participants, across the two bouts and used 
to calculate PT stiffness and YM. This is referred to as “between participant” stiffness or YM. 
This standardised the comparison of PT stiffness and YM at a consistent load between each 
participant (Onambele et al., 2007) and is used to assess differences in PT properties between 





Index of protection 
To quantify the magnitude of the protective effect between bouts, the IOP was calculated for 
MTC, DOMS, CK, iMVC and cMVC. Index of protection was calculated by the following 
equation [(B1 – B2) / B1 × 100] (Chen et al. 2016). The timepoint compared for each variable 
between bouts was the point of maximal muscle damage response following the first damaging 
bout. This was individualised for each participant to account for EIMD time course variability 
between participants. 
Eccentric exercise protocol 
The muscle damage protocol consisted of 20 sets of 5 maximal ECC actions of the knee 
extensors in the isokinetic dynamometer, at an angular velocity of 30°·s ‐1 during the eccentric 
phase, and a passive return to full extension at 60°·s‐1 in the concentric phase, with one minute 
between sets. Maximal voluntary eccentric knee extension torque was recorded during each 
action and displayed via the torque acquisition system. Real-time feedback was displayed to 
the participants throughout the exercise protocol, along with strong verbal feedback, to ensure 
that maximum effort was performed during each repetition.  
VL fascicle lengthening 
Image acquisition and analysis of fascicle lengthening has been previously described in section 
4-2.3. To quantify VL fascicle lengthening during the ECC exercise protocol, two repetitions 
were selected for analysis. One at the point at which the participant was ‘fresh’ (set 1, rep 5) 
and the other when it was expected that force decrements would occur (set 20, rep 5). Images 
were analysed offline (at every 10° during eccentric contractions) using imaging software 
(ImageJ 1.45; National Institutes of Health, Bethesda, MD, USA). Fascicle lengths from the 
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still images were analysed as previously described (Figure 4-2). Fascicle length changes were 
measured as absolute change (FL at 110° knee angle ‒ FL at 30° knee angle) and relative 
change (percentage increase in FL from 30° (0%), in 10° increments, to a knee angle of 110°). 
5-2.3 Statistical analysis 
Statistical analysis was performed using SPSS (v20, SPSS Inc., Chicago, IL). All data are 
reported as mean ± SD. CK data was log transformed prior to analysis due to data not being 
normally distributed. Sphericity was assessed using Mauchly’s test of sphericity . Where 
sphericity was violated, a greenhouse-Geisser correction was used (Maxwell and Delaney, 
2004). To investigate the effect of the RBE independent of group, data for all participants were 
combined and responses to different bouts over time were assessed using a 2 × 6 ANOVA 
(bout × time). To investigate whether responses differed between males, eumenorrheic females, 
and OCP-using females, differences in responses between groups across bouts (B1 and B2) 
over time (pre, 24, 48, 72, 96 and 168 hours) were assessed using a 3 × 2 × 6 ANOVA (group 
× bout × time). Where significant group × bout × time interactions were present, a series of 
two-way ANOVAs were performed to compare between groups for the first bout and second 
bout. Where significant bout × time interactions were present, least significant difference post 
hoc comparisons were implemented to assess differences between bouts. Where data were 
combined, paired sample t-tests were used to assess for differences at baseline between bouts. 
One-way ANOVAs were used to assess for differences in IOP between groups. Where a 
significant difference was present, least significant difference post hoc comparisons were 
implemented to assess differences in IOP between groups. Paired sample t-tests were used to 
assess for differences in total work (kJ) between bouts. A 3 × 2 ANOVA (group × bout) was 
used to assess for differences between groups at baseline. Where significant group × bout 
interactions were present, least significant difference post hoc comparisons were implemented 
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to assess differences between bouts. Linear correlations (Pearson r) were used to investigate 
whether significant associations were present between markers of EIMD, VL MTU behaviour 
and IOP. Statistical significance was set at an alpha level of  0.05. 
5-5 RESULTS 
Baseline characteristics 
Participant baseline characteristics are presented in Table 5-1. There were no between group 
differences in age (P = 0.557), VL FL (P = 0.200) or PA (P = 0.356). Males were taller than 
OCP using females (+0.10 m, P < 0.001) and eumenorrheic females (+0.15 m, P < 0.001) with 
no differences between OCP using females and eumenorrheic females (P = 0.127). Males were 
heavier than OCP using females (+13.5 kg, P = 0.015) and eumenorrheic females (+19.6 kg, P 
< 0.001), with no differences between OCP using females and eumenorrheic females (P = 
0.257). Males had a larger VL CSA than the OCP group (+7.5 cm 2, P = 0.001) and 
eumenorrheic group (+5.8 cm2, P < 0.001), with no differences between OCP using females 
and eumenorrheic females (P = 0.228). Males had a longer PTMA than the OCP using females 
(+0.5 cm, P = 0.004) and eumenorrheic females (+0.5cm2, P < 0.003), with no differences 
between OCP using females and eumenorrheic females (P = 0.883).  
Sex hormone concentrations in eumenorrheic females 
Serum estradiol levels were similar between B1 (146.3 ± 51.4 pg·ml-1) and B2 (148 ± 64.7 
pg·ml-1, P = 0.414). Serum progesterone levels were similar between B1 (12.1 ± 5.1 ng·ml-1) 
and B2 (11.8 ± 5.7 ng·ml-1, P = 0.271), confirming, in addition to positive ovulation tests, that 
eumenorrheic females were ovulatory and in the mid-luteal (progesterone > 7.9 ng·ml-1) phase 
of the menstrual at the time of testing in both visits (Stricker et al., 2006, Arce et al., 2011).  
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Eccentric exercise and markers of EIMD 
The total amount of work performed by all participants was similar for B1 and bout B2 (19.6 
± 4.8 kJ and 19.9 ± 4.6 kJ, respectively. P = 0.198). Males performed more total work than the 
OCP and eumenorrheic group in B1 (24.3 ± 2.7 kJ vs 17.6 ± 3.8 kJ, P < 0.001 and 16.8 kJ P < 
0.001) and B2 (24.1 ± 3.1 kJ vs 18.3 ± 3.7 kJ, P < 0.001 and 17.2 kJ P < 0.001), with no 
difference between OCP users and eumenorrheic female groups in B1 or B2 (P = 0.577 and P 
= 0.464, respectively).  
Isometric strength 
Changes in iMVC relative to baseline following ECC exercise are displayed in Figure 5-2 (a) 
for B1 and Figure 5-2 (b) for B2. In B1, iMVC force loss peaked at 24 h (77 ±14% of pre ECC, 
P < 0.001) and remained below baseline at 168 h (95 ± 12% of pre ECC, P = 0.013).  In B2, 
iMVC reduction peaked at 24 h (92 ± 13% of pre ECC, P < 0.001) and returned to baseline by 
48 h. iMVC force loss was lower in B2 compared to B1 based on a main effect of bout (P < 
0.001), and at all time points (P < 0.001), based on a bout × time interaction (P  < 0.001). No 
group differences were present (bout × time × group P = 0.112).  
Concentric strength 
Changes in cMVC relative to baseline following ECC exercise are displayed in Figure 5-2 (c) 
for B1 and Figure 5-2 (d) for B2. In B1, cMVC force loss peaked at 24 h (80 ± 19% of pre 
ECC, P < 0.001) and returned to pre- ECC levels by 168 h.  In B2, cMVC reduction peaked at 
24 h (89 ± 13% of pre ECC, P < 0.001) and returned to baseline by 72 h. cMVC force loss was 
lower in B2 compare2 to B1 based on a main effect of bout (P < 0.001). cMVC force loss was 
lower in B2 compared to B1 at 24 h (–8.5% P = 0.014), 48 h (–8.9%, P = 0.007), 72 h (–9.2%, 
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P = 0.006) and at 96 h (–10.3%, P = 0.005), based on a bout × time interaction (P = 0.012). 













Figure 5-2 Changes in maximal isometric force following ECC exercise in B1 (a) and bout 2 (b) and changes in maximal concentric force following ECC 
exercise in B1 (c) and B2 (d). iMVC = maximal isometric voluntary contraction, cMVC maximal concentric voluntary contraction, OCP = oral contraceptive 
pill, * P = < 0.05 compared to pre-exercise levels within bout; ** P < 0.05 bout 1 vs bout 2; # P < 0.05 bout 1 vs bout 2 at the respective time point. The grey 
dashed line represents 100% of pre-exercise values. Combined n = 36, males, n =12; OCP females n = 12, eumenorrheic females, n = 12.
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Delayed onset of muscle soreness 
Changes in DOMS are displayed in Figure 5-3 (a) for B1 and Figure 5-3 (b) for B2. DOMS 
peaked at 48 h post ECC in B1 and B2 (106.0 ± 40.6 mm and 85.9 ± 48.7 mm, respectively) 
and had returned to the respective pre-ECC levels by 168 h in both bouts. DOMS was lower in 
B2 in comparison to B1, based on a main effect of bout (P < 0.001) but no bout × time 
interaction was present (P = 0.158). No further interactions or group differences were present. 
Creatine Kinase 
Changes in CK are displayed in Figure 5-3 (c) for B1 and Figure 5-3 (d) for B2. In B1, CK 
levels were increased from pre ECC levels by 312.4 IU∙L-1 at 24 h (P < 0.001), with a maximum 
absolute increase of 1331.3 IU∙L-1 at 96 h (P < 0.001) and remained elevated at 168 h. In B2, 
CK levels were increased from pre ECC levels by 157.1 IU∙L-1 at 24 h (P < 0.001), reduced 
but remained elevated by 63.7 IU∙L-1 at 48 h (P = 0.011), before returning to pre ECC levels 
by 72 h. CK levels were lower in B2 compared to B1 based on a main effect of bout (P < 
0.001).  There were no differences between pre ECC CK levels in B1 and B2 (P = 0.882). CK 
levels were lower in B2 in comparison to B1 at 24 h (–147.5 IU∙L-1, P = 0.005), 48 h (–435.4 
IU∙L-1), P < 0.001), 72 h (–522.7 IU∙L-1, P = 0.001), 96 h (–1298.4 IU∙L-1, P < 0.001), and 168 
h (–672.6 IU∙L-1, P < 0.001). No group interactions were present. To account for differences 
in VL CSA, between the male group and the OCP using and eumenorrheic female groups, CK 














Figure 5-3 Changes in delayed onset of muscle soreness (DOMS) following ECC exercise in B1 (a) and bout 2 (b) and changes in CK following ECC exercise 
in B1 (c) and B2 (d). DOMS = delayed onset of muscle soreness, CK = creatine kinase, OCP = oral contraceptive pill, * P < 0.05 compared to pre-exercise 
levels within bout for all participants combined; ** P < 0.05 bout 1 vs bout 2 for all participants combined; # P < 0.05 bout 1 vs bout 2 at the respective time 
point for all participants combined. Combined n = 36, males, n =12; OCP females n = 12, eumenorrheic females, n = 12. 
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Optimal angle of force production from concentric knee extension 
Changes in OA are displayed in Figure 5-4a for B1, and Figure 5-4b for B2. A main effect of 
bout (P = 0.021) showed that OA of force production from concentric knee extension was at a 
longer muscle length in B2 in comparison to B1 (69.5 ± 7.9 vs 67.7 ± 9.0°, respectively, P = 
0.021). No other interactions including group or time were present.  
Mid-thigh circumference 
Changes in MTC are displayed in Figure 5-4c for B1, and Figure 5-4d for B2. In B1, the largest 
increase on MTC was recorded at 48 h (+1.2% vs pre ECC, P < 0.001) and returned to pre ECC 
levels by 168 h. In B2, MTC peaked at 24 h (+0.7% vs pre ECC, P < 0.001) and returned to 
pre-ECC levels by 96 h. A main effect of bout showed that overall MTC was lower in B2 in 
comparison to B1 (100.3 ± 0.7% vs 100.6 ± 1.0%, respectively, P = 0.006). There was a bout 
× time interaction, with post-hoc tests showing differences between B1 and B2 at 48 h (101.2 
± 1.0% vs 100.6 ± 0.8%, respectively, P = 0.003), 72 h (100.9 ± 0.7% vs 100.3 ± 0.7%, 
respectively, P = 0.001) and 96 h (100.5 ± 0.7% vs 100.1 ± 0.7%, respectively  P = 0.027). No 














Figure 5-4 Changes in OA following ECC exercise in B1 (a) and bout 2 (b) and changes in MTC following ECC exercise in B1 (c) and B2 (d).  OA = Optimal 
angle of force production, MTC = mid-thigh circumference, OCP = oral contraceptive pill, * P = < 0.05 compared to pre-exercise levels within bout; ** P < 
0.05 bout 1 vs bout 2; # P < 0.05 bout 1 vs bout 2 at the respective time point. The grey dashed line represents 100% of pre-exercise values. Combined n = 36, 
males, n =12; OCP females n = 12, eumenorrheic females, n = 12.
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Patella tendon properties prior to ECC exercise in bouts 1 and 2 
For combined data, PT CSA was similar between both bouts (Table 5 -2). Patella tendon 
stiffness for within-participant (standardised to the lowest tendon force across both bouts, per 
participant) and between-participant (standardised to the weakest tendon force for all 
participants, 1612 N) was not statistically different between bouts (P = 0.088 and P = 0.089, 
respectively). Between participant YM was lower in B2 in comparison to B1 (597.8  ± 134.0 
MPa vs 629.8 ± 163.8 MPa, respectively, P = 0.05). Within participant YM was not statistically 
different between bouts (P = 0.058). Males displayed higher within-participant stiffness in B1 
(1405.7 ± 449.5 N∙mm-1), in comparison to the OCP group (1045.1 ± 264.5 N∙mm-1, P = 0.013) 
and eumenorrheic group (958.2 ± 280.8 N∙mm -1, P = 0.003), but not in B2 (P = 0.051). No 










Table 5-2 Pre-ECC exercise VL and patella tendon properties and 
optimal angle of force production for all participants combined (n = 36). 
 Bout 1 Bout 2 P 
VL CSA (cm2) 28.2 ± 6.5 28.2 ± 6.4 0.175 
VL FL (mm) 67.3 ± 11.9 65.0 ± 15.4 0.196 
VL PA (degs) 19.4 ± 3.0 19.2 ± 3.0 0.069 
PT CSA (mm2) 71.1 ± 14.7 70.5 ± 13.4 0.435 
PT Stiffness        
    Within (N∙mm-1) 1136.3 ± 385.9 1087.4 ± 353.4 0.088 
    Between (N∙mm-1) 758.4 ± 174.5 729.2 ± 139.2 0.089 
PT Young’s Modulus        
    Within (MPa) 925.7 ± 265.1 875.8 ± 244.9 0.058 
    Between (MPa) 629.8 ± 163.8 597.8 ± 134.0 0.05* 
Optimal Angle (degs)        
   iMVC 72.2 ± 6.9 73.9 ± 6.2 0.070 
   cMVC 65.0 ± 9.5 68.8 ± 6.7 0.005* 
Data are presented as mean ± SD. VL = vastus lateralis, PT = patella tendon, 
CSA = cross-sectional area, FL = fascicle length, PA = pennation angle, iMVC 
= maximal isometric voluntary contraction, cMVC = maximal concentric 












Figure 5-5 (A) Pre-exercise patella tendon stiffness values for each group relative to the lowest patella tendon force within participant, across the two bouts. 
(B) Pre-exercise patella tendon stiffness for each group relative to the lowest patella tendon force produced across the two bouts. (C) Pre-exercise patella tendon 
YM scores for each group relative to the lowest patella tendon force within participant, across the two bouts. (D) Pre-exercise patella tendon YM scores for 
each group to the lowest patella tendon force produced across the two bouts. YM = Young’s modulus; OCP = oral contraceptive pill; * P < 0.05 males vs OCP 
using females; # P < 0.05 males vs eumenorrheic females.  Males, n =12; OCP females n = 12, eumenorrheic females, n = 12.
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Vastus lateralis properties prior to ECC exercise in bouts 1 and 2 
There were no changes in VL CSA, FL, or PA between B1 and B2 (Table 5-2). Additionally, 
there was no difference in OA derived from iMVC between B1 and B2 (Table 5-2).  
Vastus lateralis fascicle behaviour during ECC exercise 
For all participants combined, absolute and relative VL fascicle lengthening during set 1 of 
ECC exercise was reduced in B2 in comparison to B1 by 4.8 mm and 7.5% respectively (both 
P < 0.001, Table 5-3). Absolute and relative VL fascicle lengthening during set 20 of ECC 
exercise was reduced in B2 in comparison to B1 by 5.3 mm and 7.7% respectively (both P < 
0.001), respectively (Table 5-3). Vastus lateralis fascicle lengthening during ECC exercise 
reduced similarly between B1 and B2 for all groups, with no group differences in VL FL 
behaviour (Figure 5-6).  
Table 5-3 VL fascicle lengthening during ECC exercise for all participants 
(n = 36). 
 Bout 1 Bout 2 P 
Set 1        
    Absolute FL (mm) 45.4 ± 9.0 40.6 ± 7.5 <0.001* 
    Relative FL (%) 66.7 ± 18.2 59.2 ± 14.8 <0.001* 
Set 20        
    Absolute FL mm) 46.7 ± 9.1 41.4 ± 8.2 <0.001* 
    Relative FL (%) 65.1 ± 15.5 57.4 ± 13.4 <0.001* 
Data are presented as mean ± SD. VL = vastus lateralis, FL = fascicle lengthening, 







Set 1 fascicle lengthening by knee angle 
Combined data for ECC torque and VL fascicle lengthening at every 10° throughout the full 
range of motion (30-110°) are displayed in Figure 5-7, for both bouts. Fascicle lengthening 
between B1 and B2 during set 1 remained similar at lower knee angles (between 30 -70° for 
absolute FL, and 30-60° for relative FL). At higher knee angles, fascicle lengthening was 
reduced in B2 vs B1. Specifically, for relative fascicle lengthening, B2 showed reduced fascicle 
lengthening in comparison to B1 at a knee angle of 70° (–3.1%, P = 0.017), and for both 
absolute and relative scores,  fascicle lengthening was reduced at knee angles between 80° and 
110° (80° absolute –1.8 mm, P = 0.045, relative –4.0%, P = 0.010; 90° absolute –1.7 mm, P 
= 0.034, relative –3.8%, P = 0.008; 100° absolute –3.5 mm, P < 0.001, relative –6.5%, P < 
0.001; and 110° –4.3 mm, P < 0.001, relative –7.5%, P < 0.001).  
Set 20 fascicle lengthening by knee angle 
Similar to set 1, absolute and relative VL fascicle lengthening between B1 and B2 during set 
20 remained similar at lower knee angles between 30-60°. B2 showed reduced fascicle 
lengthening in comparison to B1 at knee angles of 70° (absolute –2.3 mm, P = 0.049, relative 
–3.3%, P = 0.033), 80° (absolute –2.7 mm, P = 0.016, relative –4.1%, P = 0.014 ), 90° 
(absolute –3.7 mm, P = 0.001, relative –5.6%, P = 0.001), 100° (absolute –4.9 mm, P < 0.001, 
relative –7.5%, P < 0.001) and 110° (absolute –5.1 mm, P < 0.001, relative –7.7%, P < 0.001).  
Set 1 eccentric torque by knee angle 
Total ECC torque across all knee angles was similar in B1 and B2, based on no main effect of 
bout (P = 0.096). There was a bout × time interaction (P = 0.048), with post hoc analysis 
revealing that ECC torque was higher in B2 in comparison to B1 at knee angles of 70° (+20.8 
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N∙m, P = 0.003) and 80° (+26.7 N∙m, P = 0.001). ECC torque was similar between groups 
based on no bout × angle × group interaction (P = 0.539) and no bout × group interaction (P = 
0.902). 
Set 20 eccentric torque by knee angle. Total ECC torque was similar between B1 and B2 in set 
20, based on no main effect of bout (P = 0.437) with no other interaction effects present. 
Eccentric torque was similar between groups based on no bout × angle × group interaction (P 














Figure 5-6 Absolute change in VL fascicle length for each group during set 1 (a) and set 20 (b) of eccentric exercise. Relative change in VL fascicle length for 
each group during set 1 (c) and set 20 (d) of eccentric exercise. VL = vastus lateralis, OCP = oral contraceptive pill, * P < 0.01 bout 1 vs bout 2; # P < 0.001 



















Figure 5-7 VL fascicle length (left y axis) and ECC torque (right y axis) every 10° knee angle during set 1 (a) and set 20 (b) of ECC exercise.  Percentage 
change in VL fascicle length (left y axis) and ECC torque (right y axis) every 10° knee angle during set 1 (c) and set 20 (d) of ECC exercise. ECC = eccentric; 
* P < 0.05 B1 vs B2 torque at the respective time point; # P < 0.05 B1 vs B2 at the respective time point; ## P < 0.01 B1 vs B2. n = 36. 
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Index of protection  
Figure 5-8 shows the index of protection for each marker of EIMD. MTC was omitted from 
Figure 5-8 due to the low values, which are presented below. With all participants combined, 
the largest protective effect was present for CK (54 ± 43%), followed by cMVC (28 ± 27%), 
DOMS (26 ± 35%), iMVC (24 ± 20%) and MTC (0.7 ± 1.2%). For cMVC, males had a higher 










Figure 5-8 Index of protective effect for creatine kinase (CK), maximal concentric strength (cMVC), 
delayed onset of muscle soreness (DOMS) and maximal isometric strength (iMVC). OCP = oral 
contraceptive pill. * P = 0.006 males vs OCP using females. Index of protection was calculated by the 
following equation [(B1 - B2) / B1 × 100]. The timepoint compared for each variable used was the point 
of maximal muscle damage response following B1 for each individual. Combined n = 36, males, n =12; 
OCP females n = 12, eumenorrheic females, n = 12.
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Associations between fascicle lengthening and markers of EIMD and the RBE 
In bout one, relative VL fascicle lengthening was significantly correlated with absolute and 
relative losses in iMVC force at 24 h post exercise (r = –0.51, P = 0.002 and r = –0.39, P = 
0.020, respectively), cMVC force at 24 h post exercise (r = –0.36, P = 0.030 and r = –0.43, P 
= 0.010, respectively) in B1. No other significant correlations were found between VL fascicle 
lengthening and markers of EIMD in either bout.  
A greater IOP for iMVC was significantly correlated with greater absolute (Figure 5-9a, r = 
0.44, P = 0.007) and relative (Figure 5-9b, r = 0.34, P = 0.044) magnitude of VL fascicle 
lengthening during set 1 of eccentric exercise. A greater IOP for iMVC was significantly 
correlated with greater absolute (Figure 5-9c, r = 0.43, P = 0.008) and relative (Figure 5-9d, r 
= 0.37, P = 0.026) VL fascicle lengthening during set 20 of eccentric exercise. The IOP for 
iMVC was also significantly correlated with the amount of absolute (Figure 5-10a, r = 0.41, P 
= 0.013) and relative (Figure 5-10b, r = 0.52, P = 0.001) iMVC force loss at 24 h post-exercise 
in B1. However, it must be acknowledged that the r2 values for all relationships were low (≤ 
0.27), therefore must be interpreted with caution. No other significant correlations between VL 
MTU properties and EIMD markers or IOP were present. There was no correlation between 
the reduction in VL fascicle lengthening between bouts and the IOP. Additionally, in the 
eumenorrheic female group, serum estradiol levels were not significantly correlated with VL 















Figure 5-9 Correlation between the index of protection for maximal isometric voluntary contraction (iMVC) and absolute vastus lateralis (VL) fascicle 
lengthening (A) and relative VL fascicle lengthening (B) during the eccentric repetition performed in set 1 of the f irst bout of eccentric exercise. Correlation 
between the index of protection for maximal iMVC and absolute VL fascicle lengthening (C) and relative VL fascicle lengthening (D) during the eccentric 















Figure 5-10 Correlation between the index of protection for isometric voluntary contraction (iMVC) and absolute (A) and relative (B) iMVC force loss at 24 




The primary aim of this study was to assess whether adaptations in MTU behaviour during 
maximal lengthening contractions could explain the RBE, and whether these adaptations 
differed between males, eumenorrheic females, and females taking the OCP. The main findings 
of this study were that 100 maximal ECC repetitions of the knee extensors elicited significant 
responses in markers of EIMD (loss of muscle function, increased DOMS, increased blood CK 
and increased swelling), which were all attenuated following a repeated bout of ECC exercise 
performed ~ four weeks later, with no differences in the magnitude of the RBE between males 
and females. The RBE was accompanied by a reduced VL fascicle lengthening, which was 
evident at longer knee angles, despite a higher torque in the second bout, and this  adaptation 
was consistent between males and females. A secondary aim of this study was to investigate 
the potential relationships between MTU behaviour and the magnitude of EIMD and the RBE. 
This analysis revealed associations between force loss and fascicle lengthening, such that 
higher fascicle lengthening in bout 1 was accompanied by a greater magnitude of the RBE in 
bout 2. Collectively the results of the study show that adaptations in MTU behaviour – 
specifically a reduction in fascicle lengthening at larger knee angles – might partly underpin 
the RBE, and that this adaptation is similar between, males, eumenorrheic females, and females 
taking the OCP. 
Vastus lateralis muscle-tendon unit behaviour and the repeated bout effect 
A single bout of maximal ECC exercise can trigger a profound RBE, which results in a 
reduction in the magnitude of EIMD markers after the second bout, compared to the first 
(Nosaka and Clarkson, 1995). The current study reported data consistent with the RBE 
phenomena; a reduced loss and faster recovery of maximal strength, a lower efflux of CK into 
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the blood, less soreness and swelling, and a shift in OA to a longer muscle length in B2, 
compared to B1. Though several mechanisms might be responsible for driving the RBE, 
mechanical adaptations in the MTU (Hyldahl et al., 2017) are particularly pertinent to the 
current study as there was both a reduction in markers in EIMD, and ~7.6% less fascicle 
lengthening in B2, compared to B1, both at the start (set 1) and end (set 20) of the eccentric 
protocol. The reduction in fascicle lengthening in B2 was present despite total ECC torque 
being similar, or higher, in B2 compared to B1, indicating that the changes in VL fascicle 
behaviour between the two bouts were independent of ECC torque. Additionally, the change 
in VL fascicle behaviour was not different between males and females. It is plausible to posit 
that the changes observed in MTU behaviour during contraction could partly explain the RBE. 
A reduced amount of fascicle lengthening would lead to fewer sarcomeres being actively 
lengthened onto the descending limb of the LT curve; this would reduce the amount of strain 
experienced by the sarcomeres, with sarcomere strain being denoted as a main determinant of 
EIMD (Lieber and Friden 1993, Talbot and Morgan 1998). This is the first study to report a 
reduction in muscle fascicle lengthening during a repeated bout of maximal ECC knee 
extension exercise coupled with an attenuation of various markers of EIMD following the 
second bout, in comparison to the first. This adds weight to previous research that suggest 
changes in MTU behaviour as a mechanism of the RBE (Lau et al., 2015, Hyldahl et al., 2017).  
The reduction in fascicle lengthening on repeat bouts supports previous observations in 
eccentric cycling and extends these to maximal eccentric actions. Penailillo et al. (2015) 
reported a 16% reduction in fascicle lengthening during a repeated bout of ECC cycling, 
(Penailillo et al., 2015). In line with the current study, Penailillo et al. (2015) reported less 
muscle soreness after the second bout of exercise, with the authors indicating that the changes 
in fascicle behaviour were a contributor to the RBE, however, there was no difference in 
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isometric torque loss between B1 and B2, with both bouts failing to record a drop in torque 
below pre-exercise levels, making it difficult to ascertain whether a potent RBE was in fact, 
present. This could possibly be explained by the submaximal ECC cycling protocol used by 
Penailillo et al. (2015) failing to elicit sufficient damage, which has been seen in earlier 
submaximal EIMD research (Nosaka and Newton, 2002). Despite the lack of force deficit 
found by Penailillo et al. (2015), VL fascicle behaviour was altered, indicating that fascicle 
changes might not be dependent on the intensity of the exercise protocol used. This theory is 
strengthened with findings from the current study that found that VL changes appear to be 
independent of ECC torque, though this needs to be directly investigated.  
The amount of fascicle lengthening experienced by a muscle and the subsequent EIMD 
response has been the focus of much research in previous years (Guilhem et al., 2011, Hoffman 
et al., 2014) with evidence to suggest that greater amounts of fascicle lengthening result in an 
exaggerated EIMD response (Guilhem et al., 2016, Hicks et al., 2017). This observation was 
also confirmed in the current study as a greater magnitude of fascicle lengthening was 
correlated with a greater amount of iMVC force loss at 24 h post-exercise after B1. In partial 
support, Lau et al., (2015) found a decrease in displacement of the MTJ, meaning less muscle 
lengthening, during a repeated bout of maximal ECC exercise of the elbow flexors, though 
muscle fascicle lengthening was not directly measured. Similar to the current study, Lau et al., 
(2015) found that markers of EIMD, including iMVC torque, recovered more quickly in B2, 
compared with B1, showing an RBE. Lau et al., (2015) speculated that smaller changes in MTJ 
displacement during the second bout of ECC exercise could have imposed less strain on the 
muscle fibres, thus inducing less damage. Furthermore, Hyldahl et al., (2017) theorised that the 
smaller changes in MTJ displacement seen in the study by Lau et al., (2015) might be due to 
201 
 
an increase in tendon compliance, however this has not been directly measured and therefore 
remains speculation.  
As muscles and tendons do not act in isolation, it is important to acknowledge the contribution 
of various elements of the MTU when assessing muscle fascicle behaviour. As previously 
mentioned, Lau et al., (2015) stated that changes in tendon compliance might be responsible 
for the RBE, so it would be prudent to measure tendon properties directly in RBE studies 
investigating muscle lengthening. In the current study, tendon compliance was directly 
measured  prior to both bouts of exercise, and there was a significant decrease in YM from B1 
to B2 when standardised to the weakest participant (Figure 5-5), and the difference approached 
significance when YM was standardised to the lowest force produced by each individual 
participant (P = 0.058). As a more compliant tendon can reduce the amount of fascicle 
lengthening experienced during ECC exercise (Guilhem et al., 2016, Hicks et al., 2013), the 
reduction in YM before the second bout of exercise in the current study would seem a 
reasonable explanation for the reduced VL fascicle lengthening recorded in B2. Ho wever, 
differences in fascicle lengthening between the two bouts did not occur until a knee angle of 
70°, with peak ECC torque occurring at a knee angle of 80° in both bouts. Though a difference 
in YM was almost evident when PT force was standardised to the lowest ‘within participant’ 
force (P = 0.058), YM was only statistically different between bouts at the lower ‘between 
participant’ force, suggesting that any differences in tendon behaviour during the two bouts of 
ECC exercise would occur at the start of the repetition, when forces were low and before the 
tendon had fully extended, at least for the participants capable of producing PT forces well in 
excess of the 1612 N used to standardise between participants. Although there was evidence of 
a trend showing that within participant PT YM was different between bouts, this was not 
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statistically significant. Therefore, differences in tendon compliance cannot fully explain why 
the reductions in VL fascicle lengthening between bouts.   
Though tendons have been shown to act as a mechanical ‘buffer’ and protect muscle fascicles 
from excessive lengthening (Guilhem et al., 2016, Hicks et al., 2013), other structures might 
affect fascicle lengthening by increasing the passive stiffness of the muscle itself, such as the 
ECM. Alterations in the extra-cellular matrix between two bouts of damaging ECC exercise 
has previously been presented as a mechanism underpinning the RBE (Hyldahl et al., 2017), 
and might play a key part in both the reduced fascicle lengthening observed in B2 vs B1 of the 
current study and the subsequent protection against EIMD. An example of ECM modification 
and EIMD response was evidenced in an animal model when Lapier et al. (1995) found that 
following immobilisation, increased intramuscular connective tissue was present, and this 
attenuated an EIMD response following electrically stimulated ECC contractions. Although 
not induced by an initial ECC bout, the increase in connective tissue still conferred a protective 
effect against EIMD. Takagi et al. (2016) found that rat gastrocnemius muscle exposed to ECC 
contractions showed an increase in collagen expression prior to a second bout of ECC exercise, 
separated by 4 weeks. In comparison to a control group, rats that had been previously exposed 
to ECC exercise showed a lower reduction of isometric strength, demonstrating that the RBE 
is present, with the authors stating the increased intramuscular collagen as an explanation 
(Takagi et al., 2016). In human studies, a bout of ECC exercise has resulted in inc reased 
staining of VL tenascin C (Crameri et al., 2007, Raastad et al., 2010), increased NH2 – terminal 
propeptide of procollagen III in the endomysium (Raastad et al., 2010), and increased lamanin-
β1 and types of type I and type III collagen (Mackey et al., 2011), with the latter study 
suggesting this strengthening of the connective tissue plays a role in the RBE found in the 
study. Taken together, evidence from both animal and human studies suggests that 
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intramuscular connective tissue remodelling could explain a reduction in fascicle lengthening 
following repeated bouts of ECC exercise and could potentially be a mechanism underpinning 
the RBE.  
Magnitude of the repeated bout effect 
The repeated bout effect typically results in participants experiencing less exaggerated markers 
of EIMD after completion of the second bout in comparison to the first, which is what occurred 
in the current study. However, when the magnitude of the RBE is assessed by the protective 
effect conferred by the initial bout of exercise on EIMD markers on the second (the IOP), the 
current study provides different results to the literature. For example, in the current study, an 
IOP of 24% was found for iMVC, which is smaller than previous research that reported an 
iMVC IOP of ~60% in the knee extensors (Chen et al., 2019). The difference in IOP in the 
knee extensors might be explained by the contraction type used in each study. In the current 
study, maximal isokinetic ECC contractions were used, whereas Chen et al. (2019) used a free-
weight machine with an isotonic load of 80% maximal iMVC, throughout a range of motion 
of 0°-110° (0° = full extension). However, peak iMVC force losses for B1 in both studies (both 
occurring at 24 h post exercise) were similar at ~ 20%, therefore the magnitude of damage is 
unlikely to be a factor that can account for the difference in IOP between the two studies. A 
main difference between the current study and the study by Chen et al. (2019) was the 
respective four-week and two-week time periods between exercise bouts. (Nosaka et al. 
(2005b) displayed that the RBE is less potent when an eight-week time period is present 
between exercise bouts in comparison to four weeks. Therefore, it seems possible that the lower 
IOP evidenced in the current study in comparison to Chen et al. (2019), was due to the 
diminishing potency of the RBE over time. To confirm this, further research is required 
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investigating differences in IOP with a two- and four-week time period between identical bouts 
of ECC exercise.  
Mediators of the repeated bout effect 
A protective effect against EIMD following a maximal bout of ECC contractions can be 
induced by several different exercise conditions, including low volume ECC contractions (Burt 
et al., 2015), isometric contractions at long muscle lengths (Chen et al., 2018), and cumulative 
bouts of low-intensity ECC exercise (Chen et al., 2010), all of which can produce varying levels 
of protection against EIMD markers following a maximal bout of exercise (Hyldahl et al., 
2017). What is less well understood is what factors determine the magnitude of the RBE when 
the two bouts of ECC exercise are identical. Two novel findings in the current study were that 
the IOP for iMVC was associated with a greater loss of iMVC force at 24 h after B1, and a 
greater magnitude of VL fascicle lengthening during B1 of ECC exercise. Moreover, there was 
also a positive correlation between the amount of VL fascicle lengthening and the magnitude 
of iMVC force loss at 24 h post exercise in B1, but this relationship was not present in B2. 
From these results, it appears that a greater magnitude of VL fascicle lengthening induces 
higher levels of force loss at 24 h post exercise, which corroborates findings showing that 
EIMD is greater when fascicle strain is higher (Guilhem et al., 2016). To the best of the authors 
knowledge, this is the first study to report that MTU behaviour is related to the magnitude of 
the RBE. The evidence presented indicates that greater fascicle lengthening results in greater 
EIMD (measured by iMVC) and this provides a more enhanced protection against subsequent 
damage in future exercise bouts. However, as no correlation was found between the overall 
reduction in VL fascicle lengthening between bouts and the IOP, it is unlikely that a reduction 
in VL fascicle lengthening is the sole determinant of the IOP. To further understand the 
205 
 
relationship between MTU properties and the RBE magnitude, additional research needs to be 
performed, which will be discussed further in chapter 6.  
Group differences in exercise induced muscle damage and the repeated bout effect 
There has been much debate in recent years as to whether sex differences are present in the 
magnitude of EIMD response to damaging ECC exercise. The current study does not support 
a sex difference in muscle damage response, with no differences detected for a range of 
commonly measured indirect markers of EIMD. This corroborates recent findings in the 
literature that no sex differences in EIMD response are present (Lee et al., 2017, Radaelli et 
al., 2014), even when controlled for strength, muscle size and bodyweight (Morawetz et al., 
2019). Previous research has reported sex differences in the CK response to ECC exercise 
(Sewright et al., 2008, Oosthuyse and Bosch, 2017), including Hicks et al. (2016), who reported 
an increase in the CK response in males compared to females following ECC knee extension 
exercise. The authors stated that the differences in CK response between males and females 
might be due, in part, to the membrane stabilising effect of oestrogen (Wiseman and Quinn, 
1994, Minahan et al., 2015).  However, no such difference between males, OCP users and 
eumenorrheic females were present in the current study. The sex differences in CK found in 
the study by Hicks et al. (2016) and not in the current study might be due to the menstrual cycle 
phase at which the eumenorrheic females were tested at. Oestrogen peaks ~ day 14 of the 
menstrual cycle (671 pmol·L-1) and is slightly lower during mid-luteal phase (495 pmol·L-1) 
(Stricker et al., 2006). As the eumenorrheic females in the study by Hicks et al. (2016) were in 
the menstrual cycle phase where oestrogen was higher, it is possible that the cell membrane 
stabilising effects of oestrogen were prominent and this is the reason why sex difference in CK 
was found, in contrast with the current study, where participants were tested in the mid -luteal 
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phase. Moreover, progesterone during the mid-luteal phase is considerably higher than at 
ovulation [36.0 vs 2.5 nmol·L-1, respectively (Stricker et al., 2006)]. Therefore, as progesterone 
is an antagonist of oestrogen activity (Mester and Baulieu, 1984, Hsueh et al., 1975, Hodgen 
et al., 1994), the cell-stabilising effect of oestrogen might have been lost, resulting in similar 
responses between the male and OCP using group. Although estradiol levels were not measured 
in males and OCP users, it was assumed that these were low as the OCP supresses oestrogen 
levels (Bryant et al., 2008, Fleischman et al., 2010) and males have naturally occurring lower 
levels of oestrogen than eumenorrheic females (Tepperman, 1987, Kendall and Eston, 2002). 
It is therefore likely that oestrogen had no influence on the EIMD response to ECC exercise, 
although testing eumenorrheic females at ovulation, when the oestrogen to progesterone ratio 
is at its highest (Stricker et al., 2006) might have produced different results.  
To the author’s knowledge, this is the first study to comprehensively investigate the difference 
in the magnitude of the RBE between males, OCP users and eumenorrheic females. The only 
difference in IOP between groups was that males had a 29.6% higher IOP for concentric 
strength than females in the OCP group, which was surprising, given that no differences in 
EIMD responses between the two groups were present for any marker of EIMD. Typically, 
isokinetic concentric contractions in the lower limb are deemed reliable in recording both peak 
torque (Timmins et al., 2016) and the torque-angle relationship (Oranchuk et al., 2020), 
however this might depend on how well-practiced participants are with the contraction type.  
Chan et al. (2020) recently reported that isokinetic strength assessment at 60°·s -1 required 15 
contractions to produce reliable measurements, however, no current data is available for female 
participants, though it is unlikely that reliability would differ between males and females, 
considering that chapter 4 found no differences between groups in the reliability of functional 
measures of strength. Nevertheless, it remains possible that in B1, the male participan ts had 
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not performed sufficient repetitions to provide reliable results and the large IOP was due to a 
learning effect, whether this variation exists between sexes requires further research. 
Conclusion 
The main aim of this thesis was to use ultrasonography to further understand the properties and 
behaviour of the PT and VL in males and females and how these properties contribute to the 
EIMD response to ECC exercise and the magnitude of the repeated bout effect. To address this 
aim, the current study assessed whether adaptations in MTU behaviour during maximal 
lengthening contractions can explain the RBE, and whether these adaptations differ between 
males, eumenorrheic females, and females taking the OCP. An additional aim of this study was 
to investigate the potential relationships between MTU behaviour and the magnitude of EIMD 
and the RBE. It was found that a bout of 100 maximal ECC repetitions of the knee extensors 
elicited significant responses in markers of EIMD which were all attenuated f ollowing a second 
bout of ECC exercise performed ~ four weeks later, confirming the RBE. Vastus lateralis 
fascicle lengthening during ECC exercise was reduced in the RBE, in comparison to the first. 
This change might, in part, be attributed to an increase in patella tendon compliance as Young’s 
modulus was reduced prior to the second bout of ECC exercise. Furthermore, the amount of 
fascicle lengthening experienced during the initial bout of exercise correlated with both the 
magnitude of isometric force loss at 24 h post-exercise and the magnitude of protective effect 
against isometric force loss following a repeated bout of ECC exercise. Finally, VL MTU 
behaviour did not differ between males, OCP using females, and eumenorrheic females, nor 
did the EIMD response following an initial and repeated bout of maximal ECC exercise, with 
the magnitude of the protective effect remaining similar between groups. These data show that 
reduced muscle fascicle lengthening during a second bout of ECC knee extension exercise is a 
208 
 








The overall aim of this thesis was to examine the properties and behaviour of the PT VL at rest 
and during repeated bouts of maximal ECC exercise using US and investigate how this relates 
to the EIMD response. To achieve this, three studies were designed and constituted the 
experimental chapters within this thesis. Chapter 3 aimed to establish the reliability and validity 
of US measurements of the patella tendon by comparison to the “gold standard” MRI. It was 
established that US showed excellent agreement with MRI when used to assess PT CSA. 
Moreover, US derived measures of PT CSA showed excellent test re-test reliability, 
irrespective of operator experience. Chapter 4 aimed to determine the reliability of using US to 
quantify PT properties at rest and during maximal isometric exercise, and VL properties at rest 
and during maximal ECC exercise. The results from chapter 4 established that US could be 
used to measure VL and PT properties at rest and during maximal exercise with excellent test-
re-test reliability. Moreover, reliability was consistently excellent for males, OCP using 
females and eumenorrheic females. Chapter 5 assessed whether adaptations in MTU behaviour 
during maximal lengthening contractions could explain the RBE, and whether these 
adaptations differed between males, eumenorrheic females, and females taking the OCP. It was 
found that VL muscle fascicle lengthening was lower during a repeated bout of ECC exercise 
and this was associated with lower reductions in muscle force at 24 h post-exercise. Moreover, 
the reduced muscle fascicle lengthening might be attributed to a reduction in PT Young’s 
modulus at low patella tendon forces. Finally, there were no between group differences in MTU 
behaviour or EIMD response between males, OCP using female, and eumenorrheic females 
following ECC exercise in either bout. This chapter will discuss the main findings of this thesis 
in relation to the existing literature. 
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6-2 MAIN FINDINGS 
6-2.1 Ultrasound as a measurement tool for measuring muscle-tendon unit properties at rest 
and during exercise. 
Over the last few decades, the use of 2D B-mode ultrasonography has been used to assess the 
architectural and mechanical properties of human skeletal muscle and tendons. This has 
allowed the in vivo measurement of real-time MTU mechanics during various activities, which 
has led to a greater understanding of how MTU properties can influence human performance 
(Massey et al., 2017), injury risk in sport (Ribeiro-Alvares et al., 2020), and the EIMD response 
to strenuous exercise (Hicks et al., 2016, Hicks et al., 2017). Any measurement tool needs to 
be subjected to rigorous testing to ensure that valid and reliable results are obtained, and US is 
no different. Chapter 3 showed that US had excellent agreement with MRI when measuring PT 
CSA and that US produced reliable results over repeated measures, irrespective of operator 
experience. Furthermore, chapter 4 showed that US measures of resting and dynamic VL MTU 
properties were also reliable over multiple measures. Understanding the variability in the 
measures obtained in chapter 4 allowed the interpretation of results from chapter 5 to be made 
with confidence. However, the measures that were tested for reliability (chapters 3 and 4) and 
to assess the MTU behaviour over repeated bouts of exercise (chapter 5), were chosen due to 
the limitations relating to available equipment and their respective capabilities. Though the 
chosen measures had been used in previous literature, supplementary methodologies might be 
able to address some of the areas that this thesis was unable to answer. 
The constituent structures of the muscle-tendon unit can be measured independently using US 
(Fukunaga et al., 1997), but the simultaneous measurement of the muscle and tendon is more 
difficult. Previous research has shown that fascicles are actively lengthened to a lesser extent 
during ECC contractions when tendon compliance is higher (Guilhem et al., 2016, Hicks et al., 
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2013), however, the direct measurement of the tendinous contribution to these ECC 
contractions has not been directly assessed. Hicks et al. (2013, 2017) directly measured PT 
elongation during a ramped iMVC and calculated tendon stiffness and YM based on these 
measures. However, direct assessment of the PT was not conducted during ECC exercise and 
the relationships between PT compliance and VL fascicle lengthening reported by Hicks et al. 
(2013) were based on the ramped iMVC data and a post hoc calculation of VL excursion, that 
estimated total MTU lengthening (Spoor et al., 1990). Similarly, Guilhem et al. (2016) based 
the tendinous contributions to total MTU behaviour during ECC plantar flexor exercise on 
indirect calculations, displaying that a compliant tendon meant that fascicles lengthened less. 
In chapter 5, no relationships were found between tendon properties and VL fascicle 
lengthening, based on VL PT properties during a ramped iMVC. However, across two bouts 
of identical ECC exercise, VL fascicle behaviour changed significantly in the absence of PT 
compliance changes at high forces. Though alternative explanations were presented to explain 
the changes in VL behaviour between exercise bouts, there is a possibility that the tendon 
behaviour did change, but the methodology implemented did not allow these changes to be 
detected. Although speculative, had PT elongation been measured during the ECC exercise, 
differences in PT lengthening, stiffness and/or YM might have been detected. However, to 
date, no studies have directly measured PT behaviour during maximal ECC contractions, 
meaning that any muscle-tendon interactions can only be indirectly inferred.  
 Whilst it would be logistically difficult, directly assessing muscle and tendon behaviour 
simultaneously is possible. For example, using two ultrasound machines synchronised with the 
same torque acquisition system, Massey et al. (2017) implemented the concurrent recording of 
VL fascicle and PT behaviour during ramped contractions, allowing the calculation of absolute 
MTU stiffness and the contributions of the VL and PT, independently. In theory, the same 
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methodology could be implemented during ECC contractions, which would allow a more 
accurate interpretation of the contribution of both the PT and the VL to total MTU behaviour. 
Should this be achieved, additional methodological considerations would need to be employed. 
For example, PT tendon stiffness and by extension, PT YM is calculated using PTMA 
(Onambele et al., 2007), which has been shown to change during knee flexion (Wretenberg et 
al., 1996, Tsaopoulos et al., 2006, Krevolin et al., 2004). This would then require the 
measurement of PTMA over the range of motion to be used in the exercise, so that appropriate 
tendon forces could be calculated at a given knee joint angle. As was found in chapter 5, VL 
fascicle lengthening between two identical bouts of ECC exercise did not dif fer until a knee 
angle of 70°, therefore having the means to distinguish the contribution of the tendon at, and 
beyond this point might ascertain why the differences in VL lengthening between bouts were 
occurring. Unfortunately, measuring PTMA over a range of motion is difficult and either 
requires a series of static images measured over several joint angles (Wretenberg et al., 1996, 
Hashizume et al., 2012), or real-time MRI (Fiorentino et al., 2013). Moreover, high force 
contractions, albeit isometric, have been shown to increase joint moment arm by 22-44% 
(Maganaris et al., 1999, Maganaris et al., 1998), which implicates the calculation of tendon 
stiffness further. Whilst dynamic measurement of PTMA is achievable at low forces 
(Fiorentino et al., 2013), it remains unclear if it is possible to measure PTMA at higher forces, 
given the limitations of MRI scanning logistics. Nevertheless, future research should seek to 
implement more joint specific measures of PTMA and PT elongation, so that a better estimation 
of mechanical tendon properties can be obtained at specific joint angles during dynamic 
movement.  
Young’s modulus is reliant on the measurement of tendon CSA (Onambele et al., 2007), which 
can be accurately and reliably obtained via US, as reported in chapters 3 and 4. At present, 
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calculations of YM are based on resting PT CSA at a fixed knee angle (Onambele et al., 2007) 
and therefore do not include potential variations of PT CSA as a result of strain. In chapter 5, 
at low PT forces, YM was reduced prior to the second bout of ECC exercise, in comparison to 
the first bout and it was stated that this difference might contribute to the reduction in VL 
fascicle lengthening seen during the second bout of ECC exercise, in comparison to the first. 
However, as previously discussed, this interpretation is based on two different contraction 
modalities and at a fixed knee angle. To more accurately understand the contribution of changes 
in YM to changes in fascicle lengthening, more appropriate measurement of PT CSA could be 
used to calculate YM. Due to the crimped region on the tendon (Whittaker and Canham, 1991, 
Stouffer et al., 1985), the diameter of the PT would not conform to Poisson’s ratio (Poisson, 
1827, Greaves et al., 2011), whereby the diameter would decrease at a constant to the strain. 
As US is a reliable tool for measuring CSA, it seems feasible that measuring PT CSA under 
strain is another area of research that could be conducted. To date, this is an area of research 
that has yet to be explored but would contribute to the more accurate interpretation of the 
relationship between tendon compliance and fascicle behaviour. 
In summary, the use of US technology to measure muscle and tendon properties has allowed 
the studies in chapter 4 and 5 of this thesis, and several other studies,  to explore the intricate 
relationship within the MTU, with chapter 5 exploring how this relationship changes upon 
exposure to maximal ECC exercise. However, alterations in methodological approach, such as 
measuring tendon behaviour during ECC exercise, might allow researchers to further 
understand these MTU interactions. Through this approach, the findings form this thesis would 
be strengthened, and it would create a platform for future research opportunity. 
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6-2.2 The role of the muscle tendon unit and the magnitude of EIMD response 
As stated in section 2-6, several key determinants are purported to be responsible for eliciting 
EIMD, and the results from chapter 5 add some interesting data to this debate. One proposed 
determinant of EIMD is the length at which the muscle is exercised. Specifically, ECC exercise 
at longer muscle lengths elicits a greater magnitude of EIMD (Nosaka et al., 2005a, Newham, 
1988). Chapter 5 showed that a greater amount of VL fascicle lengthening correlated with a 
greater amount of iMVC force lost at 24 h post-exercise after the first ECC bout, thereby 
supporting the claim that ECC exercise at longer muscle lengths elicits more damage. However, 
as all of the participants in chapter 5 exercised through the same range of motion, it would 
appear that the measurement of muscle length needs to go beyond the amount of degrees  of 
rotation that the limb has travelled through. The findings from chapter 5 support previous 
research that has reported that greater fascicle strain over the same range of motion is correlated 
with a greater amount of iMVC force loss (Guilhem et al., 2016). This is contrary to the findings 
of Hicks et al. (2016), who found no relationship between the degree of VL fascicle lengthening 
and iMVC force loss, however a relationship was found for CK efflux, which was not present 
in chapter 5. Using CK to determine structural damage following ECC exercise is difficult, as 
individual responses can be highly variable and do not correlate well with other markers of 
EIMD (Nosaka and Clarkson, 1996, Heled et al., 2007, Fridén and Lieber, 2001). However, a 
loss in maximal force has been suggested as a highly valid and reliable marker of EIMD in 
humans (Damas et al., 2016, Warren et al., 1999) and might be a better indicator of damage to 
the muscle, in the absence of direct techniques. In chapter 5, an end range of motion of 110° 
knee angle was used, in comparison to 90° used by Hicks et al. (2017); the participants in 
chapter 5 would most likely have had more sarcomeres actively lengthened further down the 
descending limb of the LT curve, exposing a greater number of weaker sarcomeres to stress 
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and damage, as explained by the popping sarcomere theory (Morgan, 1990, Morgan and 
Proske, 2004). It would therefore appear that ECC exercise to a knee angle of at least 110° is 
required to cause iMVC force losses that are attributable to the amount of fascicle lengthening 
in the VL. 
As the muscle and tendon are both constituents of the wider MTU, the behaviour of both tissues 
must be considered when evaluating the involvement of MTU behaviour in EIMD. Chapter 5 
uncovered some results that are inconsistent with the literature. For instance, despite the 
relationship between greater VL fascicle lengthening and greater iMVC loss, there was no such 
relationship for any measured tendon properties. It has been reported that the tendon can act as 
a mechanical buffer, thereby protecting the muscle from excessive lengthening and subsequent 
damage (Guilhem et al., 2016, Reeves and Narici, 2003). However, the results from chapter 5 
showed that no relationship existed between PT properties (stiffness and YM) and either the 
magnitude of VL fascicle lengthening or the magnitude of EIMD. Previous research that has 
shown that tendon properties influence fascicle lengthening in the VL (Hicks et al., 2013, 
Penailillo et al., 2015) or plantar flexors (Guilhem et al., 2016) but this work is not entirely 
reflective of the possible role of the tendon in ECC muscle actions. For example, Guilhem et 
al. (2016) and Penailillo et al. (2015) estimated tendon contribution to total MTU lengthening. 
As in chapter 5, Hicks et al. (2013) used tendon properties derived from ramped iMVCs to 
investigate potential relationships between PT properties and VL fascicle lengthening during 
ECC exercise. Though differences between chapter 5 and the study by Hicks et al. (2013) were 
present for the influence of tendon properties on VL fascicle lengthening, chapter 5 and another 
study by Hicks et al. (2016) are in agreement that PT properties do not correlate with markers 
of EIMD. Within the literature, there appears to be a disconnect between tendon properties, 
fascicle lengthening and the magnitude of EIMD following ECC exercise. As discussed earlier 
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in this section, chapter 4 showed that ramped iMVCs using US to measure tendon elongation 
is a reliable tool for estimating PT properties. However, PT properties derived from this method 
might not translate fully to the properties and behaviour of tendons during ECC actions. Most 
notably, the differences in contraction mechanics, such as the role of titin increasing muscle 
stiffness during ECC muscle actions and not in isometric contractions (Herzog, 2018), might 
mean that tendon behaviour during isometric contractions differs from that during ECC 
contractions. This could explain why differences in VL fascicle lengthening between bouts of 
ECC exercise in chapter 5 were present, in the absence of differences in PT properties at high 
forces. As discussed in section 6-2.1, there is potential to measure PT properties during ECC 
exercise, and this could be used to further understand the role of the tendon as a determinant 
of EIMD and its action as a mechanical buffer. 
6-2.3 Muscle-tendon adaptations as a mechanism of the repeated bout effect 
The repeated bout effect, characterised by a reduction of muscle damage following a second 
bout of ECC exercise in comparison to the first (Nosaka and Clarkson, 1995), is thought to be 
due to a multitude of mechanisms, one of which being alterations in MTU behaviour between 
bouts (Hyldahl et al., 2017). Chapter 5 provided evidence that VL fascicle lengthening was 
reduced during ECC exercise during the second bout, in comparison to the first. However, 
some previous research has found no differences in fascicle behaviour between two bouts of 
backwards downhill walking, despite an RBE being evidenced through the attenuation of 
EIMD markers following the second bout (Hoffman et al., 2016). Nevertheless, the reductions 
in VL fascicle lengthening during bout 2 in chapter 5 was accompanied by a reduction in the 
magnitude of EIMD in bout 2 in comparison to bout 1, indicating that the RBE was present. 
The reduction in muscle lengthening during the second bout of ECC exercise was consistent 
with previous research, though a mechanism behind this reduction in muscle strain was not 
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determined (Lau et al., 2015, Penailillo et al. 2015). Hyldahl et al., (2017) did speculate that 
alterations in tendon properties between bouts could be an explanatory factor for the reductions 
in muscle lengthening seen in the second bout, although this remains a theory. Though chapter 
5 did report a difference in YM prior to bout 2 in comparison to bout 1, this was only for 
calculations standardised to the lowest tendon force across all participants, and no difference 
in YM was reported when the standardisation was to the lowest tendon force per participant. 
Therefore, an alternative explanation for the reduction in VL fascicle lengthening in bout 2, 
must be involved. 
To determine what was driving the reduction in VL fascicle lengthening and markers of EIMD 
reported in bout 2 of chapter 5, adaptations in other aspects of the muscle structure following 
ECC exercise must be explored. For example, titin can increase muscle stiffness by binding to 
actin in the presence of Ca2+ during ECC contractions (Herzog, 2018). Moreover, titin-based 
elastic forces have been shown to maintain A-band centering within the sarcomere during ECC 
contractions, maintaining force generating capacity via the maintenance of a more optimal 
actin-myosin overlap (Horowits and Podolsky, 1987). Following damaging ECC exercise, 
immunogold staining demonstrated a fragmentation of titin, evidenced by a dislocation of the 
COOH terminus of titin towards the A-band and H zone of the sarcomere (Macaluso et al., 
2014). Additionally, urinary fragments of titin have been detected in response to EIMD 
(Yamaguchi et al., 2019, Kanda et al., 2017), suggesting that titin becomes damaged following 
ECC exercise. An interesting finding by Yamaguchi et al. (2019) was that titin fragments did 
not appear in the urine following a repeated bout of ECC exercise. Due to the time-course 
similarities to CK release into the bloodstream following the first bout of ECC exercise, and 
the lack of titin fragment increase following the second bout, Yamaguchi et al. (2019) 
suggested that the reason why urinary titin fragments were not increased following the second 
219 
 
bout was possibly due to reductions in sarcolemma damage, thus preventing intracellular titin 
fragments from escaping, similar to how levels of CK are reduced following repeated bouts of 
ECC exercise (Lehti et al., 2007). Though this is possible, an alternative explanation for the 
reduction in urinary titin fragments following the bout could be due to changes in titin 
properties following the first bout of ECC exercise, though this has yet to be investigated in 
humans.  
Research investigating the role of titin stiffness in ECC muscle actions and the response of titin 
to EIMD has become popular over the last few years. For example, a significant increase in the 
relative phosphorylation of the elastic PEVK-domain of titin was demonstrated in rats 
subjected to a single ECC exercise bout, which is expected to result a higher titin -based 
stiffness within the muscle (Müller et al., 2014). Additionally, increased titin phosphorylation, 
and an indication of increased titin stiffness, was also observed following three weeks of 
running in mice (Hidalgo et al., 2014). Although an increase in titin stiffness following exercise 
is yet to be confirmed in humans, the findings from Müller et al. (2014) and Hidalgo et al. 
(2014) might explain observations in chapter 5 and in a study by Penailillo et al. (2015). For 
example, both chapter 5 and Penailillo et al. (2015) observed a reduction in VL fascicle 
lengthening upon a second bout of identical ECC exercise. In chapter 5, the lack of differences 
in tendon compliance at high forces between bouts suggests that changes in PT properties 
cannot fully explain the VL changes, although it must be noted that tendon compliance was 
measured during a separate iMVC and not during the ECC exercise. An alternative theory is 
that an increase in titin stiffness between bouts is responsible for the reduction in VL fascicle 
lengthening observed during B2 in chapter 5. At the start of the contraction, the compliant Ig 
domain of titin extends first followed by the PEVK region (Linke et al., 1998), which is the 
region where increased titin stiffness is suggested to occur (Müller et al., 2014, Hidalgo et al., 
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2014). Therefore, if changes in titin stiffness would not have an effect until the PEVK region 
is stretched, it would seem feasible that muscle lengthening would remain similar at shorter 
muscle lengths where only the Ig regions of titin were being lengthened. This would explain 
observations in chapter 5, where a reduction in VL fascicle lengthening during B2, compared 
to B1, was only observed at knee angles of over 70°. Though an interesting theory, changes in 
titin stiffness and the effect on muscle lengthening between two bouts of ECC exercise have 
yet to be studies in humans and therefore, this theory remains speculative. 
A dominating theory of why the RBE occurs would be developed if a specific mechanism was 
consistently observed across all RBE studies, however, as this is not the case, it appears as 
though the RBE is very much a multifactorial phenomenon. For example, in chapter 5, although 
the amount of VL fascicle lengthening was correlated with the magnitude of the protective 
effect for iMVC, the difference in total fascicle lengthening between the two bouts was not. 
Essentially, this implies that MTU behaviour, or fascicle lengthening specifically, is more 
aligned with the magnitude of iMVC force loss following the initial bout of ECC exercise and 
it is the magnitude of EIMD that dictates the IOP following the second bout of ECC exercise, 
as there was no relationship between IOP and the difference in total fascicle lengthening 
between bouts. It therefore seems apparent that magnitude of the RBE is dictated by the 
magnitude of initial EIMD following the initial bout of exercise, a notion that has been 
supported by previous literature (Nosaka, 2011). However, until the direct measurement of 
both tendon and fascicle behaviour is measured, the definitive role of the MTU in the RBE 
cannot be ascertained.  
Although this thesis presents evidence for the role of the MTU in the RBE, changes in muscle 
and tendon during ECC exercise cannot fully explain the RBE and several questions remain. 
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For example, the contralateral RBE, whereby damage to one limb confers a protective effect 
to the limb on the opposite side of the body (Tsuchiya et al., 2018, Howatson and van Someren, 
2007), is unlikely to be due to local muscle adaptations, such as sarcomerogenesis (Proske and 
Morgan, 2001). Additionally, a protective effect against maximal ECC exercise can be 
conferred by isometric contractions that produce very little EIMD (Chen et al., 2012a, Tseng 
et al., 2016), which means adaptations due to structural remodelling are unlikely. Consistent 
with the conclusion by Hyldahl et al. (2017), the RBE remains a multi-faceted phenomenon, 
comprised of neural, inflammatory, extracellular matrix and MTU adaptations. However, the 
contribution of each mechanism remains unknown. 
6-3 PRACTICAL IMPLICATIONS AND FUTURE RESEARCH 
The results of this thesis could have a number of important practical and research implications. 
For example, the longer time period between one exercise bout and the next reduces the amount 
of protection conferred by the RBE (Nosaka et al., 2005b). Therefore, should athletes take an 
extended off -season, they would be more susceptible to EIMD and potentially more severe 
injuries (Emery and Meeuwisse, 2001, Brumitt et al., 2020). The findings from chapter 5 
illustrate that ECC exercise that requires exercise at a longer muscle length  produces more 
fascicle strain and more EIMD. Though more EIMD results in a greater amount of protection 
against damage in a repeat bout, results from chapter 5 show that muscle function had still not 
recovered after seven days. Though the protective effect is greater with more muscle 
lengthening and EIMD, waiting seven-days to perform another exercise session would be 
impractical in most sporting scenarios. Therefore, a number of options are available to strength 
and conditioning coaches to minimise EIMD and recovery time needed. One option would be 
to choose exercises that limit muscle length, quarter, or half squats as an example. This would 
reduce excessive fascicle lengthening that chapter 5 and other research has showed to impair 
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muscle function (Guilhem et al., 2016). Using findings from RBE literature beyond this thesis 
could also be implemented. For example, coaches could use a number of sub-maximal sessions 
to confer a protective effect against maximal exercise (Chen et al., 2010), though the protective 
effect is likely to diminish over time (Chen et al., 2012a), or implement maximal isometric 
exercises at long muscle lengths to give athletes some protection against EIMD from ECC 
exercise without the associated muscle soreness and decrements in function (Tseng at al., 2016, 
Chen et al., 2012b). Although individual responses would vary, implementing some of these 
strategies could allow more frequent training to occur without functional impairment.  
In terms of future research directions, this thesis provides a number of avenues that could be 
explored. The current thesis has focussed heavily on the use of the in vivo measurement of VL 
and PT properties using US. An immediate question that needs answered is how the tendon 
behaves during single and repeated bouts of ECC exercise. As discussed throughout this final 
section, current contributions of the tendon to total MTU lengthening remains either via a 
prediction (Guilhem et al., 2016, Penailillo et al., 2015) or via extrapolation from isometric 
contractions (Hicks et al., 2013). The simultaneous measurement of PT and VL fascicle 
behaviour, like that implemented by Massey et al. (2017), should be considered and this would 
give a much better understanding of the muscle-tendon interaction during ECC exercise. 
In section 6-2.3, the theory that titin stiffness changes between bouts was proposed as a 
potential mechanism behind the reduced VL fascicle lengthening seen in bout 2. Recently, the 
action of titin and the role that it plays in EIMD has become an area of speculation. The binding 
of titin to actin during active lengthening is proposed to alleviate the strain on the contractile 
filaments (Herzog, 2018, Herzog, 2014). The potential remodelling of titin following EIMD 
and the increased stiffness in titin’s PEVK region (Hidalgo et al. 2014, Müller et al. 2014) 
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provides a hypothesis that might explain the reductions in fascicle lengthening seen in a repeat 
bout of ECC exercise. Although this would be a difficult hypothesis to test, combining this 
with the concurrent measurement of VL and PT during ECC would provide a more holistic 
understanding of the interactions between the active and passive elements of the MTU.  
Finally, a key theme to this thesis was the investigation of sex differences and the role of the 
OCP in EIMD and the RBE. Results from chapter 4 showed that US measures of MTU 
behaviour during ECC exercise were reliable for males and females. In chapter 5, it was shown 
that no differences in MTU measures existed between males, eumenorrheic females and 
females using the OCP, which contradicted findings from Hicks et al. (2013, 2016) and that 
this might be due to the point in the menstrual cycle that the eumenorrheic females were tested, 
as discussed in section 5-5.4. To date, only one study has investigated EIMD across various 
phases of the menstrual cycle and found that the inflammatory response was greater in the mid -
follicular phase in comparison to the mid-luteal phase (McKinley-Barnard et al., 2018). The 
authors attributed this to oestrogen exerting a cyto-protective effect on the sarcolemma. 
However, the results of this study might have been confounded by the contralateral RBE 
(Howatson and Van Someren 2007), as the mid-follicular session was always performed first, 
with the mid-luteal session performed on the contralateral limb. Both the RBE and contralateral 
RBE make testing the same eumenorrheic female participants on multiple occasions 
problematic, as there is no guarantee a protective effect will have been induced unless a six 
month period in-between visits is employed, which is the longest known time an RBE has been 
proven to exist (Nosaka et al., 2001). Therefore, to fully understand the effect of menstrual 
cycle phase on EIMD susceptibility, a study testing groups of eumenorrheic females at specific 
menstrual cycle phases could be employed, with enough females per phase to ensure statistical 
power. Given the high intra-individual variability of EIMD response, this would require a large 
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sample size. This could also be extended to investigate the effect of menstrual cycle phase on 
the magnitude of RBE. Once established, this would give researchers a more solid basis to 
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APPENDIX 1 – EXAMPLE OF A PARTICIPANT INFORMATION 





Study Title: The influence of sex and the oral contraceptive pill on markers of 
exercise induced muscle damage and the repeated bout effect, following 
maximum, single limb, knee extension exercise 
 
Investigator: Mr. Steven Marshall 
 
Participant Information Sheet 
 
You are being invited to take part in this research study.  Before you decide it is 
important for you to read this leaflet so you understand why the study is being carried 
out and what it will involve. 
 
Reading this leaflet, discussing it with others or asking any questions you might have 
will help you decide whether or not you would like to take part. 
 
 
What is the Purpose of the Study? 
Following a bout of unfamiliar exercise, human muscle can become damaged. 
Following this, adaptations occur so that when the same exercise is performed again 
sometime later, the muscle becomes less damaged when compared to the initial bout. 
This is known as the repeated bout effect and the cause is not fully understood. The 
focus of our research is to see what changes happen in the muscle and tendon (tissue 
that connects muscle to bone) before, during and after the unfamiliar bout of exercise, 
and then again when it is repeated.  To measure these changes, we will use ultrasound 
imaging and an isokinetic dynamometer. There has also been some research to 
suggest that the response to this type of exercise might differ between males and 
females. Furthermore, females that take the oral contraceptive pill might respond 
differently to females who don’t use any type of hormone influencing contraception 
The results of this study will provide evidence of how the muscle and tendon responds 
to this repeated exposure to unfamiliar exercise. In addition, we will be able to make 
comparisons over muscle and tendon properties between males and females, which 
is a largely unexplored component of sport science research. 
 
Why have I been invited? 
You have been invited to take part in this study as you are aged between 18-35 with 
no current musculoskeletal injuries and are currently exercising at least twice per 
week. Female participants will have reported no abnormalities in their menstrual cycle, 
as assessed via a confidential menstrual cycle questionnaire. Abnormalities include 
such things large fluctuations between the length of your cycle, cycles that last 
upwards of 45 days and menstruation that lasts longer than 7 days.  You therefore 
meet the inclusion criteria for the study and are invited to participate. 
 
Do I have to take part? 
No. It is up to you whether you would like to take part in the study.  I am giving you 
this information sheet to help you make that decision.  If you do decide to take part, 
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remember that you can stop being involved in the study whenever you choose, without 
telling me why.  You are completely free to decide whether or not to take part, or to 
take part and then leave the study before completion. 
 
What will happen if I take part? 
Prior to testing, you will be asked to complete pre-screening health and menstrual 
cycle (females only) questionnaires which will ask you to disclose information about 
your health. You will be asked to attend the laboratory on thirteen separate occasions, 
the first being a practice session (visit 1). Then you will have your first experimental 
visit (visit 2), followed by follow up sessions (visits 3-7) at 24, 48, 72, 96 and 168 hours 
later. You would then repeat this about 4 weeks after your first experimental visit (visits 
8-13). Visits will take place in the neurophysiology lab on the 4th floor of the 
Northumberland Building, room NBD415. You will be asked to refrain from strenuous 
exercise and consuming alcohol in the 24 hours prior to testing and throughout the 
follow up visits. On the day of testing, you will be asked to refrain from consuming 
caffeine, non-steroidal anti-inflammatory drugs (e.g. ibuprofen) and other stimulants. 
In between visits, you will be asked to maintain your regular eating habits and keep a 
daily exercise diary. Details of the visits are given below. 
 
Visit 1 – Familiarisation session 
During the familiarisation session, you will be habituated with the study protocol and 
the techniques used to measure how your muscle behaves during contraction. Before 
this, the researcher will take your height, weight and thigh circumference, and a scan 
of your knee using a very low dose X-ray. The procedure familiarisation will involve 
you sitting in a device called a dynamometer. Then, with your knee set at a 70° angle 
(0° being fully extended), you will perform a short warm up, then push as hard as you 
can against the lever arm of the device for a few seconds, this is known as an isometric 
maximum voluntary contraction. You will repeat this at an 80° knee angle, to 
experience the differences in pushing with your leg slightly more bent. Finally, you will 
be demonstrated 5 eccentric contractions (the muscle is producing force as it gets 
longer). The researcher will start with their leg almost straight, followed by the lever of 
the device slowly forcing the leg to bend whilst they try to resist as much as possible. 
This type of movement is called a maximum eccentric contraction. The Familiarisation 
session should last between 20-30 minutes. 
 
Visit 2 – Assessment of muscle and tendon behaviour during maximal contractions of 
the quadriceps and bout 1 of ‘muscle damaging’ exercise 
The session will begin by the researcher locating the centre of the quadricep muscle 
on the outside of your leg, using an ultrasound probe. Ultrasound images of your 
patella tendon will be taken by placing a probe on the knee. A conductive gel will be 
used to enhance the image. Images will be taken at rest, during passive movement 
and during maximal isometric contractions. You will then be asked complete 
assessments of lower limb muscle soreness and pain pressure threshold (how much 
soreness you feel when a specific amount of pressure is applied). A capillary blood 
sample taken from the ear lobe will then be used to measure a specific compound 
(creatine kinase) assessed during muscle damage studies. If your creatine kinase 
score is outside of the detectable range, you will be asked to give a venous blood 
sample, taken from the arm. Ultrasound images of the quadriceps muscles will then 
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be taken during maximal and sub-maximal isometric contractions at 90°, 85°, 80°, 75°, 
70°, 65° and 60° knee angles. You will then be asked to perform maximal and sub-
maximal contractions of the hamstrings at a 90° knee angle. You will then perform 3 
concentric contractions of the quadriceps. For the ‘muscle damaging’ exercise, you 
will perform 15 sets of 10 maximal eccentric contractions of the quadriceps, against 
the lever arm of the dynamometer. Ultrasound images of the quadriceps will be taken 
during these contractions. Following this, you will perform follow up measures 
including 4 isometric contractions and 2 concentric contractions of the quadriceps, 
thigh circumference, muscle thickness, a capillary blood sample and measures of 
muscle soreness. The first experimental visit is expected to take between 2-2.5 hours. 
For female participants using oestrogen stabilising forms of contraception (e.g. the oral 
contraceptive pill), the muscle damage visit will occur on day 21 of the menstrual cycle 
(day zero will be reported to the researcher). Females who are not using any form of 
hormone-based contraception will be provided with home ovulation kits to be used 
from day 9 of their menstrual cycle. This is done by either urinating on the test strip of 
the ovulation kit for 5-6 seconds or dipping the test strip into a collected sample of 
urine for 15 seconds. This test can be done at any time of day, but the time must be 
consistent between days and the sample should be collected following a period of 4 
hours without urination. When peak levels of luteinising hormone are confirmed by the 
test kits on 2 consecutive days (by the appearance of a ‘smiley face’ on the kit), the 
first muscle damaging testing visit will occur 7 (± 2) days after this.  
 
Visits 3, 4, 5, 6 and 7 – 24, 48, 72 96 and 168 hour post-damage follow up sessions 
All of these sessions will follow the same format and will consist of a capillary blood 
sample, measures of muscle soreness and pain pressure threshold, muscle 
circumference and thickness, 4 isometric contractions and 3 concentric contractions 
of the quadriceps. Each follow up session is expected to last 20-30 minutes and will 
be performed at approximately the same type of day  
 
Visits 8, 9, 10, 11, 12 and 13 – Second muscle damaging visit and follow up sessions 
Approximately 4 weeks after the first ‘muscle damaging’ visit, you will return to the lab 
and repeat visit 2 in an identical fashion. In the days post, you will repeat the exact 
same follow up sessions you did after the first ‘muscle damaging’ visit. For female 
participants, the same procedures (described earlier) will be in place to ensure that 
testing is performed at the correct stage of the menstrual cycle. 
 
What are the possible disadvantages of taking part? 
Due to the nature of the eccentric exercise bout, you will likely experience severe 
soreness in the exercised leg. There is also some injury risk associated with the 
contractions involved in the study, however a warm up will be performed in order to 
minimize risk. If injury does occur, appropriate sports medicine treatment will be 
organised. The X-ray scan, known as a DEXA, will expose you to a very low dose of 
radiation, however this is less than 2 days’ exposure to natural background radiation. 
For comparison, a flight from the UK to North America is the equivalent to a week’s 
exposure to natural background radiation. The ultrasound procedure is non-invasive 
and should not cause any discomfort. Hypoallergenic conductive gel is used to 
enhance the signal. This gel is cold when applied but this sensation will only last a few 
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seconds. The probe is placed on the area of interest with minimal pressure and images 
are transferred to a computer.  
Venous and capillary blood sampling may result in some light, local bruising, and slight 
physical discomfort for the participant. This will be minimized by good practice and 
samples being taken by a trained phlebotomist. Standard precautions will be taken, 
such as wearing gloves, and consumables will be disposed of as per clinical waste 
guidelines. 
 
What are the possible benefits of taking part? 
By participating in the study, you will be participating in scientific research that aims to 
demonstrate the effect of sex and oral contraceptive pill use muscle damage and the 
repeated bout effect. You will gain experience and knowledge of how an experimental 
study is operationalized and will receive results of basic strength testing. 
 
Will I be reimbursed for participating in the study?  
Due to the large time commitment and the nature of the study, you will be given a £50 
Amazon voucher on completion of the study. 
 
Will my taking part in this study be kept confidential and anonymous? 
All data storage will abide by the universities Data Management Procedures. All data 
will remain anonymous to anyone other than the researcher and supervisor. A coded 
system will be used to ensure anonymity. All paperwork will be coded apart from your 
consent form, which will be stored in a secure filing cabinet in a lockable office to 
ensure confidentiality.   
 
How will my data be stored? 
All data will be stored on a secure, password protected computer system. All paper 
data will be stored in a lockable unit. Data will be backed up on a password protected 
external hard drive. All data will be stored by the lead researcher, in accordance with 
Universities Data Management Procedures. All data will be destroyed 5 years after 
data collection. 
 
What will happen to the results of the study? 
On completion of the study results will be collated with those of the other participants 
and will in no way be linked back to you. Findings may be published in scientific papers 
or presented at conferences. If you would like a copy of the summary of findings you 
may contact the researcher at the email address given below and you will be issued a 
copy once the study has ended. Please note that individual data will not be issued, 
and collated findings will not be available immediately after completion of the study. 
 
Who is Organizing and Funding the Study? 
The study will be organized and funded by Northumbria University and sport England 
TASS. 
 
Who has reviewed this study? 
This study has been reviewed and approved by the Faculty of Health and Life Sciences 
Research Ethics Committee at Northumbria University. Should you require any 
information about the ethical aspects of this study please contact;  
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Dr Mick Wilkinson, Northumberland Building, Northumbria University, Newcastle 
upon Tyne, NE1 8ST  
Email: mic.wilkinson@northumbria.ac.uk  
 
Thank you for taking the time to read this information sheet. If there are any parts you 
do not understand please do not hesitate to contact 
 
Contact for further information: 
Researcher email: s.j.marshall@northumbria.ac.uk 
Supervisor email: kevin2.thomas@northumbria.ac.uk 
Name of another person who can provide independent information or advice 
about the project 




Faculty of Health & Life Sciences 
 
INFORMED CONSENT FORM 
Project Title: The influence of sex and the oral contraceptive pill on markers of exercise 
induced muscle damage and the repeated bout effect, following maximum, single limb, 
knee extension exercise 
 
Principal Investigator: Mr. Steven Marshall                                                          
Please tick or initial 
where applicable 
I have carefully read and understood the Participant Information Sheet. 
 
 




I understand I am free to withdraw from the study at any time, without having to give 
a reason for withdrawing, and without prejudice. 
 
 
I give my permission for the still and moving images obtained during the scanning 
procedures to be used for analysis and reproduced for all scientif ic literature pertaining 
to the study. 
 
I agree to take part in this study.   
 
I agree that the following tissue or other bodily material may be taken and used for the study:  
Tissue/Bodily Material Purpose Removal Method 
Blood For estrogen and progesterone 
concentration analysis 
Venepuncture 
Blood For creatine kinase analysis Capillary sample or 
venepuncture  
I understand that if the material is required for use in any other way than that explained to me, 
then my consent to this will be specifically sought. I understand that I will not receive specific  
feedback from any assessment conducted on my samples, but should any kind of abnormality 
be discovered then the investigator will contact me.  
 
I understand that the University may store this tissue in a Licensed Tissue Bank only for 
the duration of the study, it will then be destroyed. 
Method of disposal: Clinical waste  
Signature of participant.......................................................    Date.....……………….. 
(NAME IN BLOCK LETTERS)....................................................………………………. 
 
Signature of researcher.......................................................    Date.....……………….. 












The influence of sex and the oral contraceptive pill on markers of exercise 
induced muscle damage and the repeated bout effect, following maximum, 
single limb, knee extension exercise 
 
The questionnaire will take you approximately 20 minutes to complete. The 
questionnaire consists of tick boxes or one-sentence answers. If you would prefer not 
to answer certain questions, please leave them blank. You can take the questionnaire 
away with you to allow you to answer the questions in private. If you need any help 
answering the questions, please do not hesitate to contact the Principal Investigator. 
Please see contact details at the end of the questionnaire.  
Weight (Kg): _____________Kg  Height (m):   ___________ m 
Date of Birth (dd/mm/yy): __/__/__  Sex: Male / Female 
 
1. How would you best describe your ethnicity? 
 
White         Black or Black British - Caribbean 
Black or Black British – African  Asian or Asian British – Indian 
Asian or Asian British – Pakistani  Asian or Asian British – 
Bangladeshi 
Chinese  Other Asian Background 
Other Ethnic Background 
 




2. Does your job / lifestyle require lifting heavy objects on a regular 
occasion?  
For example: Do you lift heavy boxes on and off shelves daily?  
 
Yes           No 
 
3. Are you currently competing in University level sport?  
 
Yes        No 
 





4. Are you currently taking part in regular resistance training (weight 
training)?  
 
Yes        No 
If yes, how often do you complete the following resistance sessions?  
Please all that apply      frequency per week 
 
Upper body          _____ 
 
Lower body        _____  
 
Mixed upper and lower       _____ 
 
Plyometric (repeated jumps)     _____ 
 
 
5. Have you ever taken anabolic steroids? 
 
Yes         No 
 
6. Have you ever smoked? 
 
Yes        No 
 
If you answered no, please go to question 8. 
 
7. How often did you / do you smoke? 
Please tick one       no cigarettes/day 
 
Every day        _____ 
 
Every other day       _____  
 
Twice a week       _____ 
 
Once a week        _____ 
 
8. Do you drink alcohol? 
 
Yes    No    
 




For example: A small wine (175ml) = 2.3 units, a pint of larger = 2.3 units, a 
single (25ml) measure of spirits = 1 unit, alcopop (275ml) = 1.1 units 
 
   units in a week 
 
 
9. Do you suffer from any medical conditions? 
For example: Arthritis, Myositis, Fibromyalgia, Myopathy, Diabetes Mellitus, or 
Hypothyroidism 
 
Yes        No  
 





10. Are you currently taking any medication? 
 
Yes        No  
 
If yes, please elaborate: 
 
 
11. Are you currently taking any supplements or vitamins? 
For example: Protein supplements or vitamin e tablets? 
Yes        No  
 
If yes, please elaborate: 
 
 
12. Have you ever been diagnosed or suffered from problems with your 
tendons? 
For example: Tennis elbow, Tendinitis, Avulsion (torn tendon).  
 
Yes        No  
 
If yes, please describe information regarding the type of condition / injury, 









13. Are you currently suffering from any musculoskeletal or tendon injury? 
For example: Sore muscles, broken bones or sore tendons 
 
Yes        No  
 
 
If yes, please describe information regarding the type of injury, injury 





14. Have you ever severely controlled your diet to achieve a dramatic 
change in weight? 
 
Yes        No  
 
FEMALE PARTICIPANTS ONLY 
 
15. Do you have any children? 
 
Yes No  
  
If no, please go to question 17 
  
a. Please list the date/s you had your child/ children (dd/mm/yy): 







16. Have you breast fed in the last year? 
 
Yes No  
 
17. At what age did you start your period? 
 





18. On average how long does your menstrual cycle last (how many days 




19. On average how long does your period last? 
 




20. Have you had a regular period for the last six months (one period at 
least every month and no spotting in-between periods)?  
 
Yes No  
 
21. Have your periods stopped? 
 
Yes No  
 
If no, please go to question 22 
 





22. Have you ever had a hysterectomy?  
 
Yes No  
 




24. Have you ever taken the oral contraceptive pill? 
 
Yes  No 
 
If no, please go to question 25 
 
a. What type of pill did / do you take (name and dose of oestrogen and 
progesterone)? 
Dose values can be found on the medication box. If you are unsure, please 







b. When did you start taking the pill (mm/yy)?                      ____/___ 
c. If you have, when did you stop taking the pill (mm/yy)?   ____/___ 
 
25. Have you ever used any other form of hormone-based birth control 
(injection, vaginal ring, etc.)? 
 
Yes  No 
 
If no, please go to question 26 
 
a. What type of hormone-based birth control did / do you take (name and dose 
of oestrogen and progesterone)? 
Dose values can be found on the medication box. If you are unsure, please 




b. When did you start using the contraception (mm/yy)?                      ____/___ 
c. If you have, when did you stop using the contraception (mm/yy)?   ____/___ 
 
26. Have your ever used hormone replacement therapy? 
 
 
Yes  No 
 
 
Thank you for your time and honesty whilst completing the questionnaire. Be assured 
all questionnaires will remain strictly confidential.  
 
Contact details:  
 
Steven Marshall (Principal Investigator) 
s.j.marshall@northumbria.ac.uk  
 
